Hereditary neurological disease
MONDO:0100545A heterogeneous group of genetic conditions with Mendelian (autosomal dominant, recessive, or X-linked) or chromosomal etiology characterized by abnormalities in the brain, spinal cord, nerves, or muscles.
Also known as: neurogenetic disease
5772 clinical trials for this condition and its sub-types, 6 tagged with Hereditary neurological disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Hereditary neurological disease
-
Parkinson disease 1,165 trials · 1,292 incl. sub-types
6 sub-types
- Late-onset Parkinson disease 3 trials · 143 incl. sub-types Sub-types →
- Young-onset Parkinson disease 9 trials · 11 incl. sub-types Sub-types →
- Parkinson disease 16 0 trials
- Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development 0 trials
- Parkinson disease, mitochondrial 0 trials
- Parkinsonian-pyramidal syndrome 0 trials Sub-types →
-
Anxiety 1,030 trials
-
Hereditary neuromuscular disease 3 trials · 932 incl. sub-types
22 sub-types
- Hereditary peripheral neuropathy 6 trials · 478 incl. sub-types Sub-types →
- Muscular dystrophy 74 trials · 288 incl. sub-types Sub-types →
- Hereditary motor neuron disease 1 trial · 169 incl. sub-types Sub-types →
- Hereditary spastic paraplegia 27 trials · 33 incl. sub-types Sub-types →
- Benign paroxysmal positional vertigo 18 trials
- Meniere disease 16 trials Sub-types →
- RYR1-related myopathy 5 trials · 6 incl. sub-types Sub-types →
- Congenital myasthenic syndrome 5 trials Sub-types →
- Malignant hyperthermia of anesthesia 5 trials
- SCN4A-related channelopathy 1 trial · 2 incl. sub-types Sub-types →
- Early-onset myopathy with fatal cardiomyopathy 1 trial
- Andersen-Tawil syndrome 0 trials
- CNGB3-related retinopathy 0 trials Sub-types →
- KY-related neuromyopathy 0 trials Sub-types →
- Morimoto-Ryu-Malicdan neuromuscular syndrome 0 trials
- X-linked recessive mitochondrial myopathy 0 trials
- Myofibrillar myopathy 1 0 trials
- Myotonia congenita, autosomal dominant 0 trials
- Myotonia congenita, autosomal recessive 0 trials
- Neuromuscular disorder, congenital, with dysmorphic facies 0 trials
- Periodic paralysis with later-onset distal motor neuropathy 0 trials
- Vertigo, benign recurrent, 1 0 trials
-
Inherited neurodegenerative disorder 10 trials · 807 incl. sub-types
82 sub-types
- Frontotemporal dementia 132 trials · 178 incl. sub-types Sub-types →
- Hereditary motor neuron disease 1 trial · 169 incl. sub-types Sub-types →
- Hereditary cerebellar ataxia 0 trials · 116 incl. sub-types Sub-types →
- Huntington disease and related disorders 0 trials · 91 incl. sub-types Sub-types →
- Progressive supranuclear palsy 73 trials · 77 incl. sub-types Sub-types →
- Leukodystrophy 6 trials · 72 incl. sub-types Sub-types →
- Familial Alzheimer disease 13 trials · 55 incl. sub-types Sub-types →
- Hereditary spastic paraplegia 27 trials · 33 incl. sub-types Sub-types →
- Hereditary optic atrophy 6 trials · 23 incl. sub-types Sub-types →
- Neuronal ceroid lipofuscinosis 6 trials · 23 incl. sub-types Sub-types →
- GM2 gangliosidosis 14 trials · 19 incl. sub-types Sub-types →
- Kennedy disease 19 trials
- Corticobasal syndrome 19 trials
- Frontotemporal dementia with motor neuron disease 13 trials · 19 incl. sub-types Sub-types →
- Posterior cortical atrophy 11 trials
- Chediak-Higashi syndrome 9 trials
- Neurodegeneration with brain iron accumulation 1 trial · 8 incl. sub-types Sub-types →
- APP-related brain and vascular amyloidosis 0 trials · 5 incl. sub-types Sub-types →
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 0 trials · 5 incl. sub-types Sub-types →
- Inherited Creutzfeldt-Jakob disease 5 trials
- TUBB4A-related neurologic disorder 4 trials Sub-types →
- Fatal familial insomnia 4 trials
- Mitochondrial DNA depletion syndrome 4a 3 trials
- Alzheimer disease 17 1 trial
- Alzheimer disease 18 1 trial
- Ataxia-telangiectasia-like disorder 1 trial Sub-types →
- Developmental and epileptic encephalopathy, 35 1 trial
- Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures 1 trial
- Neurodegenerative syndrome due to cerebral folate transport deficiency 1 trial
- Neuronal intranuclear inclusion disease 1 trial
- Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome 1 trial
- DCTN1-related neurodegeneration 0 trials Sub-types →
- Huntington disease-like 1 0 trials
- Huntington disease-like 2 0 trials
- ITM2B amyloidosis 0 trials Sub-types →
- PEHO syndrome 0 trials
- PRKAR1B-related neurodegenerative dementia with intermediate filaments 0 trials
- X-linked neurodegenerative syndrome, Bertini type 0 trials
- X-linked neurodegenerative syndrome, Hamel type 0 trials
- Agenesis of the corpus callosum with peripheral neuropathy 0 trials
- Amyotrophic lateral sclerosis-parkinsonism-dementia complex 0 trials
- Angioid streaks of choroid 0 trials
- Attenuated Chédiak-Higashi syndrome 0 trials
- Autosomal recessive cerebral atrophy 0 trials
- Boylan dew greco syndrome 0 trials
- Cerebellar ataxia-hypogonadism syndrome 0 trials Sub-types →
- Cerebral sclerosis similar to Pelizaeus-Merzbacher disease 0 trials
- Combined oxidative phosphorylation deficiency 29 0 trials
- Deafness dystonia syndrome 0 trials
- Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome 0 trials
- Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities 0 trials
- Early-childhood-onset neurodegeneration with retinitis pigmentosa, sensorineural hearing loss, and demyelinating peripheral neuropathy 0 trials
- Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome 0 trials
- Encephalopathy due to beta-mercaptolactate-cysteine disulfiduria 0 trials
- Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy 0 trials Sub-types →
- Facial onset sensory and motor neuronopathy 0 trials
- Fatal post-viral neurodegenerative disorder 0 trials
- Ferro-cerebro-cutaneous syndrome 0 trials
- Hereditary sensory neuropathy-deafness-dementia syndrome 0 trials
- Hypotonia, infantile, with psychomotor retardation and characteristic facies 0 trials Sub-types →
- Infantile cerebellar-retinal degeneration 0 trials
- Infantile-onset axonal motor and sensory neuropathy-optic atrophy-neurodegenerative syndrome 0 trials
- Microphthalmia-brain atrophy syndrome 0 trials
- Myoclonic cerebellar dyssynergia 0 trials
- Neurodegeneration and seizures due to copper transport defect 0 trials
- Neurodegeneration with ataxia and late-onset optic atrophy 0 trials
- Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset 0 trials
- Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities 0 trials
- Neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline 0 trials
- Neurodegeneration, childhood-onset, with cerebellar ataxia and cognitive decline 0 trials
- Neurodegeneration, childhood-onset, with cerebellar atrophy 0 trials
- Neurodegeneration, childhood-onset, with hypotonia, respiratory insufficiency, and brain imaging abnormalities 0 trials
- Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction 0 trials
- Neurodegeneration, childhood-onset, with progressive microcephaly 0 trials
- Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia 0 trials
- Neurodegeneration, infantile-onset, biotin-responsive 0 trials
- Neurodegenerative disorder with cerebellar and caudate atrophy 0 trials
- Neurodegenerative disorder, X-linked, female-restricted, with parkinsonism and cognitive impairment 0 trials
- Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome 0 trials
- Radiation sensitivity/chromosome instability syndrome, autosomal dominant 0 trials
- Severe neurodegenerative syndrome with lipodystrophy 0 trials
- Striatonigral degeneration 0 trials Sub-types →
-
Inherited retinal dystrophy 41 trials · 510 incl. sub-types
105 sub-types
- Age-related macular degeneration 190 trials · 334 incl. sub-types Sub-types →
- Retinitis pigmentosa 84 trials · 89 incl. sub-types Sub-types →
- Hereditary macular dystrophy 3 trials · 70 incl. sub-types Sub-types →
- Cone-rod dystrophy 17 trials · 21 incl. sub-types Sub-types →
- Leber congenital amaurosis 10 trials · 12 incl. sub-types Sub-types →
- ABCA4-related retinopathy 7 trials · 11 incl. sub-types Sub-types →
- BEST1-related dominant retinopathy 1 trial · 7 incl. sub-types Sub-types →
- RHO-related retinopathy 0 trials · 7 incl. sub-types Sub-types →
- RPE65-related recessive retinopathy 5 trials · 7 incl. sub-types Sub-types →
- RPGR-related retinopathy 0 trials · 7 incl. sub-types Sub-types →
- Choroideremia 6 trials Sub-types →
- PRPF31-related retinopathy 1 trial · 4 incl. sub-types Sub-types →
- X-linked retinoschisis 4 trials
- Ornithine aminotransferase deficiency 4 trials
- ELOVL4-related maculopathy 0 trials · 3 incl. sub-types Sub-types →
- RLBP1-related retinopathy 2 trials · 3 incl. sub-types Sub-types →
- Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations 3 trials
- BEST1-related recessive retinopathy 0 trials · 2 incl. sub-types Sub-types →
- EYS-related retinopathy 1 trial · 2 incl. sub-types Sub-types →
- LCA5-related retinopathy 1 trial · 2 incl. sub-types Sub-types →
- PRPH2-related retinopathy 1 trial · 2 incl. sub-types Sub-types →
- Revesz syndrome 2 trials
- Late-onset retinal degeneration 2 trials
- AIPL1-related retinopathy 1 trial Sub-types →
- ATF6-related retinopathy 0 trials · 1 incl. sub-types Sub-types →
- CNGB1-related retinopathy 0 trials · 1 incl. sub-types Sub-types →
- FLVCR1-related retinopathy with or without ataxia 0 trials · 1 incl. sub-types Sub-types →
- GUCY2D retinopathy 0 trials · 1 incl. sub-types Sub-types →
- RDH5-related retinopathy 0 trials · 1 incl. sub-types Sub-types →
- Retinoschisis of fovea 1 trial
- ADAM9-related retinopathy 0 trials Sub-types →
- CACNA1F-related retinopathy 0 trials Sub-types →
- CACNA2D4-related retinopathy 0 trials Sub-types →
- CDHR1-related retinopathy 0 trials Sub-types →
- CERKL-related retinopathy 0 trials Sub-types →
- CNGA1-related retinopathy 0 trials Sub-types →
- CNGA3-related retinopathy 0 trials Sub-types →
- CRX-related retinopathy 0 trials Sub-types →
- GNAT2-related retinopathy 0 trials Sub-types →
- GPR179-related retinopathy 0 trials Sub-types →
- GRM6-related retinopathy 0 trials Sub-types →
- GUCA1A-related retinopathy 0 trials Sub-types →
- HGSNAT-related retinopathy 0 trials Sub-types →
- IDH3B-related retinopathy 0 trials Sub-types →
- IMPDH1-related retinopathy 0 trials Sub-types →
- IMPG1-related dominant retinopathy 0 trials Sub-types →
- IMPG1-related recessive retinopathy 0 trials Sub-types →
- IMPG2-related dominant retinopathy 0 trials Sub-types →
- IMPG2-related recessive retinopathy 0 trials Sub-types →
- KCNV2-related retinopathy 0 trials Sub-types →
- KIZ-related retinopathy 0 trials Sub-types →
- LRIT3-related retinopathy 0 trials Sub-types →
- MAK-related retinopathy 0 trials Sub-types →
- MERTK-related retinopathy 0 trials Sub-types →
- MRCS syndrome 0 trials
- NMNAT1-related retinopathy 0 trials Sub-types →
- NYX-related retinopathy 0 trials Sub-types →
- Oguchi disease 0 trials Sub-types →
- PCARE-related retinopathy 0 trials Sub-types →
- PDE6A-related retinopathy 0 trials Sub-types →
- PDE6C-related retinopathy 0 trials Sub-types →
- PDE6G-related retinopathy 0 trials Sub-types →
- PROM1-related retinopathy 0 trials Sub-types →
- PRPF8-related retinopathy 0 trials Sub-types →
- RAB28-related retinopathy 0 trials Sub-types →
- RD3-related retinopathy 0 trials Sub-types →
- RDH12-related dominant retinopathy 0 trials
- RDH12-related recessive retinopathy 0 trials Sub-types →
- REEP6-related retinopathy 0 trials Sub-types →
- RP1-related dominant retinopathy 0 trials
- RP1-related recessive retinopathy 0 trials
- RP2-related retinopathy 0 trials Sub-types →
- RPE65-related dominant retinopathy 0 trials Sub-types →
- SNRNP200-related dominant retinopathy 0 trials Sub-types →
- SPATA7-related retinopathy 0 trials Sub-types →
- Sorsby fundus dystrophy 0 trials Sub-types →
- TOPORS-related retinopathy 0 trials Sub-types →
- TRPM1-related retinopathy 0 trials Sub-types →
- TTLL5-related retinopathy 0 trials Sub-types →
- X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome 0 trials
- X-linked retinal dysplasia 0 trials
- Aceruloplasminemia 0 trials
- Amaurosis-hypertrichosis syndrome 0 trials
- Choroideremia-deafness-obesity syndrome 0 trials
- Dystrophies primarily involving the retinal pigment epithelium 0 trials
- Ectopia lentis-chorioretinal dystrophy-myopia syndrome 0 trials
- Familial benign flecked retina 0 trials
- Foveal hypoplasia-presenile cataract syndrome 0 trials
- Helicoid peripapillary chorioretinal degeneration 0 trials
- Infantile cerebellar-retinal degeneration 0 trials
- Macular degeneration, early-onset 0 trials
- Microcephaly and chorioretinopathy 1 0 trials
- Microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability 0 trials
- Microcornea-myopic chorioretinal atrophy 0 trials
- Oligocone trichromacy 0 trials
- Pigmented paravenous retinochoroidal atrophy 0 trials
- Progressive bifocal chorioretinal atrophy 0 trials
- Progressive retinal dystrophy due to retinol transport defect 0 trials
- Retinal degeneration-nanophthalmos-glaucoma syndrome 0 trials
- Retinal dystrophies primarily involving Bruch's membrane 0 trials Sub-types →
- Retinal dystrophy in systemic or cerebroretinal lipidoses 0 trials
- Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies 0 trials
- Retinal dystrophy, X-linked, Gardner-Hardcastle type 0 trials
- Retinoschisis, autosomal dominant 0 trials
- Vitreoretinal dystrophy 0 trials
-
Mendelian neurodevelopmental disorder 0 trials · 207 incl. sub-types
275 sub-types
- Genetic developmental and epileptic encephalopathy 2 trials · 83 incl. sub-types Sub-types →
- Prader-Willi syndrome 31 trials Sub-types →
- Rett syndrome 31 trials
- Intellectual disability, autosomal dominant 0 trials · 23 incl. sub-types Sub-types →
- X-linked intellectual disability 1 trial · 15 incl. sub-types Sub-types →
- CACNA1A-related complex neurodevelopmental disorder 1 trial · 9 incl. sub-types Sub-types →
- Autosomal recessive primary microcephaly 0 trials · 8 incl. sub-types Sub-types →
- Smith-Magenis syndrome 5 trials
- Rubinstein-Taybi syndrome 3 trials Sub-types →
- Alternating hemiplegia of childhood 3 trials Sub-types →
- FOXG1 disorder 2 trials
- GRIN-related complex neurodevelopmental disorder 2 trials Sub-types →
- Neurodevelopmental disorder with involuntary movements 2 trials
- CAMK2D-related neurodevelopmental disorder and dilated cardiomyopathy 1 trial
- Dyneinopathy 0 trials · 1 incl. sub-types Sub-types →
- Intellectual disability, autosomal recessive 0 trials · 1 incl. sub-types Sub-types →
- Microcephalic osteodysplastic primordial dwarfism type I 1 trial
- Microcephalic osteodysplastic primordial dwarfism type II 1 trial
- Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction 1 trial
- Neurodevelopmental disorder with or without variable brain abnormalities; NEDBA 1 trial
- Orofaciodigital syndrome I 1 trial
- AFG2B-related complex neurodevelopmental disorder with motor features and hearing loss 0 trials
- AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome 0 trials
- ARF3-related neurodevelopmental disorder 0 trials
- ATXN7L3-related developmental delay, hypotonia and facial dysmorphism 0 trials
- Alzahrani-Kuwahara syndrome 0 trials
- Amish lethal microcephaly 0 trials
- Au-Kline syndrome 0 trials
- Brunet-Wagner neurodevelopmental syndrome 0 trials
- CBX1-related neurodevelopmental disorder 0 trials
- CK syndrome 0 trials
- CNOT9-related developmental disorder with seizures 0 trials
- CTR9-related neurodevelopmental disorder 0 trials
- Chilton-Okur-Chung neurodevelopmental syndrome 0 trials
- DDX17-related neurodevelopmental disorder 0 trials
- DEAF1-associated neurodevelopmental disorder 0 trials Sub-types →
- DIP2C-related developmental disorder with speech delay 0 trials
- Delpire-McNeill syndrome 0 trials
- Dentici-Novelli neurodevelopmental syndrome 0 trials
- Dursun-Ozgul neurodevelopmental syndrome 0 trials
- Dworschak-Punetha neurodevelopmental syndrome 0 trials
- EPB41L3-related developmental disorder with delayed myelination and seizures 0 trials
- El Hayek-Chahrour neurodevelopmental disorder 0 trials
- FAT4-related neurodevelopmental disorder 0 trials
- FEZF2-related neurodevelopmental disorder 0 trials
- Ferguson-Bonni neurodevelopmental syndrome 0 trials
- GABRA4-related neurodevelopmental disorder with seizures 0 trials
- GABRD-related neurodevelopmental disorder with epilepsy 0 trials
- HDAC3-related neurodevelopmental disorder 0 trials
- HMGB1-related brachyphalangy, polydactyly and tibial aplasia syndrome 0 trials
- HNRNPC-related neurodevelopmental disorder 0 trials Sub-types →
- Hao-Fountain syndrome due to USP7 mutation 0 trials
- Harel-Tora neurodevelopmental syndrome 0 trials
- Harel-Yoon syndrome 0 trials
- Hiatt-Neu-Cooper neurodevelopmental syndrome 0 trials
- Houge-Janssens syndrome 3 0 trials
- Jeffries-Lakhani neurodevelopmental syndrome 0 trials
- KCND2-related neurodevelopmental disorder with or without seizures 0 trials
- KCNH1 associated disorder 0 trials Sub-types →
- KCNK3-related developmental delay with sleep apnea 0 trials
- KDM2B-related neurodevelopmental disorder 0 trials
- Karayol-Borroto-Haghshenas neurodevelopmental syndrome 0 trials
- Kariminejad neurodevelopmental syndrome 0 trials
- Li-Takada-Miyake syndrome 0 trials
- MYCBP2-related developmental delay with corpus callosum defects 0 trials
- MYH10-related neurodevelopmental disorder with congenital anomalies 0 trials
- Marbach-Schaaf neurodevelopmental syndrome 0 trials
- NACC1-related neurodevelopmental disorder with epilepsy, cataracts and episodic irritability 0 trials
- Nil-Deshwar neurodevelopmental syndrome 0 trials
- Okur-Chung neurodevelopmental syndrome 0 trials
- PAX5-related B lymphopenia and autism spectrum disorder 0 trials
- PIP5K1C-related neurodevelopmental disorder 0 trials
- PPFIA3-related neurodevelopmental disorder 0 trials
- PPP2R1A-related intellectual disability 0 trials
- PRPF19-related neurodevelopmental disorder 0 trials
- Pitt-Hopkins-like syndrome 2 0 trials
- Poirier-Bienvenu neurodevelopmental syndrome 0 trials
- Popov-Chang syndrome 0 trials
- RFX3-related neurodevelopmental disorder with autism and other behavioural abnormalities 0 trials
- RFX4-related neurodevelopmental disorder with autism and other behavioural abnormalities 0 trials
- RNU5B-1 related neurodevelopmental disorder with seizures and joint laxity 0 trials
- Ramond-Elliott neurodevelopmental syndrome 0 trials
- SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowth 0 trials Sub-types →
- SOX11-related complex neurodevelopmental disorder with or without congenital anomalies 0 trials
- SYNCRIP-related neurodevelopmental disorder 0 trials
- Stankiewicz-Isidor syndrome 0 trials
- TRA2B-related neurodevelopmental disorder 0 trials
- WDR5-related neurodevelopmental disorder 0 trials
- Wieacker-Wolff syndrome 0 trials
- X-linked complex neurodevelopmental disorder 0 trials Sub-types →
- Aplasia cutis-enamel dysplasia syndrome 0 trials
- Autosomal dominant primary microcephaly 0 trials Sub-types →
- Cerebellar atrophy, visual impairment, and psychomotor retardation; 0 trials
- Cerebral palsy, spastic quadriplegic, 2 0 trials
- Cerebral palsy, spastic quadriplegic, 3 0 trials
- Complex cortical dysplasia with other brain malformations 5 0 trials
- Developmental delay and seizures with or without movement abnormalities 0 trials
- Developmental delay with autism spectrum disorder and gait instability 0 trials
- Developmental delay with variable intellectual impairment and behavioral abnormalities 0 trials
- Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities 0 trials
- Intellectual developmental disorder and retinitis pigmentosa; IDDRP 0 trials
- Intellectual developmental disorder with polymicrogyria and seizures 0 trials
- Intellectual disability, autosomal dominant 29 0 trials
- Microcephalic osteodysplastic primordial dwarfism, type 3 0 trials
- Microcephaly and chorioretinopathy 0 trials Sub-types →
- Microcephaly with lissencephaly and/or hydranencephaly 0 trials Sub-types →
- Microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability 0 trials
- Microcephaly, progressive, with simplified gyral pattern and cerebellar hypoplasia 0 trials
- Neurocardiorenal malformation syndrome 0 trials
- Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity 0 trials
- Neurodevelopmental disorder plus optic atrophy 0 trials
- Neurodevelopmental disorder with absent language and variable seizures 0 trials
- Neurodevelopmental disorder with absent speech and movement and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with achalasia, polyneuropathy, and alacrima 0 trials
- Neurodevelopmental disorder with alopecia and brain abnormalities 0 trials
- Neurodevelopmental disorder with ataxia and brain abnormalities 0 trials
- Neurodevelopmental disorder with ataxia, hypotonia, and microcephaly 0 trials
- Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter 0 trials
- Neurodevelopmental disorder with behavioral abnormalities and childhood-onset spastic paraplegia 0 trials
- Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia 0 trials
- Neurodevelopmental disorder with behavioral, ear, and skeletal abnormalities 0 trials
- Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies 0 trials
- Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities 0 trials
- Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies 0 trials
- Neurodevelopmental disorder with central and peripheral motor dysfunction 0 trials
- Neurodevelopmental disorder with central hypotonia and dysmorphic facies 0 trials Sub-types →
- Neurodevelopmental disorder with cerebellar atrophy and with or without seizures 0 trials
- Neurodevelopmental disorder with cerebellar hypoplasia and spasticity 0 trials
- Neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism 0 trials
- Neurodevelopmental disorder with characteristic facial and ectodermal features and tetraparesis 1 0 trials
- Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities 0 trials
- Neurodevelopmental disorder with congenital cardiac defects and variable renal and ocular abnormalities 0 trials
- Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects 0 trials
- Neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasia 0 trials
- Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies 0 trials
- Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies 0 trials
- Neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia 0 trials
- Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities 0 trials
- Neurodevelopmental disorder with dysmorphic facies and thin corpus callosum 0 trials
- Neurodevelopmental disorder with dysmorphic facies and variable seizures 0 trials
- Neurodevelopmental disorder with dysmorphic facies, absent speech and ambulation, and brain abnormalities 0 trials
- Neurodevelopmental disorder with dysmorphic facies, brain anomalies, and seizures 0 trials
- Neurodevelopmental disorder with dysmorphic facies, impaired speech, and hypotonia 0 trials
- Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities 0 trials
- Neurodevelopmental disorder with dystonia and seizures 0 trials
- Neurodevelopmental disorder with early-onset parkinsonism and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with early-onset seizures, facial dysmorphism, and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with epilepsy and brain atrophy 0 trials
- Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum 0 trials
- Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination 0 trials
- Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy 0 trials
- Neurodevelopmental disorder with eye movement abnormalities and ataxia 0 trials
- Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-pelger-huet anomaly 0 trials
- Neurodevelopmental disorder with gait disturbance, dysmorphic facies, and behavioral abnormalities, X-linked 0 trials
- Neurodevelopmental disorder with growth impairment, quadriparesis, and poor or absent speech 0 trials
- Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities 0 trials
- Neurodevelopmental disorder with hearing loss and spasticity 0 trials
- Neurodevelopmental disorder with hyperkinetic movements and dyskinesia 0 trials
- Neurodevelopmental disorder with hyperkinetic movements, seizures, and structural brain abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements 0 trials
- Neurodevelopmental disorder with hypotonia and brain abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures 0 trials
- Neurodevelopmental disorder with hypotonia and characteristic brain abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia and dysmorphic facies 0 trials
- Neurodevelopmental disorder with hypotonia and gross motor and speech delay 0 trials
- Neurodevelopmental disorder with hypotonia and seizures 0 trials
- Neurodevelopmental disorder with hypotonia and speech delay, with or without seizures 0 trials
- Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia, brain anomalies, distinctive facies, and absent language 0 trials
- Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures 0 trials
- Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia, epilepsy, and absent speech 0 trials
- Neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia, feeding difficulties, facial dysmorphism, and brain abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures 0 trials
- Neurodevelopmental disorder with hypotonia, microcephaly, and seizures 0 trials
- Neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency, and thermodysregulation 0 trials
- Neurodevelopmental disorder with hypotonia, neuropathy, and deafness 0 trials
- Neurodevelopmental disorder with hypotonia, poor growth, dysmorphic facies, and agammaglobulinemia 0 trials
- Neurodevelopmental disorder with hypotonia, seizures, and absent language 0 trials
- Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia 0 trials
- Neurodevelopmental disorder with impaired language and ataxia and with or without seizures 0 trials
- Neurodevelopmental disorder with impaired language, behavioral abnormalities, and dysmorphic facies 0 trials
- Neurodevelopmental disorder with impaired speech and hyperkinetic movements 0 trials
- Neurodevelopmental disorder with infantile epileptic spasms 0 trials
- Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies 0 trials
- Neurodevelopmental disorder with intracranial hemorrhage, seizures, and spasticity 0 trials
- Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures 0 trials
- Neurodevelopmental disorder with language delay and seizures 0 trials
- Neurodevelopmental disorder with language delay and variable cognitive abnormalities 0 trials
- Neurodevelopmental disorder with language impairment and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with language impairment, autism, and attention deficit-hyperactivity disorder 0 trials
- Neurodevelopmental disorder with microcephaly and dysmorphic facies 0 trials
- Neurodevelopmental disorder with microcephaly and movement abnormalities 0 trials
- Neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities 0 trials
- Neurodevelopmental disorder with microcephaly and structural brain anomalies 0 trials
- Neurodevelopmental disorder with microcephaly, absent speech, and hypotonia 0 trials
- Neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies 0 trials
- Neurodevelopmental disorder with microcephaly, ataxia, and seizures 0 trials
- Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities 0 trials
- Neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment 0 trials
- Neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity 0 trials
- Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy 0 trials
- Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination 0 trials
- Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies 0 trials
- Neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures 0 trials
- Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities 0 trials
- Neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities 0 trials
- Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures 0 trials
- Neurodevelopmental disorder with microcephaly, seizures, and brain atrophy 0 trials
- Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy 0 trials
- Neurodevelopmental disorder with microcephaly, seizures, and neonatal cholestasis 0 trials
- Neurodevelopmental disorder with microcephaly, short stature, and speech delay 0 trials
- Neurodevelopmental disorder with midbrain and hindbrain malformations 0 trials
- Neurodevelopmental disorder with motor abnormalities, seizures, and facial dysmorphism 0 trials
- Neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities 0 trials
- Neurodevelopmental disorder with motor and speech delay and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with motor regression, progressive spastic paraplegia, and oromotor dysfunction 0 trials
- Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features 0 trials
- Neurodevelopmental disorder with neuromuscular and skeletal abnormalities 0 trials
- Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures 0 trials
- Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart 0 trials
- Neurodevelopmental disorder with or without autism or seizures 0 trials
- Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities 0 trials
- Neurodevelopmental disorder with or without early-onset generalized epilepsy 0 trials
- Neurodevelopmental disorder with or without seizures and gait abnormalities 0 trials
- Neurodevelopmental disorder with or without variable movement or behavioral abnormalities 0 trials
- Neurodevelopmental disorder with poor growth and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with poor growth and skeletal anomalies 0 trials
- Neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies 0 trials
- Neurodevelopmental disorder with poor growth, seizures, and brain abnormalities 0 trials
- Neurodevelopmental disorder with poor language and loss of hand skills 0 trials
- Neurodevelopmental disorder with poor or absent speech, dysmorphic facies, and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies 0 trials
- Neurodevelopmental disorder with progressive movement abnormalities 0 trials
- Neurodevelopmental disorder with progressive spasticity and brain abnormalities 0 trials
- Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities 0 trials
- Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures 0 trials
- Neurodevelopmental disorder with relative macrocephaly and with or without cardiac or endocrine anomalies 0 trials
- Neurodevelopmental disorder with seizures and brain atrophy 0 trials
- Neurodevelopmental disorder with seizures and gingival overgrowth 0 trials
- Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements 0 trials
- Neurodevelopmental disorder with seizures and speech and walking impairment 0 trials
- Neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities 0 trials
- Neurodevelopmental disorder with seizures, hypotonia, and variable spasticity 0 trials
- Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities 0 trials
- Neurodevelopmental disorder with seizures, spasticity, and complete or partial agenesis of the corpus callosum 0 trials
- Neurodevelopmental disorder with severe motor impairment and absent language 0 trials
- Neurodevelopmental disorder with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy 0 trials
- Neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties 0 trials
- Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures 0 trials
- Neurodevelopmental disorder with spastic quadriplegia, optic atrophy, seizures, and structural brain anomalies 0 trials
- Neurodevelopmental disorder with spasticity and poor growth 0 trials
- Neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia 0 trials
- Neurodevelopmental disorder with spasticity, seizures, and brain abnormalities 0 trials
- Neurodevelopmental disorder with spasticity, thin corpus callosum, and decreased brain white matter 0 trials
- Neurodevelopmental disorder with speech delay and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with speech delay and variable ocular anomalies 0 trials
- Neurodevelopmental disorder with speech delay, movement abnormalities, and seizures 0 trials
- Neurodevelopmental disorder with speech impairment and dysmorphic facies 0 trials
- Neurodevelopmental disorder with speech impairment and with or without seizures 0 trials
- Neurodevelopmental disorder with speech or visual impairment and brain hypomyelination 0 trials
- Neurodevelopmental disorder with structural brain abnormalities and craniofacial abnormalities 0 trials
- Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies 0 trials
- Neurodevelopmental disorder with thin corpus callosum, hypotonia, and absent language 0 trials
- Neurodevelopmental disorder with variable familial hypercholanemia 0 trials
- Neurodevelopmental disorder with visual defects and brain anomalies 0 trials
- Neurodevelopmental disorder with white matter abnormalities and gait disturbance 0 trials
- Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures 0 trials
- Neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus 0 trials
- Otofacial neurodevelopmental syndrome 0 trials
- Parenti-mignot neurodevelopmental syndrome 0 trials
- Squalene synthase deficiency 0 trials
-
Obsessive-compulsive disorder 196 trials
-
Hereditary ataxia 2 trials · 119 incl. sub-types
20 sub-types
- Hereditary cerebellar ataxia 0 trials · 116 incl. sub-types Sub-types →
- Spastic ataxia 1 trial · 2 incl. sub-types Sub-types →
- EAST syndrome 1 trial
- Hereditary episodic ataxia 0 trials · 1 incl. sub-types Sub-types →
- Hereditary spastic paraplegia 7 1 trial
- Richards-Rundle syndrome 0 trials
- Ataxia with fasciculations 0 trials
- Ataxia-hypogonadism-choroidal dystrophy syndrome 0 trials
- Ataxia-tapetoretinal degeneration syndrome 0 trials
- Autosomal dominant sensory ataxia 1 0 trials
- Autosomal recessive ataxia due to PEX16 deficiency 0 trials
- Autosomal recessive ataxia due to PEX2 deficiency 0 trials
- Cataract-ataxia-deafness syndrome 0 trials
- Ichthyosis-hepatosplenomegaly-cerebellar degeneration syndrome 0 trials
- Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome 0 trials
- Muscular atrophy-ataxia-retinitis pigmentosa-diabetes mellitus syndrome 0 trials
- Myoclonus-cerebellar ataxia-deafness syndrome 0 trials
- Severe microbrachycephaly-intellectual disability-athetoid cerebral palsy syndrome 0 trials
- Spinocerebellar ataxia-dysmorphism syndrome 0 trials
- Tremor-ataxia-central hypomyelination syndrome 0 trials
-
Essential tremor 102 trials · 104 incl. sub-types
6 sub-types
- Tremor, hereditary essential, 1 2 trials
- Tremor, hereditary essential, 2 0 trials
- Tremor, hereditary essential, 3 0 trials
- Tremor, hereditary essential, 4 0 trials
- Tremor, hereditary essential, 5 0 trials
- Tremor, hereditary essential, 6 0 trials
-
Neurofibromatosis 19 trials · 94 incl. sub-types
5 sub-types
- Neurofibromatosis type 1 73 trials Sub-types →
- NF2-related schwannomatosis 21 trials
- Schwannomatosis 3 trials Sub-types →
- Neurofibromatosis-Noonan syndrome 2 trials Sub-types →
- Neurofibromatosis, type IV, of Riccardi 0 trials
-
Inherited orthostatic hypotension 0 trials · 71 incl. sub-types
3 sub-types
- Postural orthostatic tachycardia syndrome 71 trials
- Orthostatic hypotension 1 0 trials
- Orthostatic hypotension 2 0 trials
-
Nonsyndromic genetic hearing loss 4 trials · 67 incl. sub-types
6 sub-types
- Prelingual non-syndromic genetic hearing loss 5 trials · 37 incl. sub-types Sub-types →
- X-linked nonsyndromic hearing loss 0 trials · 32 incl. sub-types Sub-types →
- Hearing loss, autosomal recessive 1 trial · 17 incl. sub-types Sub-types →
- Postlingual non-syndromic genetic hearing loss 6 trials · 10 incl. sub-types Sub-types →
- Autosomal dominant nonsyndromic hearing loss 1 trial · 2 incl. sub-types Sub-types →
- Nonsyndromic deafness, Y-linked 0 trials Sub-types →
-
Inherited vitreoretinopathy 0 trials · 58 incl. sub-types
5 sub-types
- Vitreoretinal degeneration 0 trials · 45 incl. sub-types Sub-types →
- Congenital vitreoretinal dysplasia 0 trials · 9 incl. sub-types Sub-types →
- Vitreous detachment 5 trials
- NDP-related vitreoretinopathy 0 trials Sub-types →
- TSPAN12-related vitreoretinopathy 0 trials Sub-types →
-
Paraganglioma 53 trials · 57 incl. sub-types
12 sub-types
- Sympathetic paraganglioma 0 trials · 16 incl. sub-types Sub-types →
- Head and neck paraganglioma 1 trial Sub-types →
- Non-secreting paraganglioma 0 trials Sub-types →
- Parasympathetic paraganglioma 0 trials Sub-types →
- Pheochromocytoma/paraganglioma syndrome 1 0 trials
- Pheochromocytoma/paraganglioma syndrome 2 0 trials
- Pheochromocytoma/paraganglioma syndrome 3 0 trials
- Pheochromocytoma/paraganglioma syndrome 4 0 trials
- Pheochromocytoma/paraganglioma syndrome 5 0 trials
- Pheochromocytoma/paraganglioma syndrome 6 0 trials
- Pheochromocytoma/paraganglioma syndrome 7 0 trials
- Sporadic pheochromocytoma/secreting paraganglioma 0 trials Sub-types →
-
Retinal detachment 28 trials · 52 incl. sub-types
2 sub-types
- Rhegmatogenous retinal detachment 23 trials Sub-types →
- Retinal perforation 18 trials
-
Tuberous sclerosis 41 trials · 44 incl. sub-types
2 sub-types
- Tuberous sclerosis 1 33 trials
- Tuberous sclerosis 2 2 trials
-
Endogenous depression 42 trials
-
Specific phobia 22 trials · 42 incl. sub-types
3 sub-types
- Nosophobia 2 trials · 16 incl. sub-types Sub-types →
- Animal phobia 5 trials
- Flying phobia 1 trial
-
Combined pituitary hormone deficiencies, genetic form 1 trial · 42 incl. sub-types
9 sub-types
- Isolated congenital growth hormone deficiency 38 trials Sub-types →
- Panhypopituitarism 2 trials Sub-types →
- Congenital isolated adrenocorticotropic hormone deficiency 1 trial
- Pituitary hormone deficiency, combined, 1 1 trial
- Septooptic dysplasia 1 trial Sub-types →
- Non-acquired combined pituitary hormone deficiency with spine abnormalities 0 trials
- Pituitary hormone deficiency, combined or isolated, 8 0 trials
- Pituitary hormone deficiency, combined, 6 0 trials
- Short stature-pituitary and cerebellar defects-small sella turcica syndrome 0 trials
-
Tourette syndrome 41 trials
-
Familial partial epilepsy 0 trials · 39 incl. sub-types
7 sub-types
- Temporal lobe epilepsy 31 trials Sub-types →
- Mesial temporal lobe epilepsy with hippocampal sclerosis 10 trials
- Self-limited epilepsy with centrotemporal spikes 3 trials Sub-types →
- Generalized epilepsy-paroxysmal dyskinesia syndrome 1 trial
- Autosomal dominant epilepsy with auditory features 0 trials
- Familial focal epilepsy with variable foci 0 trials Sub-types →
- Familial sleep-related hypermotor epilepsy 0 trials Sub-types →
-
Cerebral lipidosis with dementia 0 trials · 38 incl. sub-types
8 sub-types
- Sandhoff disease 13 trials Sub-types →
- Tay-Sachs disease 13 trials Sub-types →
- Gaucher disease type I 12 trials
- Cerebrotendinous xanthomatosis 6 trials
- Juvenile neuronal ceroid lipofuscinosis 6 trials Sub-types →
- Adult Krabbe disease 0 trials
- Adult neuronal ceroid lipofuscinosis 0 trials Sub-types →
- Infantile neuronal ceroid lipofuscinosis 0 trials Sub-types →
-
Inherited dystonia 0 trials · 36 incl. sub-types
24 sub-types
- Combined dystonia 1 trial · 12 incl. sub-types Sub-types →
- Isolated dystonia 4 trials · 11 incl. sub-types Sub-types →
- Lymphatic malformation 5 8 trials
- Dystonia, focal, task-specific 4 trials
- Dopa-responsive dystonia due to sepiapterin reductase deficiency 1 trial
- Dystonia 28, childhood-onset 1 trial
- Torsion dystonia 7 1 trial
- Woodhouse-Sakati syndrome 0 trials
- Ataxia - oculomotor apraxia type 4 0 trials
- Autosomal dominant dopa-responsive dystonia 0 trials Sub-types →
- Developmental malformations-deafness-dystonia syndrome 0 trials
- Dystonia 22, adult-onset 0 trials
- Dystonia 22, juvenile-onset 0 trials
- Dystonia 30 0 trials
- Dystonia 31 0 trials
- Dystonia 32 0 trials
- Dystonia 33 0 trials
- Dystonia 34, myoclonic 0 trials
- Dystonia 35, childhood-onset 0 trials
- Dystonia 37, early-onset, with striatal lesions 0 trials
- Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities 0 trials
- Familial idiopathic torsion dystonia 0 trials
- Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome 0 trials
- Striatonigral degeneration, childhood-onset 0 trials
-
Normal pressure hydrocephalus 35 trials
-
Mismatch repair cancer syndrome 1 34 trials
-
Hereditary generalized epilepsy 0 trials · 33 incl. sub-types
2 sub-types
- Idiopathic generalized epilepsy 11 trials · 29 incl. sub-types Sub-types →
- Generalized epilepsy with febrile seizures plus 0 trials · 4 incl. sub-types Sub-types →
-
X-linked deafness 0 trials · 32 incl. sub-types
2 sub-types
- X-linked nonsyndromic hearing loss 0 trials · 32 incl. sub-types Sub-types →
- X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome 0 trials
-
Familial isolated pituitary adenoma 1 trial · 31 incl. sub-types
6 sub-types
- Cushing disease due to pituitary adenoma 23 trials
- Prolactin-producing pituitary gland adenoma 11 trials
- Growth hormone secreting pituitary adenoma 1 1 trial
- Pituitary adenoma 3, multiple types 0 trials
- Pituitary adenoma 5, multiple types 0 trials
- Pituitary adenoma, growth hormone-secreting, 2 0 trials
-
Von Hippel-Lindau disease 27 trials
-
Specific language impairment 26 trials
5 sub-types
- Specific language impairment 1 0 trials
- Specific language impairment 2 0 trials
- Specific language impairment 3 0 trials
- Specific language impairment 4 0 trials
- Specific language impairment 5 0 trials
-
Stutter disorder 22 trials
4 sub-types
- Stuttering, familial persistent, 1 0 trials
- Stuttering, familial persistent, 2 0 trials
- Stuttering, familial persistent, 3 0 trials
- Stuttering, familial persistent, 4 0 trials
-
Moyamoya disease 20 trials
8 sub-types
- Moyamoya disease 2 0 trials
- Moyamoya disease 5 0 trials
- Moyamoya disease 8 0 trials
- Moyamoya disease with early-onset achalasia 0 trials
- Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome 0 trials
- Moyamoya disease 1 0 trials
- Moyamoya disease 3 0 trials
- Moyamoya disease 7 0 trials
-
Angelman syndrome 19 trials
-
Cerebral amyloid angiopathy 16 trials · 17 incl. sub-types
4 sub-types
- ACys amyloidosis 1 trial
- Cerebral amyloid angiopathy, APP-related 0 trials · 1 incl. sub-types Sub-types →
- ABri amyloidosis 0 trials
- ADan amyloidosis 0 trials
-
Li-Fraumeni syndrome 16 trials
-
Childhood apraxia of speech 16 trials
-
Intracranial berry aneurysm 12 trials
12 sub-types
- Aneurysm, intracranial berry type 1 0 trials
- Aneurysm, intracranial berry, 10 0 trials
- Aneurysm, intracranial berry, 11 0 trials
- Aneurysm, intracranial berry, 12 0 trials
- Aneurysm, intracranial berry, 2 0 trials
- Aneurysm, intracranial berry, 3 0 trials
- Aneurysm, intracranial berry, 4 0 trials
- Aneurysm, intracranial berry, 5 0 trials
- Aneurysm, intracranial berry, 6 0 trials
- Aneurysm, intracranial berry, 7 0 trials
- Aneurysm, intracranial berry, 8 0 trials
- Aneurysm, intracranial berry, 9 0 trials
-
Progressive myoclonus epilepsy 5 trials · 12 incl. sub-types
15 sub-types
- MERRF syndrome 5 trials
- Lafora disease 1 trial Sub-types →
- Unverricht-Lundborg syndrome 1 trial
- Neuronal ceroid lipofuscinosis 8 northern epilepsy variant 1 trial
- Action myoclonus-renal failure syndrome 0 trials
- Early-onset Lafora body disease 0 trials
- Epilepsy, progressive myoclonic, 11 0 trials
- Epilepsy, progressive myoclonic, 12 0 trials
- Epilepsy, progressive myoclonic, 1B 0 trials
- Familial encephalopathy with neuroserpin inclusion bodies 0 trials
- Progressive myoclonic epilepsy type 3 0 trials
- Progressive myoclonic epilepsy type 6 0 trials
- Progressive myoclonic epilepsy type 7 0 trials
- Progressive myoclonic epilepsy type 8 0 trials
- Progressive myoclonic epilepsy type 9 0 trials
-
DiGeorge syndrome 11 trials
-
Major affective disorder 6 11 trials
-
Auditory neuropathy 7 trials · 11 incl. sub-types
5 sub-types
-
Spastic quadriplegic cerebral palsy 10 trials
-
Chiari malformation type I 9 trials
-
Neurohypophyseal diabetes insipidus 9 trials
-
Sturge-Weber syndrome 8 trials
-
Progressive external ophthalmoplegia 4 trials · 8 incl. sub-types
3 sub-types
- Kearns-Sayre syndrome 5 trials
- Progressive external ophthalmoplegia with mitochondrial DNA deletions 0 trials · 2 incl. sub-types Sub-types →
- Autosomal recessive progressive external ophthalmoplegia 0 trials Sub-types →
-
Qualitative or quantitative defects of protein involved in O-glycosylation of alpha-dystroglycan 0 trials · 8 incl. sub-types
9 sub-types
- Qualitative or quantitative defects of FKRP 0 trials · 8 incl. sub-types Sub-types →
- Myopathy caused by variation in FKTN 1 trial · 2 incl. sub-types Sub-types →
- Myopathy caused by variation in CRPPA 0 trials · 1 incl. sub-types Sub-types →
- Myopathy caused by variation in GMPPB 0 trials · 1 incl. sub-types Sub-types →
- Myopathy caused by variation in POMT1 0 trials · 1 incl. sub-types Sub-types →
- Myopathy caused by variation in POMT2 0 trials · 1 incl. sub-types Sub-types →
- Qualitative or quantitative defects of protein O-mannosyltransferase 1 0 trials · 1 incl. sub-types Sub-types →
- Qualitative or quantitative defects of protein O-mannosyltransferase 2 0 trials · 1 incl. sub-types Sub-types →
- Limb-girdle muscular dystrophy due to POMK deficiency 0 trials
-
Red-green color blindness 7 trials
-
Duane retraction syndrome 6 trials
4 sub-types
- Duane retraction syndrome 2 0 trials
- Duane retraction syndrome 3 with or without deafness 0 trials
- Duane retraction syndrome with congenital deafness 0 trials
- Duane syndrome type 1 0 trials
-
Arthrogryposis 4 trials · 6 incl. sub-types
5 sub-types
- Freeman-Sheldon syndrome 1 trial Sub-types →
- Congenital contractural arachnodactyly 1 trial
- Boylan dew greco syndrome 0 trials
- Distal arthrogryposis Moore weaver type 0 trials
- Massa casaer ceulemans syndrome 0 trials
-
Undetermined early-onset epileptic encephalopathy 1 trial · 6 incl. sub-types
16 sub-types
- Developmental and epileptic encephalopathy, 13 3 trials
- Developmental and epileptic encephalopathy, 25 1 trial
- Developmental and epileptic encephalopathy, 42 1 trial
- Developmental and epileptic encephalopathy, 21 0 trials
- Developmental and epileptic encephalopathy, 24 0 trials
- Developmental and epileptic encephalopathy, 26 0 trials
- Developmental and epileptic encephalopathy, 28 0 trials
- Developmental and epileptic encephalopathy, 29 0 trials
- Developmental and epileptic encephalopathy, 31A 0 trials
- Developmental and epileptic encephalopathy, 32 0 trials
- Developmental and epileptic encephalopathy, 33 0 trials
- Developmental and epileptic encephalopathy, 41 0 trials
- Developmental and epileptic encephalopathy, 44 0 trials
- Developmental and epileptic encephalopathy, 45 0 trials
- Developmental and epileptic encephalopathy, 46 0 trials
- Developmental and epileptic encephalopathy, 47 0 trials
-
Inborn aminoacylase deficiency 0 trials · 6 incl. sub-types
2 sub-types
- Canavan disease 6 trials Sub-types →
- Aminoacylase 1 deficiency 0 trials
-
Narcolepsy 1 5 trials
-
Nevoid basal cell carcinoma syndrome 5 trials
2 sub-types
- Basal cell nevus syndrome 1 0 trials
- Basal cell nevus syndrome 2 0 trials
-
GLUT1 deficiency syndrome 4 trials · 5 incl. sub-types
2 sub-types
-
Congenital nystagmus 4 trials · 5 incl. sub-types
10 sub-types
- Spinocerebellar ataxia 27A 1 trial
- Nystagmus 1, congenital, X-linked 0 trials
- Nystagmus 2, congenital, autosomal dominant 0 trials
- Nystagmus 3, congenital, autosomal dominant 0 trials
- Nystagmus 5, congenital, X-linked 0 trials
- Nystagmus 6, congenital, X-linked 0 trials
- Nystagmus 7, congenital, autosomal dominant 0 trials
- Nystagmus, congenital, autosomal recessive 0 trials
- Nystagmus, hereditary vertical 0 trials
- Nystagmus, myoclonic 0 trials
-
Congenital stationary night blindness 2 trials · 5 incl. sub-types
14 sub-types
- Congenital stationary night blindness autosomal dominant 1 3 trials
- Congenital stationary night blindness autosomal dominant 2 1 trial
- Oguchi disease 0 trials Sub-types →
- X-linked congenital stationary night blindness 0 trials Sub-types →
- Cone-rod synaptic disorder, congenital nonprogressive 0 trials
- Congenital stationary night blindness 1B 0 trials
- Congenital stationary night blindness 1C 0 trials
- Congenital stationary night blindness 1D 0 trials
- Congenital stationary night blindness 1E 0 trials
- Congenital stationary night blindness 1F 0 trials
- Congenital stationary night blindness 1G 0 trials
- Congenital stationary night blindness 1H 0 trials
- Congenital stationary night blindness autosomal dominant 3 0 trials
- Night blindness, congenital stationary, type1i 0 trials
-
Qualitative or quantitative defects of beta-sarcoglycan 0 trials · 5 incl. sub-types
1 sub-type
-
Corpus callosum, agenesis of 4 trials
2 sub-types
- Kozlowski Ouvrier syndrome 0 trials
- Calloso-genital dysplasia 0 trials
-
Velocardiofacial syndrome 4 trials
-
TTN-related myopathy 2 trials · 4 incl. sub-types
2 sub-types
- Autosomal recessive titinopathy 0 trials · 2 incl. sub-types Sub-types →
- Autosomal dominant titinopathy 0 trials Sub-types →
-
Qualitative or quantitative defects of gamma-sarcoglycan 1 trial · 4 incl. sub-types
1 sub-type
-
Hoyeraal-Hreidarsson syndrome 3 trials
-
Riley-Day syndrome 3 trials
-
Bilirubin encephalopathy 3 trials
1 sub-type
- Kernicterus due to isoimmunization 0 trials
-
Familial congenital mirror movements 3 trials
4 sub-types
- Mirror movements 1 and/or agenesis of the corpus callosum 0 trials Sub-types →
- Mirror movements 2 0 trials
- Mirror movements 3 0 trials
- Mirror movements 4 0 trials
-
Pyridoxine-dependent epilepsy 3 trials
2 sub-types
-
Encephalopathy, acute, infection-induced 2 trials · 3 incl. sub-types
1 sub-type
-
TPM2-related myopathy 1 trial · 3 incl. sub-types
2 sub-types
- Central core myopathy 2 trials
- Congenital myopathy 23 0 trials
-
Congenital hydrocephalus 1 trial · 3 incl. sub-types
8 sub-types
- X-linked hydrocephalus with stenosis of the aqueduct of Sylvius 1 trial
- Hydrocephalus, nonsyndromic, autosomal recessive 1 1 trial
- Autosomal recessive hydrocephalus due to congenital stenosis of aqueduct of Sylvius 0 trials
- Congenital communicating hydrocephalus 0 trials
- Congenital non-communicating hydrocephalus 0 trials
- Hydrocephalus, congenital, 3, with brain anomalies 0 trials
- Hydrocephalus, nonsyndromic, autosomal recessive 2 0 trials
- Hydrocephalus-blue sclerae-nephropathy syndrome 0 trials
-
Pontocerebellar hypoplasia 1 trial · 3 incl. sub-types
21 sub-types
- Pontocerebellar hypoplasia type 6 2 trials
- Pontocerebellar hypoplasia type 1 0 trials Sub-types →
- Pontocerebellar hypoplasia type 10 0 trials
- Pontocerebellar hypoplasia type 2 0 trials Sub-types →
- Pontocerebellar hypoplasia type 2E 0 trials
- Pontocerebellar hypoplasia type 3 0 trials
- Pontocerebellar hypoplasia type 4 0 trials
- Pontocerebellar hypoplasia type 5 0 trials
- Pontocerebellar hypoplasia type 7 0 trials
- Pontocerebellar hypoplasia type 8 0 trials
- Pontocerebellar hypoplasia type 9 0 trials
- Pontocerebellar hypoplasia, IIA 17 0 trials
- Pontocerebellar hypoplasia, type 11 0 trials
- Pontocerebellar hypoplasia, type 12 0 trials
- Pontocerebellar hypoplasia, type 13 0 trials
- Pontocerebellar hypoplasia, type 14 0 trials
- Pontocerebellar hypoplasia, type 15 0 trials
- Pontocerebellar hypoplasia, type 16 0 trials
- Pontocerebellar hypoplasia, type 1D 0 trials
- Pontocerebellar hypoplasia, type 1E 0 trials
- Pontocerebellar hypoplasia, type 1F 0 trials
-
Familial porencephaly 0 trials · 3 incl. sub-types
7 sub-types
- Brain small vessel disease 1 with or without ocular anomalies 3 trials
- Brain small vessel disease 2A, autosomal dominant 1 trial
- Brain small vessel disease 2B, autosomal recessive 0 trials
- Brain small vessel disease 3 0 trials
- Brain small vessel disease 4 0 trials
- Brain small vessel disease 5 with osteoporosis 0 trials
- Brain small vessel disease 6 with leukoencephalopathy 0 trials
-
Inherited reflex epilepsy 0 trials · 3 incl. sub-types
2 sub-types
- Photosensitive epilepsy 1 trial · 2 incl. sub-types Sub-types →
- Hot water reflex epilepsy 1 trial Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin 0 trials · 3 incl. sub-types
4 sub-types
-
Qualitative or quantitative defects of alpha-sarcoglycan 0 trials · 3 incl. sub-types
1 sub-type
-
Chiari malformation type II 2 trials
-
Central nervous system lupus 2 trials
-
Choroid plexus papilloma 2 trials
-
Hereditary retinoblastoma 2 trials
-
1 sub-type
-
Childhood-onset nemaline myopathy 1 trial · 2 incl. sub-types
6 sub-types
- Nemaline myopathy 6 1 trial
- Congenital myopathy 23 0 trials
- Congenital myopathy 2a, typical, autosomal dominant 0 trials
- Congenital myopathy 4B, autosomal recessive 0 trials
- Nemaline myopathy 2 0 trials
- Nemaline myopathy 9 0 trials
-
ATP1A3-associated neurological disorder 0 trials · 2 incl. sub-types
4 sub-types
-
PAX6-related ocular dysgenesis 0 trials · 2 incl. sub-types
2 sub-types
- Isolated optic nerve hypoplasia 2 trials
- Foveal hypoplasia 1 0 trials
-
SPAST-related motor disorder 0 trials · 2 incl. sub-types
1 sub-type
- Hereditary spastic paraplegia 4 2 trials
-
Leukoencephalopathy, megalencephalic 0 trials · 2 incl. sub-types
-
Qualitative or quantitative defects of delta-sarcoglycan 0 trials · 2 incl. sub-types
2 sub-types
-
Retinal ciliopathy 0 trials · 2 incl. sub-types
9 sub-types
- Leber congenital amaurosis 10 2 trials
- Leber congenital amaurosis with early-onset deafness 0 trials
- Cone-rod dystrophy 16 0 trials
- Retinitis pigmentosa 23 0 trials
- Retinitis pigmentosa 51 0 trials
- Retinitis pigmentosa 55 0 trials
- Retinitis pigmentosa 64 0 trials
- Retinitis pigmentosa 74 0 trials
- Retinitis pigmentosa 80 0 trials
-
Brown syndrome 1 trial
-
TPM3-related myopathy 1 trial
3 sub-types
- Cap myopathy 0 trials
- Congenital myopathy 4A, autosomal dominant 0 trials
- Congenital myopathy 4B, autosomal recessive 0 trials
-
Anencephaly 1 trial
4 sub-types
- Anencephaly 1 0 trials
- Anencephaly 2 0 trials
- Hydranencephaly 0 trials Sub-types →
- Isolated anencephaly 0 trials
-
10 sub-types
- Basal ganglia calcification, idiopathic, 1 0 trials
- Basal ganglia calcification, idiopathic, 10, autosomal recessive 0 trials
- Basal ganglia calcification, idiopathic, 11, autosomal recessive 0 trials
- Basal ganglia calcification, idiopathic, 4 0 trials
- Basal ganglia calcification, idiopathic, 5 0 trials
- Basal ganglia calcification, idiopathic, 6 0 trials
- Basal ganglia calcification, idiopathic, 7, autosomal recessive 0 trials
- Basal ganglia calcification, idiopathic, 8, autosomal recessive 0 trials
- Basal ganglia calcification, idiopathic, 9, autosomal recessive 0 trials
- Basal ganglia calcification, idiopathic, childhood-onset 0 trials
-
Coloboma of optic nerve 1 trial
1 sub-type
- Morning glory syndrome 0 trials
-
Dilated cardiomyopathy 3B 1 trial
-
Familial meningioma 1 trial
-
5 sub-types
- Cerebral cavernous malformation 1 1 trial
- Cerebral cavernous malformation 2 0 trials
- Cerebral cavernous malformation 3 0 trials
- Cerebral cavernous malformation 4 0 trials
- Cerebral cavernous malformations 5 0 trials
-
Iris hypoplasia with glaucoma 1 trial
-
Linear nevus sebaceous syndrome 1 trial
-
Multiminicore myopathy 1 trial
5 sub-types
- Rigid spine muscular dystrophy 1 1 trial Sub-types →
- Antenatal multiminicore disease with arthrogryposis multiplex congenita 0 trials
- Classic multiminicore myopathy 0 trials
- Congenital multicore myopathy with external ophthalmoplegia 0 trials
- Moderate multiminicore disease with hand involvement 0 trials
-
Myoclonus, familial 1 trial
2 sub-types
- Myoclonus, familial, 1 0 trials
- Myoclonus, familial, 2 0 trials
-
Neurocutaneous melanocytosis 1 trial
-
2-hydroxyglutaric aciduria 0 trials · 1 incl. sub-types
3 sub-types
- D,L-2-hydroxyglutaric aciduria 1 trial
- D-2-hydroxyglutaric aciduria 0 trials Sub-types →
- L-2-hydroxyglutaric aciduria 0 trials
-
PRRT2-associated paroxysmal movement disorder 0 trials · 1 incl. sub-types
3 sub-types
- Episodic kinesigenic dyskinesia 1 1 trial
- Infantile convulsions and choreoathetosis 0 trials
- Seizures, benign familial infantile, 2 0 trials
-
Familial hemiplegic migraine 0 trials · 1 incl. sub-types
5 sub-types
-
Familial periodic paralysis 0 trials · 1 incl. sub-types
6 sub-types
- Hyperkalemic periodic paralysis 1 trial
- Hypokalemic periodic paralysis 1 trial Sub-types →
- Andersen-Tawil syndrome 0 trials
- Normokalemic periodic paralysis 0 trials
- Periodic paralysis with later-onset distal motor neuropathy 0 trials
- Thyrotoxic periodic paralysis 0 trials
-
Myopathy caused by variation in POMGNT1 0 trials · 1 incl. sub-types
-
Neuromuscular disease caused by qualitative or quantitative defects of plectin 0 trials · 1 incl. sub-types
2 sub-types
-
Neuromuscular disease caused by qualitative or quantitative defects of telethonin 0 trials · 1 incl. sub-types
2 sub-types
-
Qualitative or quantitative defects of desmin 0 trials · 1 incl. sub-types
5 sub-types
- Rigid spine syndrome 0 trials · 1 incl. sub-types Sub-types →
- Autosomal dominant limb-girdle muscular dystrophy type 1E (DES) 0 trials
- Dilated cardiomyopathy 1I 0 trials
- Myofibrillar myopathy 1 0 trials
- Neurogenic scapuloperoneal syndrome, Kaeser type 0 trials
-
Severe congenital nemaline myopathy 0 trials · 1 incl. sub-types
5 sub-types
- Nemaline myopathy 8 1 trial
- Congenital myopathy 2a, typical, autosomal dominant 0 trials
- Nemaline myopathy 10 0 trials
- Nemaline myopathy 2 0 trials
- Nemaline myopathy 9 0 trials
-
Bailey-Bloch congenital myopathy 0 trials
-
Behr syndrome 0 trials
-
Behrens Baumann dust syndrome 0 trials
-
Brody myopathy 0 trials
-
DHDDS-related syndrome 0 trials
2 sub-types
-
Frey syndrome 0 trials
-
Griscelli syndrome type 1 0 trials
-
HSD10 mitochondrial disease 0 trials
3 sub-types
- HSD10 disease, atypical type 0 trials
- HSD10 disease, infantile type 0 trials
- HSD10 disease, neonatal type 0 trials
-
Johanson-Blizzard syndrome 0 trials
-
KIF5A-related neurological disorder 0 trials
3 sub-types
-
NPHP3-related Meckel-like syndrome 0 trials
-
PEHO-like syndrome 0 trials
-
PrP systemic amyloidosis 0 trials
-
Prader-Willi-like syndrome 0 trials
3 sub-types
- 6q16 deletion syndrome 0 trials
- BDV syndrome 0 trials
- SIM1-related Prader-Willi-like syndrome 0 trials
-
Ritscher-Schinzel syndrome 0 trials
4 sub-types
- Ritscher-Schinzel syndrome 1 0 trials
- Ritscher-Schinzel syndrome 2 0 trials
- Ritscher-Schinzel syndrome 3 0 trials
- Ritscher-Schinzel syndrome 4 0 trials
-
SERAC1-related neurological disorder 0 trials
-
SLC39A8-CDG 0 trials
-
2 sub-types
-
TUBB3-related tubulinopathy 0 trials
-
Uner Tan Syndrome 0 trials
-
VPS11-related neurological disorder 0 trials
2 sub-types
- Dystonia 32 0 trials
- Hypomyelinating leukodystrophy 12 0 trials
-
X-linked immunoneurologic disorder 0 trials
-
Achromatopsia 6 0 trials
-
Adult-onset nemaline myopathy 0 trials
-
Age-related hearing impairment 1 0 trials
-
Age-related hearing impairment 2 0 trials
-
Alpha-actinopathy 0 trials
4 sub-types
- Cap myopathy 0 trials
- Congenital myopathy 2a, typical, autosomal dominant 0 trials
- Progressive scapulohumeroperoneal distal myopathy 0 trials
- Zebra body myopathy 0 trials
-
Angioid streaks 0 trials
1 sub-type
- Angioid streaks of choroid 0 trials
-
Aniridia 2 0 trials
-
Aniridia 3 0 trials
-
Band heterotopia of brain 0 trials
-
Benign familial infantile epilepsy 0 trials
5 sub-types
-
Benign neonatal seizures 0 trials
4 sub-types
-
Bilateral generalized polymicrogyria 0 trials
-
Blue color blindness 0 trials
-
Bradyopsia 0 trials
2 sub-types
-
Brain-lung-thyroid syndrome 0 trials
-
Caveolinopathy 0 trials
1 sub-type
-
Cerebellar-facial-dental syndrome 0 trials
-
Choreoathetosis, familial inverted 0 trials
-
Cluster headache, familial 0 trials
-
12 sub-types
- Complex cortical dysplasia with other brain malformations 1 0 trials
- Complex cortical dysplasia with other brain malformations 2 0 trials
- Complex cortical dysplasia with other brain malformations 3 0 trials
- Complex cortical dysplasia with other brain malformations 4 0 trials
- Complex cortical dysplasia with other brain malformations 5 0 trials
- Complex cortical dysplasia with other brain malformations 6 0 trials
- Complex cortical dysplasia with other brain malformations 7 0 trials
- Cortical dysplasia, complex, with other brain malformations 10 0 trials
- Cortical dysplasia, complex, with other brain malformations 11 0 trials
- Cortical dysplasia, complex, with other brain malformations 12 0 trials
- Cortical dysplasia, complex, with other brain malformations 9 0 trials
- Polymicrogyria with optic nerve hypoplasia 0 trials
-
Encephalopathy, acute transient 0 trials
-
Epilepsy, familial adult myoclonic 0 trials
8 sub-types
- Benign adult familial myoclonic epilepsy 0 trials
- Epilepsy, familial adult myoclonic, 1 0 trials
- Epilepsy, familial adult myoclonic, 2 0 trials
- Epilepsy, familial adult myoclonic, 3 0 trials
- Epilepsy, familial adult myoclonic, 4 0 trials
- Epilepsy, familial adult myoclonic, 5 0 trials
- Epilepsy, familial adult myoclonic, 6 0 trials
- Epilepsy, familial adult myoclonic, 7 0 trials
-
Familial hyperprolactinemia 0 trials
-
Familial panic disorder 0 trials
3 sub-types
- Panic disorder 1 0 trials
- Panic disorder 2 0 trials
- Panic disorder 3 0 trials
-
Familial schizencephaly 0 trials
-
Familial syringomyelia 0 trials
-
Febrile seizures, familial, 11 0 trials
-
Folinic acid-responsive seizures 0 trials
-
Glycine encephalopathy 0 trials
5 sub-types
- Atypical glycine encephalopathy 0 trials
- Glycine encephalopathy 1 0 trials
- Glycine encephalopathy 2 0 trials
- Infantile glycine encephalopathy 0 trials
- Neonatal glycine encephalopathy 0 trials
-
Hereditary hyperekplexia 0 trials
5 sub-types
- Developmental and epileptic encephalopathy, 8 0 trials
- Hyperekplexia 1 0 trials
- Hyperekplexia 2 0 trials
- Hyperekplexia 3 0 trials
- Hyperekplexia 4 0 trials
-
Holoprosencephaly 0 trials
17 sub-types
- Alobar holoprosencephaly 0 trials Sub-types →
- Chromosome 1q41-q42 deletion syndrome 0 trials
- Holoprosencephaly 1 0 trials
- Holoprosencephaly 10 0 trials
- Holoprosencephaly 11 0 trials
- Holoprosencephaly 12 with or without pancreatic agenesis 0 trials
- Holoprosencephaly 13, X-linked 0 trials
- Holoprosencephaly 14 0 trials
- Holoprosencephaly 2 0 trials
- Holoprosencephaly 3 0 trials Sub-types →
- Holoprosencephaly 4 0 trials
- Holoprosencephaly 6 0 trials
- Holoprosencephaly 7 0 trials
- Holoprosencephaly 8 0 trials
- Lobar holoprosencephaly 0 trials Sub-types →
- Microform holoprosencephaly 0 trials Sub-types →
- Semilobar holoprosencephaly 0 trials
-
Hyperlexia 0 trials
-
Hypermanganesemia with dystonia 2 0 trials
-
Lateral meningocele syndrome 0 trials
-
Lissencephaly spectrum disorders 0 trials
14 sub-types
- Baraitser-Winter cerebrofrontofacial syndrome 0 trials Sub-types →
- Warburg micro syndrome 0 trials Sub-types →
- X-linked lissencephaly with abnormal genitalia 0 trials
- Classic lissencephaly 0 trials Sub-types →
- Cobblestone lissencephaly 0 trials Sub-types →
- Craniotelencephalic dysplasia 0 trials
- Lissencephaly 10 0 trials
- Lissencephaly 7 with cerebellar hypoplasia 0 trials
- Lissencephaly 8 0 trials
- Lissencephaly spectrum disorder with complex brainstem malformation 0 trials Sub-types →
- Lissencephaly type 3 0 trials Sub-types →
- Lissencephaly with cerebellar hypoplasia 0 trials Sub-types →
- Massa casaer ceulemans syndrome 0 trials
- Microlissencephaly 0 trials Sub-types →
-
Major affective disorder 1 0 trials
-
Major affective disorder 2 0 trials
-
Major affective disorder 3 0 trials
-
Major affective disorder 4 0 trials
-
Major affective disorder 5 0 trials
-
Major affective disorder 7 0 trials
-
Major affective disorder 8 0 trials
-
Major affective disorder 9 0 trials
-
Myofibrillar myopathy 5 0 trials
-
Myopic macular degeneration 0 trials
-
Myosclerosis 0 trials
-
Narcolepsy 3 0 trials
-
Narcolepsy 7 0 trials
-
2 sub-types
-
3 sub-types
- MYH7-related skeletal myopathy 0 trials
- Congenital myopathy 7A, myosin storage, autosomal dominant 0 trials
- Hyaline body myopathy 0 trials
-
2 sub-types
-
Neuroocular syndrome 0 trials
2 sub-types
-
Oculocerebrocutaneous syndrome 0 trials
-
Orofaciodigital syndrome type 6 0 trials
-
Parietal foramina 0 trials
3 sub-types
- Parietal foramina 1 0 trials
- Parietal foramina 2 0 trials
- Parietal foramina 3 0 trials
-
Parkinsonism with polyneuropathy 0 trials
-
Paroxysmal extreme pain disorder 0 trials
-
Periventricular nodular heterotopia 0 trials
8 sub-types
- Chromosome 5Q14.3 deletion syndrome, distal 0 trials
- Heterotopia, periventricular, X-linked dominant 0 trials
- Heterotopia, periventricular, associated with chromosome 5P anomalies 0 trials
- Periventricular heterotopia with microcephaly, autosomal recessive 0 trials
- Periventricular nodular heterotopia 6 0 trials
- Periventricular nodular heterotopia 7 0 trials
- Periventricular nodular heterotopia 8 0 trials
- Periventricular nodular heterotopia 9 0 trials
-
Phakomatosis pigmentokeratotica 0 trials
-
Prosopagnosia, hereditary 0 trials
-
Red color blindness 0 trials
-
Schizophrenia 15 0 trials
-
Schizophrenia 16 0 trials
-
Schizophrenia 19 0 trials
-
Typical nemaline myopathy 0 trials
6 sub-types
- Congenital myopathy 23 0 trials
- Congenital myopathy 2a, typical, autosomal dominant 0 trials
- Nemaline myopathy 10 0 trials
- Nemaline myopathy 2 0 trials
- Nemaline myopathy 7 0 trials
- Nemaline myopathy 9 0 trials
Most studied deeper sub-types
Showing the 400 most recently updated of 2094 trials in this tab.
-
Can stem cells restore vision in stargardt disease? a First-in-Human trial aims to find out
Cure Recruiting nowThis early-phase trial tests a single injection of ASP2020, stem cells turned into retinal cells, placed under the retina in people with Stargardt disease or similar inherited macular dystrophies. The main goal is to check safety and tolerability, while also looking for signs tha…
Phase 1 • Sponsor: Astellas Institute for Regenerative Medicine • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Can a single gene injection preserve sight in inherited blindness?
Cure Recruiting nowThis trial tests a gene therapy called SPVN20, given as a single injection into the eye, for people with advanced rod-cone dystrophy, a genetic condition that causes progressive vision loss. The study includes adults with a confirmed genetic diagnosis and some remaining cone cell…
Phase 1/2 • Sponsor: SparingVision • Aim: Cure
Last updated Sep 10, 2026 00:00 UTC
-
Can a single gene fix a fatal heart condition? a trial aims to find out
Cure Recruiting nowThis phase 2 trial tests whether a single dose of LX2006 gene therapy can improve heart muscle thickening and damage in people with Friedreich ataxia, a genetic disorder that often leads to life-threatening cardiomyopathy. Participants aged 6 and older with confirmed heart enlarg…
Phase 2 • Sponsor: Lexeo Therapeutics • Aim: Cure
Last updated Sep 04, 2026 00:00 UTC
-
Can Lab-Grown brain cells replace what Parkinson's destroys?
Cure Recruiting nowThis early-stage trial tests whether transplanting lab-grown dopamine-producing cells into the brains of people with Parkinson's disease is safe and might help replace the cells lost to the disease. About 7 adults with Parkinson's who have not responded well to standard medicatio…
Phase 1 • Sponsor: University of California, San Diego • Aim: Cure
Last updated Aug 19, 2026 00:00 UTC
-
Can a vaccine train the body to fight Parkinson's?
Vaccine Recruiting nowThis early-stage trial is testing an experimental vaccine called TRB-001 in people with Parkinson's disease who have previously received a type of immunotherapy targeting a protein called alpha-synuclein. The vaccine is designed to prompt the immune system to produce antibodies a…
Phase 1 • Sponsor: Tridem Bioscience FlexCo • Aim: Vaccine
Last updated Sep 12, 2026 00:00 UTC
-
Hope for stargardt patients: new drug aims to slow blindness
Disease control Recruiting nowThis Phase 3 trial tests an oral drug called gildeuretinol acetate (ALK 001) in 230 people aged 8 to 45 with Stargardt disease, a genetic condition that causes progressive vision loss. Participants take the drug or a placebo daily for 24 months. The goal is to see if the drug can…
Phase 3 • Sponsor: Alkeus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Watch and wait: could immunotherapy let some GI cancer patients avoid surgery?
Disease control Recruiting nowThis study looks at people with early-stage gastrointestinal cancers that have a mismatch repair deficiency, a feature that can make tumors respond well to immunotherapy. Part A is a registry that tracks all such patients, whether they have surgery or immunotherapy. Part B follow…
Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Tiny implant aims to restore sight in eyes that resist standard AMD therapy
Disease control Recruiting nowResearchers are testing a new treatment called PAL-222 for people with neovascular age-related macular degeneration (AMD) whose disease has not responded to existing therapies. The study will enroll up to 10 adults aged 18 to 85 with this condition. Each participant will have a s…
Sponsor: PharmaBio Corporation • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Radiation boosts cancer drug in Tough-to-Treat myeloma
Disease control Recruiting nowThis study tests whether adding low-dose radiation to the drug elranatamab can better kill cancer cells in people with multiple myeloma that has come back or not responded to treatment and has spread outside the bone. About 34 adults will receive the combination. The goal is to s…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New injection aims to tackle Alzheimer's at its roots
Disease control Recruiting nowThis study tests a new drug called ARO-MAPT-SC in healthy people and those with early Alzheimer's. The goal is to check if it is safe and how the body processes it. Participants receive either the drug or a placebo by injection under the skin. The trial is still in early stages, …
Phase 1/2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New study to track gene Therapy's Real-World impact on spinal muscular atrophy
Disease control Recruiting nowThis study will follow 36 people with spinal muscular atrophy (SMA) who receive a gene therapy called onasemnogene abeparvovec (ITVISMA) injected into the spinal fluid. The goal is to see how well it works and how safe it is in everyday medical practice. Participants must be at l…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill for duchenne MD enters Mid-Stage trial in young boys
Disease control Recruiting nowThis study tests an oral drug called SAT-3247 in 51 boys aged 7 to 10 with Duchenne muscular dystrophy who can still walk. The goal is to find the best dose, check safety, and see if it helps muscle strength. Participants take the drug or a placebo for 12 weeks, and all continue …
Phase 2 • Sponsor: Satellos Bioscience, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a compound in grapes help Parkinson's? new trial launches
Disease control Recruiting nowThis early-phase trial will test whether a special form of resveratrol (JOTROL) is safe and tolerable for people with Parkinson's disease. About 30 participants will receive either a low dose, high dose, or placebo daily for three months. The study will also measure how the drug …
Phase 2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New eye drug tiespectus takes on aflibercept in major wet AMD trial
Disease control Recruiting nowThis study tests a new medicine called tiespectus (EYE201) for wet age-related macular degeneration, a leading cause of vision loss. About 960 people will receive either tiespectus or the standard treatment aflibercept via eye injections. The goal is to see if tiespectus can impr…
Phase 2/3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Sleep pill may shield brain from Alzheimer's damage
Disease control Recruiting nowThis study tests whether the insomnia medication lemborexant (Dayvigo) can lower blood markers of brain damage in adults aged 40–65 with insomnia. Twenty participants will take the drug or a placebo for two weeks each, then have their blood tested for proteins linked to Alzheimer…
Phase 2 • Sponsor: Woolcock Institute of Medical Research • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
One-Shot hope for blinding eye disease? new trial underway
Disease control Recruiting nowThis study tests a single injection into the eye of a new drug (SAR446597) for people with geographic atrophy, a progressive form of age-related macular degeneration that causes vision loss. About 104 participants aged 60 and older will be followed for 2 years, with an optional 3…
Phase 1/2 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo aims to halt blinding eye disease
Disease control Recruiting nowThis phase 3 trial tests two injectable drugs, pozelimab and cemdisiran, alone or together, to slow the growth of geographic atrophy—an advanced form of dry age-related macular degeneration that causes central vision loss. About 975 participants will receive either the drugs or a…
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Brain pacemaker trial aims to tame Parkinson's symptoms
Disease control Recruiting nowThis study follows 300 adults with Parkinson's disease, essential tremor, or dystonia who receive deep brain stimulation (DBS). DBS uses a device implanted in the chest to send electrical pulses to brain areas controlling movement. Researchers will track symptom severity, medicat…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Lung cancer vaccine trial aims to stop tumors from coming back
Disease control Recruiting nowThis study tests whether adding an experimental mRNA vaccine (V940) to the immunotherapy drug pembrolizumab (Keytruda) can keep lung cancer from returning after surgery. It includes 680 people with stage II to IIIB non-small cell lung cancer whose tumors did not fully respond to …
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo aims to tackle bipolar depression and suicidal thoughts
Disease control Expanded accessThis study offers NRX-101, a combination of two drugs, to adults aged 18-65 with treatment-resistant bipolar depression and suicidal thoughts. Participants receive the medication from their own psychiatrist and undergo regular check-ins on mood, suicidal ideation, and side effect…
Sponsor: NeuroRx, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could a cancer drug ease rett syndrome? early trial launches
Disease control Recruiting nowThis early-stage trial is testing the drug vorinostat in 15 girls and young women with Rett syndrome, a rare genetic disorder that affects brain development. Each participant will receive placebo and two different doses of vorinostat, acting as their own control. The study aims t…
Phase 1 • Sponsor: Unravel Biosciences, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New combo therapy aims to extend life in advanced lung cancer
Disease control Recruiting nowThis phase 3 trial tests whether adding the experimental drug MK-2870 to the standard immunotherapy pembrolizumab helps people with advanced non-small cell lung cancer live longer compared to pembrolizumab alone. The study enrolls about 614 adults whose tumors have high PD-L1 lev…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New Triple-Drug attack on cervical cancer enters final testing
Disease control Recruiting nowThis phase 3 trial tests whether adding the experimental drug sacituzumab tirumotecan (sac-TMT) to standard immunotherapy (pembrolizumab) and a targeted therapy (bevacizumab) helps people with metastatic cervical cancer live longer. About 1,000 participants whose cancer has sprea…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill aims to tackle Huntington's at its source
Disease control Recruiting nowThis clinical trial tests an oral drug called SKY-0515 in 400 adults with Huntington's disease. The goal is to see if it can lower harmful proteins linked to the disease and improve symptoms like movement and thinking. Participants take the drug or a placebo daily for 18 months.
Phase 2/3 • Sponsor: Skyhawk Therapeutics, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Gut bacteria trial aims to slow ALS and dementia
Disease control Recruiting nowThis study tests whether a special probiotic supplement can change fat-related molecules in the blood of people with ALS and frontotemporal dementia (FTD). Researchers will compare those taking the probiotic to those taking a placebo over 24 weeks. The goal is to see if the probi…
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Which drug first? trial tests sequence of carboplatin and olaparib in aggressive prostate cancer
Disease control Recruiting nowResearchers are comparing two sequences of treatment for metastatic castration-resistant prostate cancer that carries certain DNA repair gene mutations. Participants receive either carboplatin first and olaparib second, or olaparib first and carboplatin second, switching after th…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill could slow blindness in inherited eye disease
Disease control Recruiting nowThis early-stage trial tests a new oral drug called OCT-980 for people with a specific inherited eye disease (autosomal dominant retinitis pigmentosa) that causes gradual vision loss and blindness. The study first gives a single dose to healthy volunteers to check safety, then mu…
Phase 1/2 • Sponsor: Octant, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New eye drug aims to offer cheaper option for blinding disease
Disease control Recruiting nowThis phase 3 trial tests whether a new drug called ABP 938 works as well as the approved treatment Eylea HD for wet age-related macular degeneration, a leading cause of vision loss. About 304 people aged 50 and older with untreated wet AMD will receive injections of either drug i…
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill aims to slow Parkinson's progression in early stages
Disease control Recruiting nowThis study tests whether a daily pill called BHV-8000 can slow the worsening of motor skills in people recently diagnosed with Parkinson's disease. About 550 adults aged 40 to 85 with early Parkinson's will receive either BHV-8000 (10 mg or 20 mg) or a placebo for up to 48 weeks.…
Phase 2/3 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Hope for Huntington's: new drug aims to slow decline in major trial
Disease control Recruiting nowThis study tests whether the drug pridopidine can slow the worsening of Huntington's disease (HD) in adults. About 400 participants will take either pridopidine or a placebo twice daily for one year, then everyone can receive pridopidine for two more years. The goal is to see if …
Phase 3 • Sponsor: Prilenia • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for womb cancer: drug duo aims to slow tumor growth
Disease control Recruiting nowThis study tests whether adding sacituzumab tirumotecan (Sac-TMT) to pembrolizumab helps people with advanced or recurrent endometrial cancer live longer without the cancer getting worse. About 1,100 participants with a specific type of endometrial cancer (pMMR) will receive eith…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill hopes to tame rare childhood brain diseases
Disease control Recruiting nowThis Phase 3 trial tests an oral drug called nizubaglustat (AZ-3102) in people aged 4 and older with Niemann-Pick type C disease, GM1 gangliosidosis, or GM2 gangliosidosis. The study lasts 18 months and compares the drug to a placebo to see if it is safe and can slow disease prog…
Phase 3 • Sponsor: Azafaros B.V. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New spinal injection aims to tame Huntington's
Disease control Recruiting nowThis early-stage study tests an experimental drug called ALN-HTT02 in 66 adults with Huntington's disease. The drug is given as a single injection into the spine to see if it is safe and how it affects the body. The goal is to reduce levels of the harmful protein that causes the …
Phase 1 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could a drink replace daily shots for growth hormone deficiency?
Disease control Recruiting nowThis study tests an oral medicine called GS3-007a for children with growth hormone deficiency. In the first part, kids receive different doses or a placebo for 14 days to check safety. In the second part, they take the chosen dose or a standard injection for 52 weeks to see how w…
Phase 1/2 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Eye drops could replace injections for wet AMD
Disease control Recruiting nowResearchers are testing a new eye drop called NT-101 in people with wet age-related macular degeneration, a condition where abnormal blood vessels leak fluid into the retina and damage central vision. The trial enrolls 66 adults aged 50 and older who have active leaking vessels u…
Phase 2 • Sponsor: NexThera Co., Ltd. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New pill targets tough cancers with genetic flaw
Disease control Recruiting nowThis study tests an experimental oral drug, GSK5460025, alone or with other cancer drugs, in adults whose solid tumors have specific genetic changes (dMMR or MSI-H). The goal is to see if the drug can shrink tumors and to check its safety. About 47 people with advanced cancers th…
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Brain pacemaker registry tracks Real-Life results for Parkinson's patients
Disease control Recruiting nowThis registry is collecting information from 1,500 people with Parkinson's disease who are receiving deep brain stimulation (DBS) with the Vercise system. The goal is to see how DBS affects quality of life in everyday practice, and to evaluate new programming tools. Participants …
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could a pill shrink nerve tumors in NF1? new trial aims to find out
Disease control Recruiting nowThis study tests the drug abemaciclib, typically used for cancer, in people with neurofibromatosis type 1 (NF1) who have atypical neurofibromas that cannot be surgically removed. The goal is to find a safe dose and see if it can shrink or stabilize these tumors. Participants take…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for rare brain disease: platform trial targets PSP
Disease control Recruiting nowThis study tests several experimental treatments for progressive supranuclear palsy (PSP), a rare brain disease that affects movement and thinking. About 440 people with early-stage PSP will receive one of the treatments or a placebo. The goal is to see if any of the treatments c…
Phase 2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
One-Shot gene therapy could slash eye injections for wet AMD
Disease control Recruiting nowThis study tests a gene therapy called ABBV-RGX-314 for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The goal is to see if a single treatment can reduce the need for frequent eye injections while keeping vision stable. About 561 adults a…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug shows promise for rare, severe childhood epilepsy
Disease control Recruiting nowThis study tests whether clemizole HCl (EPX-100) can safely reduce seizures when added to current treatments for Lennox-Gastaut syndrome, a severe form of epilepsy. About 260 children and adults aged 2 to 55 will receive either the drug or a placebo. The main goal is to measure c…
Phase 3 • Sponsor: Epygenix • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Hope for duchenne: new drug targets rare gene mutation in phase 3 trial
Disease control Recruiting nowThis study tests an experimental drug called AOC 1044 for boys with Duchenne muscular dystrophy (DMD) who have a specific genetic change (exon 44 skipping). About 70 boys aged 7 to 16 who can still walk will receive either the drug or a placebo. The main goal is to see if the dru…
Phase 3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug MTX325 enters first human tests for Parkinson's
Disease control Recruiting nowThis early-stage study tests a new drug called MTX325 in healthy volunteers and people with mild to moderate Parkinson's disease. The main goals are to check safety, how the body processes the drug, and whether it reaches the brain. If successful, MTX325 might one day slow the pr…
Phase 1 • Sponsor: Mission Therapeutics • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New shot every 6 months could slow rare nerve disease
Disease control Recruiting nowThis Phase 3 trial tests a new drug called nucresiran in 125 people with a rare inherited condition that damages nerves (hATTR-PN). The drug is given as a shot under the skin every 6 months and aims to slow nerve damage and improve quality of life. Researchers will compare it to …
Phase 3 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for dravet syndrome: phase 3 trial of EPX-100 aims to cut seizures
Disease control Recruiting nowThis study tests an experimental drug called EPX-100 (clemizole) in 150 children and adults with Dravet syndrome, a severe form of epilepsy. The goal is to see if adding EPX-100 to current treatments can safely reduce the number of motor seizures. Participants will be randomly as…
Phase 3 • Sponsor: Epygenix • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Cell therapy trial aims to halt vision loss in dry AMD
Disease control Recruiting nowThis study tests a cell therapy called OpRegen for people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes blind spots. About 60 participants will receive a one-time injection of retinal cells under the retina during eye surgery. The m…
Phase 2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for kids with SMA: experimental drug ARGX-119 enters Mid-Stage trial
Disease control Recruiting nowThis study tests a new biologic drug called ARGX-119 in children aged 5 to 17 with spinal muscular atrophy (SMA). About 60 participants will receive either ARGX-119 or a placebo by IV infusion for 24 weeks, alongside their usual SMA therapy. The goal is to find the best dose and …
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug targets Alzheimer's proteins in Early-Onset patients
Disease control Recruiting nowThis early-stage trial tests a drug called ALN-APP (mivelsiran) in 60 adults with mild cognitive impairment or mild dementia due to early-onset Alzheimer's disease. The drug is given via a spinal injection to see if it safely lowers certain proteins linked to Alzheimer's in the b…
Phase 1 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Eye injection safety tracked in long-term study for vision loss
Disease control Recruiting nowThis study follows people who already received an eye injection of JNJ-81201887 or a sham in earlier studies for geographic atrophy, a form of advanced age-related macular degeneration that causes vision loss. The goal is to check long-term safety, including side effects and eye …
Phase 2/3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Smart brain pacemaker learns to adjust itself for Parkinson's patients
Disease control Recruiting nowThis study tests a new automated method to fine-tune adaptive deep brain stimulation (aDBS) for people with Parkinson's disease. aDBS uses brain signals to adjust stimulation in real time, but setting it up is complex. The trial will compare automated aDBS to standard continuous …
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug hopes to boost muscle power in babies with SMA
Disease control Recruiting nowThis study tests a drug called apitegromab in children under 2 years old who have spinal muscular atrophy (SMA), a genetic condition that causes muscle weakness. The drug works by blocking a protein that limits muscle growth. Researchers want to see if adding apitegromab to stand…
Phase 2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New hope for ALS: first human trial of Gene-Targeting drug begins
Disease control Recruiting nowThis study tests an experimental drug called ALN-SOD in people with ALS caused by a mutation in the SOD1 gene. The drug is given via spinal injection to target the root cause of the disease. The main goal is to check safety, but researchers will also measure effects on biomarkers…
Phase 1/2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New hope for aggressive breast cancer: drug combo trial launches
Disease control Recruiting nowThis study tests whether a new drug, sacituzumab tirumotecan (Sac-TMT), given alone or with pembrolizumab, helps people with advanced triple-negative breast cancer live longer or keep their cancer from growing. About 1,000 adults whose cancer has spread and who have not had prior…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Experimental gene therapy offers hope for fatal nerve disease
Disease control Recruiting nowThis study tests a gene therapy for GM1 gangliosidosis, a fatal disorder that destroys nerve cells. The therapy uses a harmless virus to deliver a working gene, helping the body produce a missing enzyme. Up to 54 children with Type I (ages 6-12 months) or Type II (ages 1-12 years…
Phase 1/2 • Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a Two-Drug combo quiet the tremors Parkinson's patients still feel?
Disease control Recruiting nowThis phase 2 trial tests an experimental drug called VIM0423 in adults with Parkinson's disease whose tremor does not respond well to standard dopaminergic therapy. Researchers want to see if VIM0423 can reduce tremor severity, improve daily function and quality of life, and be s…
Phase 2 • Sponsor: Vima Therapeutics • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New gene therapy trial hopes to restore muscle protein in duchenne boys
Disease control Recruiting nowThis study tests a one-time gene therapy called delandistrogene moxeparvovec in 83 people with Duchenne muscular dystrophy. The goal is to see if it is safe and helps the body make dystrophin, a protein missing in Duchenne. The trial is now enrolling non-ambulatory participants (…
Phase 1 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug cocktail aims to wipe out aggressive breast cancer before surgery
Disease control Recruiting nowThis phase 3 trial is testing whether adding a targeted therapy called Sacituzumab tirumotecan (Sac-TMT) to standard chemotherapy and immunotherapy (pembrolizumab) can better eliminate cancer before surgery in people with high-risk, early-stage triple-negative or hormone-receptor…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Brain pacemaker study aims to shake up essential tremor treatment
Disease control Recruiting nowThis study is collecting information from 500 people with essential tremor who are using a Boston Scientific deep brain stimulation (DBS) system, which is already approved for use. The goal is to see how the device affects quality of life in real-world settings, not just in contr…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New surgery trial aims to restore vision after macular bleeding
Disease control Recruiting nowThis phase 3 trial tests whether adding surgery (vitrectomy, clot-busting drug, and gas bubble) to standard anti-VEGF injections can improve vision more than injections alone for people with a macular bleed from wet AMD. About 210 participants across Europe will be randomly assig…
Phase 3 • Sponsor: King's College Hospital NHS Trust • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New hope for angelman syndrome: drug trial targets brain function
Disease control Recruiting nowThis study tests a drug called rugonersen, given via spinal injection, to see if it can improve thinking and communication skills in people with Angelman syndrome. The trial includes 165 children and adults aged 1 to 50. Researchers will compare the drug against a sham procedure …
Phase 3 • Sponsor: OHB Pediatrics Ltd. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Sound waves aimed at the brain may quiet temporal lobe seizures
Disease control Recruiting nowResearchers are testing a non-invasive device that uses focused ultrasound to target the hippocampus, a brain region involved in temporal lobe epilepsy. The study enrolls adults whose seizures continue despite medication. Participants receive ultrasound treatments twice a week fo…
Sponsor: Genovate-NaviFUS (Australia) Pty Ltd. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New eye injection aims to halt blindness from dry AMD in major trial
Disease control Recruiting nowThis study tests an experimental drug called ONL1204, given as an eye injection, to see if it can slow the growth of blind spots in people with geographic atrophy, an advanced form of dry age-related macular degeneration. About 324 adults aged 55 and older will receive either the…
Phase 2 • Sponsor: ONL Therapeutics • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can a second treatment help kids with SMA who stalled after gene therapy?
Disease control Recruiting nowThis study tests whether adding risdiplam, a daily oral medicine, can help children under 2 with spinal muscular atrophy (SMA) who stopped getting better or started declining after receiving gene therapy. The study will enroll 28 children and measure changes in motor skills over …
Phase 4 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Gene therapy trial aims to save sight in boys and men with rare retinal disease
Disease control Recruiting nowThis study tests a gene therapy called ATSN-201 in males aged 6 and older with X-linked retinoschisis, a genetic eye condition that leads to vision loss. The therapy delivers a working copy of the RS1 gene to the retina. The trial has three parts: first, finding the right dose; s…
Phase 3 • Sponsor: Atsena Therapeutics Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
One-Time gene shot aims to stop rare nerve disease in kids
Disease control Recruiting nowThis early-phase trial tests a single injection of gene therapy (ELP-02) into the spinal fluid of 8 children and young adults with CMT4J, a rare genetic nerve disease that causes muscle weakness. The therapy delivers a working copy of the FIG4 gene to nerve cells, potentially slo…
Phase 1/2 • Sponsor: Elpida Therapeutics SPC • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New device aims to seal brain aneurysms and prevent strokes
Disease control Recruiting nowThis study is testing a device called a flow modulator to treat wide-necked brain aneurysms. The device is placed inside the artery to redirect blood flow away from the aneurysm, helping it close off. Researchers will check if the device is safe and effective in 214 adults over 1…
Sponsor: phenox Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug FWY003 aims to halt blinding eye disease
Disease control Recruiting nowThis Phase 2 trial tests FWY003, an experimental drug, in 272 people with geographic atrophy (a form of advanced age-related macular degeneration). The goal is to see if different doses can slow the growth of damaged areas in the eye and preserve vision. Participants receive eith…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Amniotic gel could patch macular holes without complex surgery
Disease control Recruiting nowThis study tests a new gel made from donated amniotic membrane to treat large macular holes, a condition that blurs central vision. The gel is injected into the eye during surgery to help close the hole. Researchers will compare this method to the standard flap technique in 26 ad…
Sponsor: Walailak University • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
3-D brain mapping could sharpen ultrasound treatment for hand tremors
Disease control Recruiting nowThis study tests whether using 3-D tractography—a detailed brain imaging method—can make focused ultrasound ablation safer and more effective for people with essential tremor. Twenty-four adults with moderate to severe tremor that hasn't responded to medication will receive the p…
Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New pill plus immunotherapy shows promise for tough lung cancer
Disease control Recruiting nowThis phase 3 study is testing whether adding an experimental pill called calderasib (MK-1084) to the immunotherapy drug pembrolizumab (Keytruda) works better than pembrolizumab alone for people with advanced non-small cell lung cancer that has a KRAS G12C mutation and high PD-L1 …
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can magnetic pulses ease OCD in teens who Haven't improved?
Disease control Recruiting nowThis pilot study tests whether transcranial magnetic stimulation (TMS) is safe and tolerable for teenagers aged 13 to 17 with obsessive-compulsive disorder (OCD) who have not improved enough with standard treatments. Participants receive TMS sessions five days a week for three we…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a gut supplement ease anxiety and depression in obesity?
Disease control Recruiting nowThis trial tests whether a daily synbiotic supplement, which combines prebiotics and beneficial bacteria, can improve gut health and mental well-being in people with obesity. Researchers will give 120 adults with a BMI between 30 and 40 either the supplement or a placebo for 12 w…
Sponsor: Celia Bañuls • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug SRP-1005 takes first step against Huntington's
Disease control Recruiting nowThis study tests a new drug called SRP-1005 in 32 adults with Huntington's disease. It is the first time this drug is being tested in humans, so the main goal is to check safety and how the body processes the drug. Participants will receive either SRP-1005 or a placebo by injecti…
Phase 1 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Could a daily pill replace growth hormone shots for kids?
Disease control Recruiting nowThis study tests an oral medication called LUM-201 for children with growth hormone deficiency who have never been treated before. The goal is to see if taking a pill every day for 12 months can improve growth rate compared to a placebo. The study involves 150 prepubertal childre…
Phase 3 • Sponsor: Lumos Pharma • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug combo aims to tame rare childhood leukemia
Disease control Recruiting nowThis study tests a combination of two drugs, trametinib and azacitidine, for children newly diagnosed with juvenile myelomonocytic leukemia (JMML), a rare blood cancer. Lower-risk patients get just these two drugs, while higher-risk patients also receive standard chemotherapy. Th…
Phase 1/2 • Sponsor: Therapeutic Advances in Childhood Leukemia Consortium • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New eye drug EYE103 aims to restore vision in macular degeneration and vein occlusion
Disease control Recruiting nowThis Phase 2 trial tests an experimental drug called EYE103 (Restoret) in 160 people with wet age-related macular degeneration or macular edema from a branch retinal vein occlusion. Participants receive three eye injections of either a low or high dose of EYE103, spaced four week…
Phase 2 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a focused electric field quiet the Brain's obsessive signals?
Disease control Recruiting nowThis trial tests whether a noninvasive technique called transcranial temporal interference stimulation (tTIS) can reduce symptoms in people with obsessive-compulsive disorder (OCD). The stimulation targets the nucleus accumbens, a deep brain region linked to OCD, using electric f…
Sponsor: Beijing HuiLongGuan Hospital • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New implant could change how SMA patients get their medicine
Disease control Recruiting nowThis study looks at how the body handles the drug nusinersen when given through a new implantable device called ThecaFlex DRx™, compared to the usual method of a lumbar puncture (spinal tap). About 58 people with spinal muscular atrophy (SMA) who are already in another study (PIE…
Phase 1 • Sponsor: Biogen • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can ultrasound make botox injections more precise for stiff muscles?
Disease control Recruiting nowThis trial tests whether using ultrasound to guide botulinum toxin injections into spastic leg muscles works better than the standard method of relying on touch and anatomical landmarks. Researchers will give 40 adults with spastic paraplegia two rounds of injections, one with ea…
Phase 4 • Sponsor: Universidade Federal Fluminense • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Belzutifan extension trial aims to extend lives in VHL and advanced cancer
Disease control Recruiting nowThis extension study follows people with von Hippel-Lindau (VHL) disease or advanced solid tumors who are already taking belzutifan in another trial. The goal is to see how long they live and how safe the drug is over the long term. About 450 participants will take belzutifan by …
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for kids with rare seizure disorder: ION337 trial launches
Disease control Recruiting nowThis study tests a new medicine called ION337 in children aged 2 to 12 with Dravet syndrome, a severe form of epilepsy. The main goal is to see if the drug is safe and tolerable when given as a spinal injection. Researchers will also measure how the drug moves through the body an…
Phase 1/2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a pill that blocks a brain protein ease Parkinson's without levodopa?
Disease control Recruiting nowThis trial tests an experimental oral medication called VG081821AC for people with early to mid-stage Parkinson's disease. The drug blocks a brain protein called the adenosine A2A receptor, which may improve movement symptoms without using levodopa. About 152 adults in China will…
Phase 2/3 • Sponsor: Zhejiang Vimgreen Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for advanced stomach cancer: experimental drug combos enter human trials
Disease control Recruiting nowThis study tests two new drug combinations for people with advanced stomach, gastroesophageal junction, or esophageal cancer that has worsened after initial treatment. About 210 participants will receive either an experimental antibody-drug conjugate plus chemotherapy, or a stand…
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New pill shows promise for rare tumors in Mid-Stage trial
Disease control Recruiting nowThis phase 2 study tests belzutifan, a daily pill that blocks a protein called HIF-2α, in people with advanced rare cancers like pheochromocytoma/paraganglioma, pancreatic neuroendocrine tumors, VHL disease-associated tumors, and certain other solid tumors. The goal is to see if …
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Gene therapy may free gaucher patients from lifelong infusions
Disease control Recruiting nowThis Phase 3 trial tests a gene therapy called FLT201 for adults with Gaucher disease type 1. The goal is to see if a single dose can keep blood counts stable so patients can stop their regular enzyme replacement or substrate reduction therapy. The study will enroll 45 people who…
Phase 3 • Sponsor: Spur Therapeutics • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug cocktail aims to outsmart aggressive uterine cancer
Disease control Recruiting nowThis phase 3 trial is testing whether a targeted drug (trastuzumab deruxtecan) combined with immunotherapy (rilvegostomig or pembrolizumab) works better than standard chemotherapy plus pembrolizumab for people with advanced or recurrent endometrial cancer that has a specific prot…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Hope for Friedreich's ataxia: new drug trial aims to slow disease progression
Disease control Recruiting nowThis study is testing the long-term safety and effectiveness of an experimental drug called CTI-1601 for people with Friedreich's ataxia, a rare genetic disease that affects movement and heart function. It includes about 85 adolescents and adults who have or have not taken the dr…
Phase 2 • Sponsor: Larimar Therapeutics, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Experimental cell shot aims to boost brain repair in kids with rare metabolic diseases
Disease control Recruiting nowThis early-stage trial tests whether adding special cells (DUOC-01) into the spinal fluid is safe for children with inherited metabolic diseases that damage the brain. Participants are ages 1 week to 21 years and are already receiving a standard umbilical cord blood transplant. T…
Phase 1 • Sponsor: Joanne Kurtzberg, MD • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could this antibody be the key to slowing Parkinson's?
Disease control Recruiting nowThis study tests an experimental drug called prasinezumab in 900 people with early-stage Parkinson's disease who are already taking levodopa. The goal is to see if the drug can delay worsening of motor symptoms compared to a placebo. Participants receive the drug or placebo by IV…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug may boost motor skills in kids with SMA after gene therapy
Disease control Recruiting nowThis study is testing whether the drug risdiplam can improve motor skills in children under 2 with spinal muscular atrophy (SMA) who have already received gene therapy. The 28 participants will take risdiplam by mouth, and researchers will measure changes in their gross motor ski…
Phase 4 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Stem cell injection aims to restore vision in dry AMD patients
Disease control Recruiting nowThis early-stage study tests a stem cell therapy called ASP7317 for people with geographic atrophy, the advanced form of dry age-related macular degeneration that causes central vision loss. The treatment involves injecting special cells under the retina to replace damaged ones. …
Phase 1 • Sponsor: Astellas Institute for Regenerative Medicine • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New shot aims to save sight in advanced macular degeneration
Disease control Recruiting nowThis study tests an experimental drug called ADX-038 in 240 people with geographic atrophy, a form of advanced age-related macular degeneration that causes blind spots. The drug is given as a shot under the skin and is compared to a placebo to see if it can slow the loss of a key…
Phase 2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a Two-Drug attack stall resistant prostate cancer?
Disease control Recruiting nowThis phase 3 trial is testing whether adding an experimental drug called rinzimetostat to the standard drug darolutamide can slow the progression of metastatic castration-resistant prostate cancer better than current treatments. The study enrolls men whose cancer has worsened aft…
Phase 3 • Sponsor: ORIC Pharmaceuticals • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for advanced breast cancer: trial tests Two-Drug combo
Disease control Recruiting nowThis phase 3 trial tests whether a new drug (MK-2870), alone or with another drug (pembrolizumab), works better than standard treatments for people with a common type of advanced breast cancer (HR+/HER2-). About 1,200 participants whose cancer has worsened after hormone therapy w…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug DYNE-101 aims to ease muscle symptoms in DM1
Disease control Recruiting nowThis Phase 3 trial tests whether DYNE-101 can improve muscle function and daily life in 150 adults with myotonic dystrophy type 1 (DM1). Participants receive either the drug or a placebo by IV every few weeks for 48 weeks. The study measures how quickly people can stand from a ch…
Phase 3 • Sponsor: Dyne Therapeutics • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could an HIV drug extend life in Creutzfeldt-Jakob disease?
Disease control Recruiting nowThis study tests whether efavirenz, a drug used for HIV, can help people with Creutzfeldt-Jakob disease (CJD) live longer. CJD is a rare, rapidly fatal brain disorder. The trial will enroll 246 adults and randomly assign them to receive either efavirenz or a placebo. The main goa…
Phase 3 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can supervised exercise calm the racing heart of POTS?
Disease control Recruiting nowThis trial tests whether a 16-week supervised exercise program can reduce symptoms of postural orthostatic tachycardia syndrome (POTS), a condition that causes a sharp rise in heart rate and symptoms like dizziness and fatigue when standing. Researchers at Lund University will en…
Sponsor: Lund University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Gene therapy injection aims to save sight in rare eye disease
Disease control Recruiting nowThis early-phase trial tests a new gene therapy called VG801 for Stargardt disease, a genetic condition that causes vision loss. Fifteen people aged 6 and older will receive a single injection under the retina. The main goal is to check safety, but researchers will also measure a…
Phase 1/2 • Sponsor: VeonGen Therapeutics GmbH • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Brain chip breakthrough: paralysis patients may control devices with thought
Disease control Recruiting nowThis study tests a brain implant that records and stimulates brain areas to help adults with severe paralysis (from spinal cord injury, ALS, or stroke) control assistive devices like computers or wheelchairs. The main goal is to check safety, and researchers will also see if part…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can two drugs together stop Alzheimer's plaques from coming back?
Disease control Recruiting nowThis trial tests two experimental drugs, donanemab and RG6289, in people who carry a specific genetic mutation that causes an inherited, early-onset form of Alzheimer's disease. The study first gives donanemab to clear amyloid plaques from the brain, then randomly assigns partici…
Phase 2/3 • Sponsor: Banner Health • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Light pulses to the eye: a new hope against dry AMD?
Disease control Recruiting nowThis study tests whether photobiomodulation (PBM), a light-based therapy delivered by the Valeda system, can safely improve vision in people with dry age-related macular degeneration (AMD). Researchers will collect data from 500 participants in routine clinical practice across Eu…
Sponsor: LumiThera, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for esophageal cancer: drug cocktail trial launches
Disease control Recruiting nowThis study tests several new drug combinations, with or without the immunotherapy pembrolizumab, in people with advanced esophageal cancer that has continued to grow after standard treatment. About 230 participants will receive different drug regimens to see which are safest and …
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Antioxidant cocktail may ease motor deficits in rett syndrome — a trial investigates
Disease control Recruiting nowThis pilot study tests whether an antioxidant cocktail called Rett-T can improve motor function in children and adolescents with Rett syndrome, a rare genetic disorder that affects movement and coordination. Participants, aged 2 to 21 and at least partially able to walk, will rec…
Phase 2 • Sponsor: Holland Bloorview Kids Rehabilitation Hospital • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug combo targets Hard-to-Treat lung cancer mutation
Disease control Recruiting nowThis study tests a new targeted therapy pill called MK-1084, alone or with other drugs, for people with advanced non-small cell lung cancer that has a specific genetic change called KRAS G12C. The goal is to see if the treatment is safe and can shrink tumors. About 130 participan…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for rare nerve tumor disorder: Multi-Drug trial launches
Disease control Recruiting nowThis study tests several experimental drugs in people with NF2-related schwannomatosis, a genetic condition that causes non-cancerous tumors on nerves. The goal is to see if these drugs can shrink tumors and control the disease. About 109 participants will receive one of three dr…
Phase 2 • Sponsor: Scott R. Plotkin, MD, PhD • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for stomach cancer: experimental drug combo trial opens
Disease control Recruiting nowThis study tests new experimental drugs combined with standard chemotherapy and immunotherapy for people with advanced stomach, gastroesophageal junction, or esophageal cancer that cannot be removed by surgery or has spread. About 160 participants will receive the combination to …
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug aims to build muscle in rare muscular dystrophy
Disease control Recruiting nowThis Phase 2 study tests a drug called apitegromab in 60 adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic condition that causes muscle weakness. Participants will receive either the drug or a placebo every 4 weeks for a year. The main goal is to see if the dru…
Phase 2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New eye implant for wet AMD under safety spotlight
Disease control Recruiting nowThis study is testing a refillable eye implant that delivers the drug ranibizumab to treat wet age-related macular degeneration (AMD). The main goal is to see if the implant affects the cells on the inner surface of the cornea. About 188 people with wet AMD will receive the impla…
Phase 4 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a single gene therapy injection hold back wet AMD for years?
Disease control Recruiting nowThis study follows people with wet age-related macular degeneration who received an injection of SKG0106, an experimental gene therapy, in an earlier trial. Researchers will track their eye health, vision, and any side effects for up to 5 years after the injection. The goal is to…
Sponsor: Skyline Therapeutics • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New Parkinson's drug enters early human testing
Disease control Recruiting nowThis early-stage study tests a new drug called LY3962681 in healthy volunteers and people with Parkinson's disease. The goal is to check if the drug is safe and how the body processes it. Participants receive either the drug or a placebo injected into the spinal fluid, and are fo…
Phase 1 • Sponsor: Prevail Therapeutics • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for duchenne: targeted therapy now available for eligible patients
Disease control Expanded accessThis program provides access to an experimental drug, AOC 1044, for people with Duchenne muscular dystrophy (DMD) whose genetic mutation can be treated by skipping exon 44. The goal is to help control the disease and improve muscle function. Participants must be at least 2 years …
Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could a cancer drug slow bile duct tumors?
Disease control Recruiting nowThis study tests a drug called tivozanib in people with bile duct cancer that cannot be removed by surgery and has already been treated with chemotherapy. The goal is to find the safest dose and see if the drug can shrink tumors or slow the cancer. Participants take tivozanib by …
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Brain pacemaker surgery tested for Parkinson's and tremor
Disease control Recruiting nowThis study is testing deep brain stimulation (DBS) surgery for people with Parkinson's disease, essential tremor, or dystonia that doesn't improve enough with medication. DBS uses a device like a pacemaker to send electrical pulses to specific brain areas that control movement. R…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Surgery offers hope for Drug-Resistant epilepsy patients
Disease control Recruiting nowThis study tests brain surgery as a treatment for people whose epilepsy doesn't improve with medication. About 300 children and adults aged 8 and older will have surgery to remove or treat the part of the brain causing seizures. The goal is to stop or greatly reduce seizures, tho…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Brain signals from daily life may sharpen Parkinson's stimulation
Disease control Recruiting nowThis trial tests whether using long-term brain recordings from daily life can improve adaptive deep brain stimulation (aDBS) for people with Parkinson's disease. Unlike standard DBS, which delivers constant stimulation, aDBS adjusts stimulation in real time based on brain activit…
Sponsor: University of California, Davis • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for Parkinson's: drug infusion studied in earlier advanced patients
Disease control Recruiting nowThis study looks at how well the drug Foslevodopa/Foscarbidopa works for people with advanced Parkinson's disease who are still in the earlier phases of that stage. About 100 adults will receive the drug as a continuous infusion under the skin for up to 6 months. Researchers will…
Sponsor: AbbVie • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can olive oil and walnuts shield the brain from stroke and memory loss?
Disease control Recruiting nowThis trial tests whether a Mediterranean diet, enriched with extra virgin olive oil or walnuts, can lower the chance of stroke and slow cognitive decline in people with cerebral amyloid angiopathy (CAA) or CADASIL, two conditions that affect blood vessels in the brain. Participan…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New shot could make cancer treatment easier for patients with advanced tumors
Disease control Recruiting nowThis study tests a new way to give the drug rilvegostomig as a shot under the skin instead of through an IV. It is for adults with advanced solid tumors who have already tried standard treatments. The goal is to find a dose that works as well as the IV version and to check for si…
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Lung cancer combo aims to wipe out tumors before surgery
Disease control Recruiting nowThis phase 2 trial is testing whether giving the immunotherapy drug pembrolizumab (Keytruda) along with chemotherapy before surgery can eliminate all signs of cancer in people with resectable stage II to IIIB non-small cell lung cancer. About 60 participants will receive the comb…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a nerve graft in the brain boost the effects of deep brain stimulation for Parkinson's?
Disease control Recruiting nowThis phase 1 trial tests whether implanting a small piece of a patient's own nerve tissue into the brain during standard deep brain stimulation (DBS) surgery can support brain cells and improve Parkinson's symptoms. Twenty-four adults with Parkinson's disease who are already sche…
Phase 1 • Sponsor: Craig van Horne, MD, PhD • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a missing protein be replaced to slow Friedreich's ataxia?
Disease control Recruiting nowThis phase 3 trial is testing whether a weekly injection of nomlabofusp can improve balance and slow the progression of Friedreich's ataxia, a genetic condition that damages the nervous system. The study includes about 150 adults and children with the disease, who will receive ei…
Phase 3 • Sponsor: Larimar Therapeutics, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Eye implant could reduce need for frequent shots for blinding disease
Disease control Recruiting nowThis study is checking the long-term safety of a small implant placed in the eye that slowly releases medicine to treat wet age-related macular degeneration, a condition that can cause rapid vision loss. About 1,000 people who have already used the implant in earlier studies will…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could a leg nerve graft help the brain? new trial for Parkinson's and MSA
Disease control Recruiting nowThis early-stage study tests if implanting a small piece of the participant's own leg nerve into a key brain area is safe and feasible for people with early Parkinson's disease or Multiple System Atrophy. Seven people will take part; four will get the nerve graft and three will h…
Phase 1 • Sponsor: Craig van Horne, MD, PhD • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug votoplam enters final phase 3 trial for Huntington's disease
Disease control Recruiting nowThis Phase 3 trial tests whether the drug votoplam can slow the progression of Huntington's disease in people with early symptoms. About 770 adults aged 21 to 70 with a confirmed genetic diagnosis will receive either votoplam or a placebo. The main goal is to see if votoplam pres…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a second brain zap tame tremors on both sides?
Disease control Recruiting nowThis study tests whether a second focused ultrasound treatment on the opposite side of the brain can further reduce tremors in people with essential tremor who already had one treatment. About 100 participants will be randomly assigned to get the second procedure or continue stan…
Sponsor: InSightec • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Magnetic pulses to the brain may tame Parkinson's drug side effects
Disease control Recruiting nowThis trial tests whether repetitive transcranial magnetic stimulation (rTMS) can reduce or delay the involuntary movements, called dyskinesia, that many Parkinson's patients develop after taking levodopa. Researchers will apply targeted magnetic pulses to a brain region involved …
Sponsor: Danish Research Centre for Magnetic Resonance • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could a Web-Based therapy ease common mental health struggles?
Disease control Recruiting nowThis trial tests whether an internet-based form of cognitive behavior therapy (CBT) can reduce symptoms of common mental disorders like anxiety, depression, and stress-related conditions in adults seeking primary care. About 500 participants will be randomly assigned to either th…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could a common ADHD drug tame attention issues in rare KBG syndrome?
Disease control Recruiting nowThis trial tests whether methylphenidate, a standard ADHD medication, can reduce attention and hyperactivity problems in children and adolescents with KBG syndrome, a rare genetic condition often accompanied by ADHD-like symptoms. Participants receive alternating blocks of the dr…
Phase 4 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Brain training targets impulse control to fight OCD and related disorders
Disease control Recruiting nowThis study tests whether a computerized training program designed to improve response inhibition — the ability to stop an automatic action — can reduce symptoms in people with obsessive-compulsive disorder, trichotillomania (hair-pulling), or skin-picking disorder. Participants a…
Sponsor: University of Wisconsin, Milwaukee • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Which treatment tames LGS seizures better: surgery or more meds?
Disease control Recruiting nowThis study looks at two ways to treat Lennox-Gastaut syndrome (LGS), a severe form of childhood epilepsy: adding more anti-seizure medications or undergoing palliative surgery (like a vagus nerve stimulator or corpus callosotomy). Researchers will track thousands of children acro…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Which brain target eases Parkinson's symptoms best? a Head-to-Head test
Disease control Recruiting nowThis trial tests a non-invasive brain stimulation technique called temporal interference stimulation (TIS) in people with Parkinson's disease. It compares two different brain targets—the subthalamic nucleus (STN) and the globus pallidus internus (GPi)—to see which one better impr…
Sponsor: Zhongnan Hospital • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Heart drug acoramidis tested for Long-Term cardiac repair in rare amyloidosis
Disease control Recruiting nowThis study tests the drug acoramidis in people with transthyretin amyloid cardiomyopathy (ATTR-CM), a condition where abnormal proteins build up in the heart, weakening it. Over 36 months, researchers measure whether acoramidis improves heart function and structure using cardiac …
Phase 4 • Sponsor: Eidos Therapeutics, a BridgeBio company • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a Two-Drug combo stop nerve tumors from turning cancerous?
Disease control Recruiting nowThis trial is testing whether combining two drugs—selumetinib and APG-115—can help people with neurofibromatosis type 1 (NF1) who have nerve sheath tumors that are either pre-cancerous or already cancerous. The study aims to find a safe dose and see if the combination can shrink …
Phase 1/2 • Sponsor: AeRang Kim • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Experimental drug aims to preserve arm and lung function in boys with advanced duchenne
Disease control Recruiting nowThis phase 3 trial tests whether givinostat, an oral drug, can slow muscle decline in boys aged 9 to 18 with Duchenne muscular dystrophy who can no longer walk. Participants receive either givinostat or a placebo for 18 months. The main goal is to see if the drug helps maintain u…
Phase 3 • Sponsor: Italfarmaco • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a stem-cell wrap boost nerve repair after carpal tunnel surgery?
Disease control Recruiting nowThis trial tests whether placing a piece of amniotic membrane soaked in a stem-cell-derived solution (secretome) on the nerve during carpal tunnel release surgery can improve symptom relief and nerve function. Adults with moderate-to-severe carpal tunnel syndrome that hasn't impr…
Early phase 1 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a smartphone app tame OCD? scientists investigate digital mindfulness
Disease control Recruiting nowThis study tests whether a 6-week digital mindfulness program, delivered through a mobile app, can help people with obsessive-compulsive disorder (OCD) manage their symptoms. The trial compares the digital therapy alone, standard medication alone, and a combination of both in 150…
Sponsor: Central South University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug cocktail aims to outperform standard immunotherapy in bile duct cancer
Disease control Recruiting nowThis phase 3 trial tests whether a combination of two experimental drugs (futibatinib and zimberelimab) plus standard chemotherapy can help people with advanced biliary tract cancer live longer compared to current standard immunotherapy combinations. The study enrolls about 784 a…
Phase 3 • Sponsor: Taiho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can leadership training boost mental health screening in malawi?
Disease control Recruiting nowThis study tests whether combining a leadership alignment program with a champion strategy helps clinics in Malawi better integrate mental health care for anxiety and depression. About 1,080 adult patients who screen positive for these conditions will take part. The goal is to se…
Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Brain pacemaker targets cerebellum to quiet severe tremors
Disease control Recruiting nowThis study tests whether electrical stimulation of a part of the brain called the deep cerebellar nuclei can safely reduce severe tremor. The participants are adults with essential tremor, cerebellar outflow tremor, or MS-related tremor that has not improved with medication or pr…
Phase 1 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could tiny doses of radiation slow Alzheimer's? a new trial investigates
Disease control Recruiting nowThis study tests whether very low doses of radiation delivered to the whole brain are safe and can help preserve thinking and memory in people with Alzheimer's disease or certain dementias with inflammation. Participants receive an initial course of 10 radiation sessions, followe…
Phase 1/2 • Sponsor: Evan Thomas • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Custom cochlear implant tuning based on ear shape may boost hearing
Disease control Recruiting nowThis study tests whether programming a cochlear implant based on each person's unique inner ear structure improves hearing compared to the standard one-size-fits-all approach. Adults with severe to profound hearing loss who already have a MED-EL cochlear implant will receive both…
Sponsor: Universitair Ziekenhuis Brussel • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could stem cells restore sight in damaged eyes?
Disease control Recruiting nowThis study tests whether injecting a person's own bone marrow stem cells into or near the eye can help treat various retinal and optic nerve diseases, including age-related macular degeneration, retinitis pigmentosa, and glaucoma. Participants receive stem cell injections via dif…
Sponsor: MD Stem Cells • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could your own stem cells heal your brain? new trial tests it
Disease control Recruiting nowThis study is testing whether stem cells taken from a person's own bone marrow and then given back through the veins and nose can improve brain and nerve function. It includes 500 people with various conditions like stroke, Parkinson's, Alzheimer's, and nerve damage. The goal is …
Sponsor: MD Stem Cells • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could a sticky solution help IVF embryos implant?
Disease control Recruiting nowThis study tests whether adding a substance called hyaluronan to the liquid used during embryo transfer can improve pregnancy rates in IVF. Researchers will compare live birth rates between women whose embryos are placed in a hyaluronan-rich medium versus a standard one. The tria…
Sponsor: ART Fertility Clinics LLC • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Smartwatch study aims to Fine-Tune Parkinson's medication timing
Disease control Recruiting nowThis study investigates whether a wrist-worn sensor (KinesiaU) can accurately measure how long people with Parkinson's disease experience 'good on-time' — periods when medication works well and symptoms are controlled without troublesome movements. Researchers are testing IPX-203…
Phase 4 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a new eye drug cut injection frequency for AMD patients?
Disease control Recruiting nowThis study looks at 100 people with wet age-related macular degeneration (AMD) who have been getting regular eye injections with older drugs. They will switch to a newer drug called faricimab. The goal is to see if faricimab can extend the time between injections, meaning fewer t…
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Brain implant that thinks for itself could transform Parkinson's care
Disease control Recruiting nowThis study tests a new type of deep brain stimulation (DBS) that automatically adjusts its settings based on real-time brain signals, unlike standard DBS which uses fixed stimulation. Sixty people with Parkinson's disease will have a special neurostimulator implanted and then exp…
Sponsor: Beijing Pins Medical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Gene therapy injection aims to restore sight in rare blindness
Disease control Recruiting nowThis study tests a gene therapy called ZVS203e for people with retinitis pigmentosa caused by a specific RHO gene mutation. The therapy is injected into the eye and uses a harmless virus to deliver a gene-editing tool. The trial includes 18 adults and will check safety and whethe…
Phase 1/2 • Sponsor: Chigenovo Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a gentle eye scan replace stressful exams for preterm infants?
Diagnosis Recruiting nowThis study tests whether a handheld, ultra-widefield eye scanner (OCT) can accurately identify preterm infants with severe retinopathy of prematurity (ROP), a condition that can harm vision. The scanner takes detailed images of the retina without touching the eye, potentially red…
Sponsor: Duke University • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Can advanced imaging reveal hidden swallowing muscle damage in IBM?
Diagnosis Recruiting nowResearchers at Johns Hopkins University are studying whether neuromuscular ultrasound and MRI can serve as reliable markers of swallowing muscle problems in people with inclusion body myositis (IBM). The study compares imaging and clinical findings in 30 participants, including p…
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Ear device could spot seizures without wires
Diagnosis Recruiting nowThis study is testing a small device that fits in the ear to detect seizures by measuring brain waves. Researchers will first test it on 5 healthy people, then on 10 people with epilepsy who are already scheduled for a standard scalp EEG. The goal is to see if the in-ear device i…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
Hearing loss in children may hide a balance problem, and doctors are testing for it
Diagnosis Recruiting nowResearchers are studying how often children with sensorineural hearing loss also have problems with their balance system. The study enrolls 48 children aged 3 to 10 with hearing loss in one or both ears. Children complete questionnaires and a series of balance and inner-ear tests…
Sponsor: Gødstrup Hospital • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
Your phone could detect dementia: new app listens for clues
Diagnosis Recruiting nowThis study is testing a smartphone app that records and analyzes speech to help diagnose and monitor neurodegenerative conditions like dementia, Parkinson's disease, multiple sclerosis, and motor neuron disease. Researchers will compare speech patterns from 150 people with these …
Sponsor: University of Edinburgh • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
Can a new PET tracer reveal hidden tau in the brain?
Diagnosis Recruiting nowThis study tests whether a radioactive tracer called 18F-S16/T807 can help diagnose tau-related brain diseases. Tau is a protein that builds up abnormally in conditions like Alzheimer's and other neurodegenerative disorders. Researchers will give 500 adults a single injection of …
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
Your face could reveal hidden light sensitivity – no words needed
Diagnosis Recruiting nowThis study aims to create an objective way to diagnose and monitor light sensitivity by measuring facial features, pupil reactions, and nerve responses to light. Researchers will compare 120 people with and without light sensitivity (due to traumatic brain injury or migraine) to …
Sponsor: Randy Kardon • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
New imaging agent could light up depression, anxiety, and heart injury
Diagnosis Recruiting nowThis study tests a radioactive tracer called 18F-AIPF-1026 that binds to monoamine oxidase A (MAO-A), an enzyme linked to depression, anxiety, and heart injury. About 200 adults with these conditions will receive a single injection of the tracer and then undergo PET/CT or MRI sca…
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
New brain scan could spot Parkinson's earlier
Diagnosis Recruiting nowThis study tests whether a special imaging agent called 18F-FPyCO/SMBT-1 can help diagnose Parkinson's disease and related conditions by detecting a brain enzyme called MAO-B. About 200 adults with suspected or confirmed Parkinson's will receive a single injection of the agent an…
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
Radioactive tracers aim to spot Parkinson's in the brain
Diagnosis Recruiting nowThis study is testing three new radioactive tracers that light up alpha-synuclein clumps in the brain during PET/CT scans. Researchers want to see if these scans can accurately diagnose Parkinson's disease and related disorders. 500 adults with suspected or confirmed Parkinson's …
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
A simple heart scan may unmask a hidden cause of heart failure
Diagnosis Recruiting nowThis study tests whether a cardiac imaging technique called a PYP scan can detect transthyretin amyloidosis in people aged 65 and older who have heart failure with preserved ejection fraction, also known as diastolic heart failure. The researchers will scan 515 participants to se…
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Sep 03, 2026 00:00 UTC
-
New brain scan tracer could spot Parkinson's and related disorder
Diagnosis Recruiting nowThis early-stage study tests a new radioactive tracer called SST001 that lights up on PET scans. Researchers want to see if it is safe and can help tell the difference between multiple system atrophy (MSA) and Parkinson's disease. The study will include 30 healthy volunteers and …
Phase 1 • Sponsor: Synusight Biotech (Shanghai) Co., Ltd. • Aim: Diagnosis
Last updated Sep 03, 2026 00:00 UTC
-
Can a simple blood test catch Cushing's earlier?
Diagnosis Recruiting nowThis study aims to improve how doctors diagnose Cushing's syndrome, a condition caused by too much cortisol. Researchers will test the accuracy of the desmopressin stimulation test in 140 people aged 18-70 who have or may have Cushing's, plus healthy volunteers. Participants will…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
Can a dual DNA-RNA approach unlock Parkinson's genetic secrets?
Diagnosis Recruiting nowThis study aims to find the missing genetic causes of Parkinson's disease in people with early-onset or familial forms who haven't received a molecular diagnosis. Researchers will use a combination of whole genome and RNA sequencing to look for hidden genetic variants. The goal i…
Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Aug 23, 2026 00:00 UTC
-
A new window into Babies' eyes: can advanced imaging improve care for premature infants?
Diagnosis Recruiting nowThis study is testing a new, noninvasive imaging device called HH-SECTR to see inside the eyes of premature infants with retinopathy of prematurity (ROP), a condition that can affect vision. The goal is to see if this technology can provide clearer, more detailed images of the re…
Sponsor: Vanderbilt University Medical Center • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
New PET tracer aims to spot Parkinson's in the brain
Diagnosis Recruiting nowThis early-phase trial tests a new radioactive tracer called [11C]MODAG-005 that binds to abnormal protein clumps in the brain linked to Parkinson's disease and multiple system atrophy. Nine participants (patients with Parkinson's, MSA, and healthy volunteers) will receive the tr…
Early phase 1 • Sponsor: MODAG GmbH • Aim: Diagnosis
Last updated Aug 02, 2026 00:00 UTC
-
Carpal tunnel surgery could spot hidden heart disease risk
Diagnosis Recruiting nowThis study looks at whether taking a small piece of ligament during routine carpal tunnel surgery can help diagnose transthyretin amyloidosis, a serious condition that often goes unnoticed until it affects the heart. Researchers will compare this new biopsy method to the standard…
Sponsor: Clinique Saint Jean, France • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New prenatal blood test aims to detect genetic disorders without invasive procedures
Diagnosis Recruiting nowThis study is testing a new blood test that looks for fetal cells in the mother's blood to detect genetic conditions like Down syndrome. The test will be compared to standard diagnostic methods such as amniocentesis or newborn testing. The study involves 1,000 pregnant individual…
Sponsor: BillionToOne Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Can a phone app nudge people toward exercise and slow Parkinson's?
Prevention Recruiting nowThis trial tests whether a smartphone app can help people with REM sleep behavior disorder, a condition that often precedes Parkinson's, become more physically active over two years. Participants receive personalized activity goals through the app and track their steps and exerci…
Sponsor: Radboud University Medical Center • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
Could a phone app nudge people to exercise and slow Parkinson's before symptoms appear?
Prevention Recruiting nowThis trial tests whether a smartphone app can help 600 people with Parkinson's-related gene mutations increase their daily physical activity over two years. Participants set their own exercise goals and get feedback through the app. Researchers will measure changes in step counts…
Sponsor: Radboud University Medical Center • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
Goji berry trial hopes to shield aging eyes from vision loss
Prevention Recruiting nowThis study tests whether eating goji berries five days a week for six months can lower the risk of age-related macular degeneration (AMD) in people aged 65 to 95. Participants will eat 14 grams of goji berries or a fiber supplement and have their eye health, gut bacteria, and oth…
Sponsor: University of California, Davis • Aim: Prevention
Last updated Jul 19, 2026 00:00 UTC
-
Can mobile eye scans in villages prevent blindness in older adults?
Prevention Recruiting nowThis trial tests whether a community-based screening program using advanced eye imaging (OCT, fundus photography, and pressure checks) can prevent vision loss from age-related macular degeneration, diabetic retinopathy, and glaucoma better than simple vision tests alone. About 60…
Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Jun 27, 2026 13:04 UTC
-
Brain pacemaker tweak could help stroke and tremor patients speak and swallow better
Symptom relief Recruiting nowThis study looks at whether adjusting deep brain stimulation (DBS) can improve movement, speech, and swallowing in people already implanted with DBS for conditions like tremor, stroke, or traumatic brain injury. Researchers will test hand dexterity, grip strength, facial movement…
Sponsor: Jorge Gonzalez-Martinez • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Exercise with or without compression: a new hope for leg swelling?
Symptom relief Recruiting nowThis study looks at whether doing resistance exercises (like leg presses) can reduce swelling in the lower legs of people with lymphedema. It also checks if wearing compression garments during exercise makes a difference. Thirty-six adults with lower limb lymphedema will exercise…
Sponsor: Carsten Bogh Juhl • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a Weight-Loss drug ease rett syndrome?
Symptom relief Recruiting nowThis Phase 3 trial tests whether fenfluramine (Fintepla) can reduce behavioral and emotional symptoms in people with Rett syndrome. About 200 participants will receive either the drug or a placebo for 14 weeks. The study measures changes in behavior, sleep, and overall condition …
Phase 3 • Sponsor: UCB BIOSCIENCES, Inc. • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
New therapy aims to help kids with speech disorder speak in phrases
Symptom relief Recruiting nowThis study tests a speech therapy called DTTC-Connect for children aged 3 to 12 with childhood apraxia of speech, a disorder that makes it hard to say words clearly. The therapy focuses on helping children move from saying single words to speaking in phrases. Sixty-eight children…
Sponsor: New York University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can video games calm anxious teens?
Symptom relief Recruiting nowResearchers are testing whether playing video games can reduce anxiety in adolescents aged 11 to 15 with elevated anxiety symptoms. The trial compares an action game designed to boost attention control, a casual puzzle game, and no game at all. Teens play at home online for six w…
Sponsor: School of Health Sciences Geneva • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Could a common anxiety drug help autistic youth? new trial aims to find out.
Symptom relief Recruiting nowThis study tests whether buspirone, a medication used for anxiety, is safe and effective for autistic youth aged 7 to 17 who also have anxiety disorders. Researchers will measure changes in anxiety symptoms over 16 weeks. The goal is to see if this drug can ease anxiety in this s…
Phase 4 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Three shots, one wrist: which injection best eases carpal tunnel?
Symptom relief Recruiting nowCarpal tunnel syndrome happens when the median nerve gets squeezed at the wrist, causing numbness, tingling, and pain in the hand. This study compares three ultrasound-guided injections for adults with mild to moderate cases: hyaluronic acid, corticosteroid, and 5% glucose. Sixty…
Early phase 1 • Sponsor: Tanta University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a group program teach teens to cope before therapy starts?
Symptom relief Recruiting nowResearchers at Penn State are testing whether the BaSICS program reduces anxiety, depression, and suicide risk in 11- to 14-year-olds from low-income families who are waiting for mental health services. The program teaches coping skills, healthy identity development, and collecti…
Sponsor: Penn State University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Coloring books in the ER: a simple fix for long waits?
Symptom relief Recruiting nowThis study tests whether giving coloring activities (nature scenes, geometric shapes, word searches, or free drawing) to adults waiting in the emergency department can lower their self-reported pain and anxiety. Researchers will measure changes using standard questionnaires. If e…
Sponsor: Stony Brook University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Horseback therapy may help Parkinson's patients move better
Symptom relief Recruiting nowThis pilot study tests whether hippotherapy, a type of physical therapy using the natural movement of a horse, can improve mobility, gait, balance, and quality of life in people with Parkinson's disease. Participants will be randomly assigned to receive either hippotherapy sessio…
Sponsor: Klinik Valens • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
New device aims to help stroke survivors move their arms again
Symptom relief Recruiting nowThis pilot study tests whether a device called IVS3 is tolerable and easy to use for arm recovery in people who had a stroke at least 6 months ago. The device uses mirrored video to create the illusion that the affected arm is moving. Researchers will track how many sessions part…
Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
New Identity-Based therapy aims to beat standard CBT for young adults
Symptom relief Recruiting nowThis study tests a new type of talk therapy called Identity-Based Transdiagnostic Therapy (IBTT) for young adults with anxiety or depression. It compares IBTT to a well-known therapy called the Unified Protocol (CBT-based). The goal is to see if IBTT is more engaging and effectiv…
Sponsor: University of Barcelona • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Could a gentle zap to the brain ease Parkinson's symptoms?
Symptom relief Recruiting nowThis study will test whether a gentle, non-invasive brain stimulation technique called tDCS can improve verbal fluency, thinking, and motor control in people with Parkinson's disease. Twenty participants aged 50-90 with Parkinson's and a verbal fluency deficit will receive the st…
Sponsor: The University of Texas at Dallas • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Sleep sounds may boost brain power and mood in anxious young adults
Symptom relief Recruiting nowThis study tests whether playing gentle sounds during deep sleep can improve thinking and emotional control in young adults (ages 18-25) with anxiety, depression, and sleep problems. Participants will spend two nights in a sleep lab, once with tones and once without, and complete…
Sponsor: Michelle Stepan • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Zapping tremors: radiation may offer new hope for Parkinson's and essential tremor patients
Symptom relief Recruiting nowThis study follows 60 people with essential tremor or Parkinson's tremor whose symptoms aren't well-controlled by medication. After receiving stereotactic radiosurgery—a precise dose of radiation to a small brain area—participants fill out questionnaires about their quality of li…
Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Alcoholism drug may boost vision in eye disease patients
Symptom relief Recruiting nowThis study looks at whether disulfiram (Antabuse), a drug used for alcohol use disorder, can improve vision in people with retinal degeneration (like macular degeneration or retinitis pigmentosa). Researchers believe it may calm overactive cells in the retina. The study involves …
Phase 1 • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can home exercise and mindfulness help people with rare brain diseases walk and sleep better?
Symptom relief Recruiting nowResearchers are testing whether a home-based program combining adapted exercise and mindfulness training can improve walking ability and sleep quality in people with rare neurodegenerative diseases such as leukodystrophy, ataxia, and adrenomyeloneuropathy. The study enrolls about…
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
New drug combo aims to ease dystonia symptoms
Symptom relief Recruiting nowThis phase 2 trial tests whether VIM0423, a combination of two drugs, can reduce symptoms of isolated dystonia (a movement disorder causing muscle spasms). About 100 adults aged 18-65 with dystonia in at least two body areas will receive either VIM0423 or a placebo. Researchers w…
Phase 2 • Sponsor: Vima Therapeutics • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Sound waves aim to ease stuttering in early trial
Symptom relief Recruiting nowThis study tests whether low-intensity focused ultrasound (LIFU), a gentle sound wave technique, can safely improve speech fluency in people who stutter. Twenty adults who stutter will receive LIFU or a sham treatment, and researchers will measure changes in stuttering severity a…
Sponsor: University of Michigan • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
New shot aims to ease depression and anxiety in cancer and chronic disease patients
Symptom relief Recruiting nowThis study tests whether a single injection of RE104 can reduce symptoms of depression or mixed depression and anxiety in people with adjustment disorder caused by a serious medical illness like cancer, ALS, multiple sclerosis, Parkinson's disease, or idiopathic pulmonary fibrosi…
Phase 2 • Sponsor: Reunion Neuroscience Inc • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Could ditching diets during pregnancy improve weight gain and mood?
Symptom relief Recruiting nowResearchers at San Diego State University are testing an 8-week online program that teaches intuitive eating principles to pregnant women with obesity. The program includes weekly video modules and workbook exercises, with optional office hours. The study will compare participant…
Sponsor: San Diego State University • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Sound waves aimed at the brain could tame seizures
Symptom relief Recruiting nowThis early study tests a device that uses low-intensity focused ultrasound to calm overactive brain areas in people with drug-resistant temporal lobe epilepsy. Eight adults will receive up to three 10-minute ultrasound sessions. Researchers will track side effects and check if se…
Phase 1/2 • Sponsor: NaviFUS Corporation • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can a nudge toward healthy habits boost an online depression and anxiety program?
Symptom relief Recruiting nowThis trial tests whether adding personalized feedback makes an ultra-brief online program more effective for adults with depression and anxiety. The program, called Things You Do, teaches skills to increase healthy actions like meaningful activities, healthy thinking, and social …
Sponsor: University of Regina • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Brain training through implanted electrodes aims to quiet Parkinson's tremors
Symptom relief Recruiting nowResearchers are testing whether people with Parkinson's disease, epilepsy, or essential tremor can use visual neurofeedback to change abnormal brain activity linked to their symptoms. Participants already scheduled for deep brain stimulation surgery use their implanted electrodes…
Sponsor: ETH Zurich • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Can a tuned brain implant sharpen thinking in Parkinson's?
Symptom relief Recruiting nowMany people with Parkinson's disease develop problems with thinking and memory, and few treatments help. This trial tests whether deep brain stimulation delivered at a specific rhythm, called theta frequency, can improve working memory. Participants already have a stimulator impl…
Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Could a wakefulness drug beat fatigue in IBD patients?
Symptom relief Recruiting nowThis study tests whether modafinil, a drug used for sleep disorders, can reduce severe fatigue in adults with inactive inflammatory bowel disease (IBD). Sixty participants will take either modafinil or a placebo for 8 weeks, starting at 100 mg daily with possible dose increases. …
Phase 2/3 • Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Brain pacemaker tweak may ease Parkinson's without fogging thinking
Symptom relief Recruiting nowThis study tests a new way to use deep brain stimulation (DBS) for Parkinson's disease. Standard DBS helps movement but can sometimes cause thinking or mood problems. The researchers will add low-frequency stimulation to a different part of the brain while keeping the usual high-…
Sponsor: University of California, Davis • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Two surgeries, one goal: easing crippling muscle tightness in kids
Symptom relief Recruiting nowChildren and teens with spastic or dystonic quadriplegia from cerebral palsy often need surgery to control severe muscle tightness that interferes with comfort, movement, and care. Doctors at Boston Children's Hospital are tracking outcomes for two approaches: implanted baclofen …
Sponsor: Boston Children's Hospital • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Internet therapy could ease OCD in kids with autism
Symptom relief Recruiting nowThis study tests whether a therapist-guided online cognitive-behavior therapy program can help reduce obsessive-compulsive disorder (OCD) symptoms in children and teens with autism. About 220 participants will receive the online treatment or a comparison condition. The goal is to…
Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Old drug showdown: can benzhexol match procyclidine for Parkinson's tremor?
Symptom relief Recruiting nowResearchers are comparing two anticholinergic medicines, benzhexol and procyclidine, to see whether they ease tremor similarly in adults with tremor-predominant Parkinson's disease. About 88 people aged 40 to 70 who already take levodopa will be randomly assigned to add one of th…
Sponsor: safia bano • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Brain implant learns to fight Parkinson's symptoms around the clock
Symptom relief Recruiting nowThis study tests whether a deep brain stimulator (DBS) that automatically adjusts its settings can better control movement and sleep problems in people with Parkinson's disease. 24 adults aged 25-75 will have electrodes placed under the scalp to record brain signals. The device w…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
New wearable tech aims to ease swallowing troubles for stroke and Parkinson's patients
Symptom relief Recruiting nowThis study tests a wearable sensor that tracks neck muscle activity during swallowing exercises, providing real-time feedback to patients. Researchers want to see if adding this device to standard therapy improves swallowing more than therapy alone. The study includes 120 adults …
Phase 2 • Sponsor: University of Illinois at Urbana-Champaign • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Parkinson's sleep breakthrough? new infusion under study
Symptom relief Recruiting nowThis study looks at whether a new pump-delivered medication (Foslevodopa/Foscarbidopa) can help improve sleep problems in people with advanced Parkinson's disease. About 103 adults in Spain will take part, and researchers will track their sleep quality over 12 weeks using a simpl…
Sponsor: AbbVie • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
School Stress-Busting program for LGBTQ teens shows promise, but study cut short
Symptom relief Recruiting nowThis study tested a school-based program called Proud & Empowered, designed to help LGBTQ students cope with minority stress and improve mental health. About 228 high school students took part. The program was led by school counselors and social workers. The study was terminated …
Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Scalpel vs sound waves: two carpal tunnel surgeries go head to head
Symptom relief Recruiting nowCarpal tunnel syndrome happens when a nerve in the wrist gets squeezed, causing pain, numbness, and weakness in the hand. Open surgery has long been the standard fix, but a newer minimally invasive method uses ultrasound to guide the release through a much smaller opening. This s…
Sponsor: AUVA General Trauma Hospital Salzburg • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can intensive speech therapy rewire speech in children with rare genetic conditions?
Symptom relief Recruiting nowResearchers are testing whether four weeks of intensive motor speech therapy can improve speech accuracy in children who have childhood apraxia of speech along with a rare genetic condition. The study enrolls up to 20 children aged 3 to 16. Each child receives 12 sessions of eith…
Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
New pill aims to smooth out Parkinson's motor swings
Symptom relief Recruiting nowThis study tests an experimental drug called AP-472 in people with Parkinson's disease who have motor fluctuations—times when their usual levodopa medication stops working well. About 150 participants will take either a low dose, a high dose, or a placebo pill for 8 weeks, added …
Phase 2 • Sponsor: Appello Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Two-Week summer program aims to ease OCD in teens
Symptom relief Recruiting nowThis study tests a two-week intensive summer treatment program for 70 adolescents aged 12-18 with obsessive-compulsive disorder (OCD) in Iceland. The program uses daily cognitive-behavioral therapy with exposure and response prevention in a group setting. Researchers will measure…
Sponsor: University of Iceland • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Ear acupuncture tested for Post-Surgery pain relief
Symptom relief Recruiting nowThis study tests whether auriculotherapy (a type of ear acupuncture) can help manage pain after carpal tunnel surgery. Fifty adults will receive either real or sham auriculotherapy before surgery, and their pain levels will be tracked for three days afterward. The goal is to see …
Sponsor: Clinique Bizet • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a little extra support boost a meditation App's power against depression?
Symptom relief Recruiting nowThis study is testing whether adding small amounts of human coaching, email reminders, or text messages to a meditation app can help people with depression and anxiety feel better. About 688 adults with elevated symptoms will use the Healthy Minds Program app for four weeks. Rese…
Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Brain retraining trial aims to ease chronic fatigue and long COVID symptoms
Symptom relief Recruiting nowThis study is testing a mind-body program called DNRS for people with ME/CFS (chronic fatigue syndrome) who may also have Long COVID. The program uses brain retraining to help calm overactive nerves and improve symptoms like fatigue, pain, and mood. Researchers will track quality…
Sponsor: University of Alberta • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Book therapy: a new way to ease anxiety before hysterectomy?
Symptom relief Recruiting nowThis study tests if reading a personal narrative book, in addition to standard care, can help women of childbearing age manage anxiety, depression, and negative thinking before a hysterectomy. About 156 women will either receive standard information or also read a book. The goal …
Sponsor: Groupe SantéCité SantéCité Enseignement-Recherche-Innovation (GCS SCERI) • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
New online therapy aims to ease cancer Survivors' mental health struggles
Symptom relief Recruiting nowThis study tests an online, therapist-guided program to help cancer survivors who have anxiety, depression, or fear of cancer returning. About 400 adults in Sweden who finished cancer treatment at least 6 months ago will take part. The goal is to see which parts of the 10-week on…
Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Could a simple amino acid ease rare brain disorders?
Symptom relief Recruiting nowThis study tests a drug called N-acetyl-L-leucine for people aged 4 and older with CACNA1A gene disorders, which can cause coordination problems, dizziness, and migraines. About 60 participants will receive either the drug or a placebo, then switch, to see if it improves movement…
Phase 3 • Sponsor: IntraBio Inc • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Mindfulness vs. relaxation: which reshapes the anxious brain?
Symptom relief Recruiting nowThis study tests whether an 8-week mindfulness program can reduce anxiety and depression in adults with mild emotional distress. Participants are randomly assigned to either mindfulness training or progressive muscle relaxation. Researchers use brain scans to see if mindfulness c…
Sponsor: Peking University • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
New Parkinson's pill aims to cut 'OFF' time and ease daily struggles
Symptom relief Recruiting nowThis Phase 2 trial tests whether adding Lu AF28996 to standard Parkinson's medications can extend the time patients feel their movement symptoms are well-controlled (called 'good ON time'). About 150 adults with Parkinson's who still experience motor fluctuations despite optimize…
Phase 2 • Sponsor: H. Lundbeck A/S • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Could a 4-Day therapy tame OCD? new study aims to find out
Symptom relief Recruiting nowThis study tests a four-day intensive therapy called Bergen Four-Day Treatment (B4DT) for people with obsessive-compulsive disorder (OCD). About 35 patients will receive the therapy, which involves exposure and response prevention exercises over four days, followed by three month…
Sponsor: Tampere University Hospital • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Stress ball may calm nerves before kidney surgery, trial hopes
Symptom relief Recruiting nowThis study tests whether using a stress ball for 15 minutes before retrograde intrarenal surgery (a type of kidney stone procedure) can lower patients' anxiety and fear, and improve heart rate and blood pressure. Sixty-six adults scheduled for elective surgery will be randomly as…
Sponsor: Mersin University • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
A 3-session online tool aims to calm caregivers' fear as cancer advances
Symptom relief Recruiting nowThis study tests a short, three-session online program designed to help caregivers of people with advanced prostate cancer manage their fear that the cancer will progress. The program teaches techniques like detached mindfulness to help caregivers relate to worrying thoughts in a…
Sponsor: University of Aarhus • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can laughter be the best medicine? improv comedy tested as an anxiety treatment.
Symptom relief Recruiting nowThis trial tests whether a four-week improv comedy program can reduce anxiety and improve mental well-being in Chinese young adults in Hong Kong who have mild-to-moderate anxiety but no diagnosed mental disorder. Participants attend weekly three-hour improv workshops and complete…
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
App aims to give a voice to those with speech difficulties
Symptom relief Recruiting nowThis pilot study tests whether the Voiceitt app can help people with speech impairments caused by conditions like cerebral palsy, stroke, ALS, or Parkinson's disease communicate more effectively. Participants use the app to see if it improves speech clarity and daily communicatio…
Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
New program aims to ease stress and anxiety in autistic college students
Symptom relief Recruiting nowThis study tests an 8-week program called MH-POWER designed to help autistic college students manage stress, anxiety, and depression. The program combines cognitive behavioral therapy, acceptance and commitment therapy, and habit formation through weekly group sessions and daily …
Sponsor: University of Texas Rio Grande Valley • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
New drug aims to reignite motivation in Parkinson's patients
Symptom relief Recruiting nowThis study tests an experimental drug called IRL757 in 75 people with Parkinson's disease who also have apathy (loss of interest or motivation). The main goal is to see if the drug is safe and tolerable over 12 weeks. Researchers will also check if it helps improve apathy symptom…
Phase 1/2 • Sponsor: Integrative Research Laboratories AB • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Teachers as frontline mental health providers: a new experiment in schools
Symptom relief Recruiting nowThis trial tests a program called Teachers Leading the Frontlines (Tealeaf) that trains elementary and middle school teachers in North Carolina to support students with mental health needs, such as depression, anxiety, and behavior challenges. Teachers learn to identify students …
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Brain zapping tailored to you: new study targets depression and anxiety
Symptom relief Recruiting nowThis study at the University of Pennsylvania is testing whether personalized brain stimulation can reduce negative emotions in people with depression and anxiety. Researchers will use brain scans to map each participant's negative emotion patterns, then apply different types of t…
Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Can a phone app lift depression? small study aims to find out
Symptom relief Recruiting nowThis pilot study will test whether a mobile phone app can help reduce depression symptoms in African American adults. Eight participants will attend six weekly 90-minute classes through the app and complete surveys over four months. The goal is to see if this approach is effectiv…
Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New gel may offer relief for persistent carpal tunnel pain
Symptom relief Recruiting nowThis study tests a gel called DYNAVISC placed around the nerve during repeat carpal tunnel surgery to see if it reduces pain and tingling better than standard surgery alone. About 50 adults with ongoing hand pain after a prior carpal tunnel release will take part. Results are mea…
Sponsor: FzioMed • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New group therapy aims to tame meltdowns in Prader-Willi teens
Symptom relief Recruiting nowThis study tests a group program to help teens (ages 13-17.5) with Prader-Willi Syndrome and their families learn practical ways to handle irritability, meltdowns, and anxiety. Ten participants will attend weekly 90-minute sessions. The goal is to see if the program improves emot…
Sponsor: Children's Mercy Hospital Kansas City • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Brain zaps + speech therapy: new hope for stuttering?
Symptom relief Recruiting nowThis study tests whether a gentle brain stimulation technique (tDCS) combined with standard speech therapy can reduce stuttering severity and its negative impact on daily life. Sixteen adults who stutter will receive both treatments, and researchers will measure changes in speech…
Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New device zaps brain in sync with tremors to quiet shaking hands
Symptom relief Recruiting nowThis study tests a non-invasive device that delivers mild electrical stimulation to the cerebellum, timed precisely to each patient's hand tremor rhythm. Ten people with Parkinson's and moderate-to-severe hand tremor will receive both real and sham stimulation to see if the real …
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Can helping with food and stress improve kids' development?
Symptom relief Recruiting nowThis study aims to help families with food insecurity and mothers with depression by providing resources like food, rent help, and mental health support. Researchers will enroll 2,000 caregivers of young children in the hospital to see if these services improve mother-child bondi…
Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
A new program aims to ease cancer survivors' fear of recurrence
Symptom relief Recruiting nowThis trial tests a program that screens cancer survivors for fear of recurrence and refers those who need help to psychological services. The program is being rolled out in cancer clinics in Hong Kong, with nurses trained to identify at-risk patients. Researchers will measure how…
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
A new approach to tame the fear that lingers after cancer
Symptom relief Recruiting nowThis trial tests a stepped-care program to help cancer survivors manage fear of their cancer returning. The program starts with an online intervention called eConquerFear, which teaches strategies to control worry and accept uncertainty. If needed, participants receive additional…
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Music that moves you: personalized beats may improve walking in Parkinson's
Symptom relief Recruiting nowThis study tests a digital music device called MyMusiQ that delivers personalized music cues to help people with Parkinson's disease walk more easily and automatically. Participants wear foot sensors and headphones; the device adjusts the music's rhythm in real time based on thei…
Sponsor: Boston University Charles River Campus • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Could pressurized oxygen ease chronic fatigue? new trial aims to find out
Symptom relief Recruiting nowThis study tests whether breathing pure oxygen in a pressurized chamber (hyperbaric oxygen therapy) can help people with mild to moderate chronic fatigue syndrome. 74 participants will receive either real treatment or a sham (placebo) for 60 sessions over 3 months. Researchers wi…
Sponsor: Assaf-Harofeh Medical Center • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Micro-Choices, macro impact? a novel behavioral approach takes on fatigue
Symptom relief Recruiting nowThis trial tests whether a program built around small, deliberate choices — called micro-choices — can help people with persistent fatigue, including those with long COVID. Participants attend a four-day group workshop and receive three weeks of digital support to build new habit…
Sponsor: University Hospital, Basel, Switzerland • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Morning light may ease OCD symptoms in night owls
Symptom relief Recruiting nowThis study tests whether wearing light therapy glasses for one hour each morning can reduce obsessive-compulsive disorder (OCD) symptoms in young adults (ages 18–35) who go to bed at 1 a.m. or later. Participants wear the glasses daily for five weeks, track their sleep, and compl…
Early phase 1 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Can a 5-Minute chat with the school nurse ease childhood anxiety?
Symptom relief Recruiting nowThis study tests a program called Grow with Grit, where school nurses screen children aged 8-12 in rural Montana for anxiety using a standard questionnaire. Children who show signs of anxiety receive a brief, 3-5 minute coping-skills session during a regular nurse visit, along wi…
Sponsor: McLaughlin Research Institute for Biomedical Sciences, Inc. • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Parkinson's pain: could a new Add-On drug bring relief?
Symptom relief Recruiting nowThis clinical trial tests whether safinamide, an add-on medication, can reduce chronic pain in people with Parkinson's disease who also experience motor fluctuations. About 60 adults with Parkinson's and pain lasting over three months will receive either safinamide or a placebo f…
Phase 3 • Sponsor: Universita di Verona • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can retraining word meanings restore lost speech?
Symptom relief Recruiting nowThis study tests whether a specialized speech therapy that focuses on word meanings can help people with mild-to-moderate semantic aphasia—a condition where brain damage impairs understanding and use of words. Participants first undergo a control period of standard language exerc…
Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Magic mushroom compound tested for Parkinson's depression
Symptom relief Recruiting nowThis study tests whether a single dose of psilocybin, given with psychological support, can improve depression in people with Parkinson's disease. Sixty adults aged 40 to 80 with mild to moderate Parkinson's and depressive symptoms will receive either a low or high dose of psiloc…
Phase 2 • Sponsor: Joshua Woolley, MD, PhD • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can rewiring fear expectations stop anxiety from coming back?
Symptom relief Recruiting nowThis study tests whether a new form of exposure therapy, called Expectancy Focused Exposure (EFE), can reduce anxiety symptoms and prevent fear from returning more effectively than traditional exposure therapy. Adults with anxiety disorders—such as social anxiety, panic disorder,…
Sponsor: University of Chile • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can a simple hydrogen drink ease chronic fatigue?
Symptom relief Recruiting nowThis trial tests whether drinking hydrogen-rich water for 16 weeks can reduce fatigue and improve physical functioning in people with ME/CFS (chronic fatigue syndrome). Half of the 80 participants will receive the active supplement, while the other half gets a placebo. The study …
Sponsor: Fred Friedberg • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Vibrating tendons may steady shaky legs — a trial puts it to the test
Symptom relief Recruiting nowThis trial tests whether adding focal tendon vibration to a two-week intensive rehabilitation program can improve balance in adults with Charcot-Marie-Tooth disease type 1A (CMT1A). CMT1A causes progressive muscle weakness and poor balance, often leading to falls. Participants wi…
Sponsor: UGECAM PACA et Corse • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Improv as therapy? a creative approach to youth mental health
Symptom relief Recruiting nowThis study tests whether theatrical improvisation can help children and adolescents aged 8 to 17 who have elevated anxiety or depression. Participants are randomly assigned to one of three groups: improv combined with wellness techniques (like cognitive-behavioral skills), improv…
Sponsor: Case Western Reserve University • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
One therapy to tackle two conditions: a trial combines exposure and habit reversal for tourettic OCD
Symptom relief Recruiting nowThis trial tests whether a therapy that blends Exposure and Response Prevention (ERP) with Habit Reversal Training (HbRT) can reduce both obsessive-compulsive and tic symptoms in adults with Tourettic OCD — a subtype where OCD and tic disorders overlap. Standard treatments usuall…
Sponsor: University College London Hospitals • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
A common antidepressant may tame anxiety in kids with autism and ADHD — a trial puts it to the test
Symptom relief Recruiting nowThis trial tests whether sertraline, a widely used antidepressant, can reduce anxiety in children and teens aged 8 to 17 with neurodevelopmental disorders such as autism, ADHD, Fragile X syndrome, and Tourette syndrome. Participants receive either sertraline or a placebo for seve…
Phase 2 • Sponsor: Holland Bloorview Kids Rehabilitation Hospital • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Can a Four-Week program ease the burden on autism caregivers?
Symptom relief Recruiting nowThis trial tests whether a culturally adapted, nurse-led program called COPE can improve the psychological wellbeing of primary caregivers of children with autism spectrum disorder in Pakistan. The program includes four weekly sessions focused on coping skills, emotional regulati…
Sponsor: Khyber Medical University Peshawar • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Sniff away the sick feeling: do essential oils and a Nerve-Zapping wristband really fight nausea?
Symptom relief Recruiting nowThis study tests whether two non-prescription therapies—inhaled essential oils and a wearable TENS device—can help adults with chronic nausea and anxiety. Participants use the essential oil products as needed for 12 weeks, then switch to the TENS device for another 12 weeks, whil…
Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Virtual group therapy aims to boost social skills in kids with rare muscle disease
Symptom relief Recruiting nowThis trial tests a 12-session telecare program for children aged 7 to 17 with limb-girdle muscular dystrophy. The group-based intervention focuses on social cognition, emotional management, and coping strategies to improve quality of life and reduce symptoms. Participants attend …
Sponsor: University of Deusto • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Dance may retrain the brain: new study tests rhythmic movement for Parkinson's and cognitive decline
Symptom relief Recruiting nowThis study investigates whether complex rhythmic movement training, like dancing with new partners, can improve mobility and learning in people with Parkinson's disease or mild cognitive impairment. Researchers will compare how participants with Parkinson's, those with memory pro…
Sponsor: Emory University • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Virtual reality boosts exercise intensity in Parkinson's cycling study
Symptom relief Recruiting nowThis study explores whether virtual reality can help people with Parkinson's disease exercise harder and enjoy it more while cycling. Participants ride a stationary bike in different conditions—with and without virtual reality, and with different cycling styles—to measure intensi…
Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Virtual reality headsets could replace painkillers after hip surgery
Symptom relief Recruiting nowThis study tests whether a 30-minute virtual reality session with nature scenes and music can reduce pain, anxiety, and improve comfort in people who just had hip replacement surgery. Participants choose from forest, beach, underwater, or outdoor footage. The goal is to see if VR…
Sponsor: Adiyaman University • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Brain zaps aim to spark motivation in Parkinson's patients
Symptom relief Recruiting nowThis study tests whether a non-invasive brain stimulation technique called TMS can help with apathy—a common lack of motivation—in people with Parkinson's disease. Sixty participants will receive TMS to two different brain areas on separate visits and perform a task where they ch…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Could a sweet sip before surgery ease Children's fears?
Symptom relief Recruiting nowThis study tests whether giving children a sugary drink (maltodextrin) two hours before surgery can reduce their anxiety and improve recovery. Children aged 3 to 17 having day surgery will receive either the sugary drink or a plain drink like water or tea. Researchers will measur…
Sponsor: Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Group therapy program aims to ease anxiety and depression in public health settings
Symptom relief Recruiting nowThis study tests a group therapy program called the Unified Protocol for adults with emotional disorders such as anxiety, depression, and related conditions. The program teaches skills like emotional awareness, flexible thinking, and facing fears. Researchers want to see if it im…
Sponsor: Patricia Fernández Couto • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Can a 5-Minute breathwork app tame anxiety?
Symptom relief Recruiting nowThis study explores whether a mobile app called FlowMD can help adults with mild anxiety. Participants use the app for 1-5 minutes of guided breathwork each day for four weeks. Surveys measure changes in anxiety levels and how easy the app is to use. The goal is to see if this ap…
Sponsor: National University of Natural Medicine • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Talking it out before knee surgery may cut pain
Symptom relief Recruiting nowThis study tests whether a videoconference with a psychologist before anterior cruciate ligament (ACL) knee surgery can reduce pain afterward. It includes 126 anxious patients scheduled for first-time ACL reconstruction. The main goal is to compare pain levels the night after sur…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Can a buddy system help young people after a mental health crisis?
Symptom relief Recruiting nowThis pilot study tests whether a peer support program can help young adults (ages 18-27) recently discharged from a psychiatric hospital. Participants get one-on-one and group meetings with trained Peer Support Specialists and recovery organizations, while a comparison group rece…
Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New anxiety program for ICU survivors shows promise in early trial
Symptom relief Recruiting nowThis pilot study tests a self-management program based on cognitive behavioral therapy to help people who survived acute respiratory failure and now struggle with anxiety. Sixty ICU survivors will either receive the program or usual care. The goal is to see if the program is prac…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Personalized exercise program aims to boost mobility in rare muscle diseases
Symptom relief Recruiting nowThis study tests whether a personalized exercise program can improve balance and physical function in adults with rare neuromuscular disorders like Charcot-Marie-Tooth disease, facioscapulohumeral muscular dystrophy, and myotonic dystrophy type 1. Participants will receive a 12-d…
Sponsor: Oslo University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Virtual reality goggles could ease pain and fear during cervical exams
Symptom relief Recruiting nowThis study tests whether using virtual reality (VR) goggles during a colposcopy can lower women's anxiety, stress, and pain. About 60 women scheduled for the procedure will either receive standard care or wear a VR headset showing calming content. The goal is to see if this simpl…
Sponsor: Osmaniye Korkut Ata University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Zap your brain to sharper thinking? new trial tests TIS for memory loss
Symptom relief Recruiting nowThis study tests a non-invasive brain stimulation technique called temporal interference stimulation (TIS) to see if it can improve cognitive function in people with mild cognitive impairment or early Alzheimer's disease. Sixty participants will receive either real TIS or a sham …
Sponsor: Tianjin Huanhu Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
New program targets exercise fear in heart patients
Symptom relief Recruiting nowThis study tests a 6-session program called BE-FIT that helps cardiac rehabilitation patients reduce anxiety about exercise. The program uses gradual exposure to feared sensations, prevents safety behaviors, and uses activity monitors for feedback. Researchers will enroll 146 adu…
Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Puppy power: study tests if therapy dogs calm kids at the dentist
Symptom relief Recruiting nowThis study looks at whether having a therapy dog present during a dental visit can lower stress in children. About 225 kids aged 4 to 8 will be randomly assigned to have a dental exam with or without a dog. Researchers will measure stress by tracking heart rate and testing saliva…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Could a brain ZAP and rehab combo ease movement problems?
Symptom relief Recruiting nowThis study tests if pairing a gentle, non-invasive brain stimulation (tDCS) with personalized physical therapy can help people with cerebellar damage (from stroke, tumor, or degeneration) improve movement and daily function. About 30 adults aged 18-75 will participate. The goal i…
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
CBD study aims to help seniors ditch cannabis for good
Symptom relief Recruiting nowThis study tests whether hemp-derived CBD (with or without THC) can help older adults (60+) who use cannabis for pain, anxiety, depression, or sleep problems. Over 8 weeks, 385 participants will take either CBD+THC, CBD alone, or a placebo. The goal is to see if CBD can reduce sy…
Phase 2 • Sponsor: University of Colorado, Boulder • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Can a massive data registry crack the code of Parkinson's and related brain diseases?
Knowledge-focused Recruiting nowResearchers are building a large database of cognitive, behavioral, lifestyle, and genetic information from people with neurodegenerative diseases such as Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. The goal is to find biomarkers that help do…
Sponsor: Vincent Mok • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Reading the Brain's signals to predict who benefits from deep brain stimulation
Knowledge-focused Recruiting nowDeep brain stimulation uses implanted electrodes to send electrical pulses to specific brain regions, and doctors are still working out how to tune it for each patient. This study records brain activity while adults with neurological or psychiatric conditions perform cognitive an…
Sponsor: Centre Hospitalier St Anne • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Massive study aims to unlock secrets of movement disorders
Knowledge-focused Recruiting nowThis natural history study is collecting information from up to 4,000 people with movement disorders (like Parkinson's disease or tremor) and their family members. Participants undergo exams, blood tests, and imaging, but receive no new treatments. The goal is to gather data that…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New brain scans aim to spot inflammation in Alzheimer's and Parkinson's
Knowledge-focused Recruiting nowThis study uses special PET scans to measure inflammation in the brains of people with Alzheimer's, Parkinson's, ALS, and other neurodegenerative diseases. Researchers will compare these scans to those from healthy volunteers to see if inflammation levels differ. The goal is to d…
Phase 1 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Massive study aims to unlock genetic secrets of movement disorders
Knowledge-focused Recruiting nowThis study aims to understand the link between genes and symptoms in people with inherited movement disorders. Researchers will study up to 2,500 participants, including patients and their family members, to identify new disease-causing genes and improve diagnosis. The goal is to…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists scan brains to unravel why effort hurts in chronic fatigue
Knowledge-focused Recruiting nowThis study uses functional MRI to see how the brain processes unpleasant sensations like pain and physical effort in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) compared to healthy volunteers. Researchers will apply mild heat and ask participants to sq…
Early phase 1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Simple skin test may spot Parkinson's risk years early
Knowledge-focused Recruiting nowThis study is testing whether a skin biopsy can detect abnormal proteins linked to Parkinson's disease in people with essential tremor, a common movement disorder. Researchers will follow 300 participants aged 50-85 for two years to see who develops Parkinson's. The goal is to fi…
Sponsor: CND Life Sciences • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists zap brain during surgery to uncover movement secrets
Knowledge-focused Recruiting nowThis study looks at how deep brain stimulation (DBS) changes movement in people with conditions like Parkinson's disease or essential tremor. About 60 people scheduled for DBS surgery will have extra temporary electrodes placed on the brain to measure muscle activity during stimu…
Sponsor: Jorge Gonzalez-Martinez • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists track rare eye disease to pave way for future treatments
Knowledge-focused Recruiting nowThis study follows 25 people aged 10 and older with Stargardt-like macular dystrophy (STDG3), a rare inherited eye disease that causes vision loss. Over three years, researchers will measure changes in the retina using eye exams, imaging, and vision tests. The goal is to understa…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Brain scans probe why some Parkinson's patients freeze Mid-Step
Knowledge-focused Recruiting nowResearchers at National Taiwan University Hospital are studying how the brain combines visual information with movement in people who have Parkinson's disease. They will compare 21 people with freezing of gait, 21 without it, and 21 healthy adults of similar age. Participants com…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists seek brain clues to impulsive and compulsive behaviors
Knowledge-focused Recruiting nowThis observational study aims to understand why some people are more impulsive or compulsive than others. Researchers will use brain scans, genetic tests, and behavioral surveys in 1,100 participants aged 6 to 80, including those with ADHD, OCD, autism, and conduct disorder. The …
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Global registry aims to map the full course of Charcot-Marie-Tooth disease
Knowledge-focused Recruiting nowResearchers are building a global registry to collect patient-reported surveys, genetic test results, and medical records from people with Charcot-Marie-Tooth disease and related inherited neuropathies. The study is open to children and adults with a confirmed or suspected diagno…
Sponsor: Hereditary Neuropathy Foundation • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
New study seeks to uncover links between ALS and dementia
Knowledge-focused Recruiting nowThis study screens 360 adults with neurodegenerative disorders like ALS, frontotemporal dementia, and progressive supranuclear palsy. Researchers will use medical history, physical exams, memory tests, movement analysis, MRI scans, and other tests to find common features and diff…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Sound waves shed light on nerve and muscle health
Knowledge-focused Recruiting nowThis study uses ultrasound, a safe imaging technique that uses sound waves, to get detailed pictures and measurements of nerves and muscles. Researchers aim to collect normal values from healthy adults and compare them with data from people who have neuromuscular disorders. The g…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
New study aims to better measure pain in NF1 patients
Knowledge-focused Recruiting nowThis study works to improve questionnaires that measure pain, daily activities, and physical function for people with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas. Participants aged 5 and older will give feedback on existing surveys through group discussions or…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists dig into why skin tumors grow in rare disease
Knowledge-focused Recruiting nowThis study looks at why people with tuberous sclerosis, a rare genetic condition, develop non-cancerous skin tumors. Researchers will examine up to 400 adults, perform skin exams, and take small tissue samples (biopsies) from tumors. The goal is to identify the cells and genetic …
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Eye fluid clues may unlock why wet AMD treatment fails for some
Knowledge-focused Recruiting nowThis study aims to find out why 20-40% of people with wet age-related macular degeneration (AMD) don't respond well to standard anti-VEGF injections. Researchers will collect fluid from inside the eye of 117 patients and compare those who respond well to treatment with those who …
Sponsor: Singapore National Eye Centre • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive heart study seeks 5,000 volunteers to uncover hidden risks
Knowledge-focused Recruiting nowThis study aims to learn more about heart and blood vessel diseases by observing people who have them or are at risk. Researchers will collect samples and perform tests like imaging and stress tests on up to 5,000 participants, including healthy volunteers and relatives of affect…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists harvest cells to grow mini retinas in lab
Knowledge-focused Recruiting nowThis study collects skin, hair, blood, urine, or saliva samples from people with certain eye diseases (like macular degeneration) and from healthy volunteers. Researchers will turn these samples into stem cells in the lab to study how the diseases develop and to test potential ne…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists seek clues to rare cancer syndrome in 5,000-Person study
Knowledge-focused Recruiting nowThis study aims to learn more about Li-Fraumeni syndrome (LFS), a genetic condition that raises the risk of several cancers. Researchers will study up to 5,000 people with LFS or related cancer histories to find new genes, understand how the TP53 gene works, and identify factors …
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive study seeks answers for rare inherited nerve diseases
Knowledge-focused Recruiting nowThis study aims to learn more about rare inherited disorders that affect the brain, spinal cord, muscles, and nerves. Researchers will collect medical history, perform exams, and run genetic tests on up to 3,500 participants. No new treatments are tested; the goal is to better un…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches study to uncover link between infections and mitochondrial disease
Knowledge-focused Recruiting nowThis study at the National Institutes of Health looks at how infections can worsen symptoms in people with mitochondrial disease, a group of disorders that affect energy production in cells. Researchers will evaluate participants' immune systems through blood tests, physical exam…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Cured of cushing as a kid? scientists want to track your health for years
Knowledge-focused Recruiting nowThis study looks at the long-term health of people who were cured of Cushing disease before age 21. Researchers want to understand how past high cortisol levels affect the body and mind years later. Participants will complete surveys and have check-ups every 5 years. The goal is …
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists hunt for better ways to spot hidden adrenal tumors
Knowledge-focused Recruiting nowThis study aims to improve how doctors find and understand pheochromocytomas and paragangliomas, rare tumors that can cause dangerous high blood pressure. Researchers will use advanced imaging scans and genetic testing in up to 3,000 participants to learn more about these tumors.…
Phase 1 • Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Brain scans may reveal how kids respond to anxiety treatment
Knowledge-focused Recruiting nowThis study looks at how the brains of children with anxiety disorders work differently from healthy children. Researchers will use brain scans and thinking tasks to track changes over a year, before and after standard treatments like therapy or medication. The goal is to find pat…
Phase 2 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists track rare brain diseases to unlock clues for future treatments
Knowledge-focused Recruiting nowThis study follows people with rare genetic disorders that cause harmful substances to build up in the body, leading to brain damage. Researchers will monitor up to 200 participants over time using exams, surveys, and lab tests. The goal is to better understand how these diseases…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists dive deep into the roots of a mysterious lung disease
Knowledge-focused Recruiting nowThis study aims to understand how lymphangioleiomyomatosis (LAM) damages the lungs at the cellular and genetic level. Researchers will follow up to 2,000 participants, including women with LAM and healthy volunteers, using advanced imaging and lab tests. The goal is to find the p…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists dive deep into endocrine tumors to unlock molecular secrets
Knowledge-focused Recruiting nowThis study enrolls people with endocrine tumors (such as thyroid, parathyroid, adrenal, or pancreatic tumors) who are scheduled for surgery or biopsy. Researchers collect samples of the tumor, nearby healthy tissue, blood, and urine to analyze genetic and molecular changes. The g…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New study tracks safety of enzyme therapy in babies with rare genetic disease
Knowledge-focused Recruiting nowThis study follows up to 10 children under 2 years old with acid sphingomyelinase deficiency (ASMD) who are already receiving olipudase alfa (Xenpozyme®) as part of their routine care. Researchers will monitor side effects and immune responses over 1 to 3 years. No new treatment …
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
First human doses of experimental drug ARO-033 begin safety testing
Knowledge-focused Recruiting nowThis study is the first time the experimental drug ARO-033 is being given to humans. Its main goal is to check the safety and tolerability of single and multiple doses in healthy adult volunteers. Researchers will also measure how the drug moves through the body. This is an early…
Phase 1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Can we map the course of a rare mitochondrial disease?
Knowledge-focused Recruiting nowThis global study follows people with POLG-related disorders, a group of rare mitochondrial conditions, to understand how the disease progresses over time. By observing clinical changes in up to 300 participants of all ages, researchers aim to identify key milestones that could s…
Sponsor: The POLG Foundation • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Millions of unpaid caregivers: study tracks hidden health toll
Knowledge-focused Recruiting nowThis study follows 2,800 unpaid caregivers of people with chronic conditions like diabetes or inherited disorders. Researchers will survey and interview caregivers over up to 5 years to track changes in their health, stress, and social support. The goal is to understand how careg…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Eye scans probe how cataract surgery shifts the vitreous gel
Knowledge-focused Recruiting nowResearchers at the University of Trieste are studying how the vitreous gel inside the eye changes after cataract surgery. They will take detailed OCT scans of 15 adults before and after the procedure, focusing on the back of the vitreous and where it meets the retina. By comparin…
Sponsor: University of Trieste • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
New study tracks safety of eplontersen in patients with liver transplants
Knowledge-focused Recruiting nowThis observational study monitors the long-term safety of eplontersen, a treatment for transthyretin amyloidosis, in patients who have had a liver transplant or have severe liver impairment. Researchers will track side effects, lab changes, and serious health events in about 320 …
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Banking blood, skin and spinal fluid to decode Parkinson's
Knowledge-focused Recruiting nowResearchers at the Luxembourg Institute of Health run a long-term observational study that gathers clinical, genetic, and digital data plus biological samples from people with Parkinson's disease and healthy volunteers. Participants include adults with typical Parkinson's or atyp…
Sponsor: Luxembourg Institute of Health • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Heart rhythm gene hunt: 2,000 patients join biobank
Knowledge-focused Recruiting nowThis study collects blood and tissue samples from 2,000 people with or without heart rhythm problems. Researchers will analyze the samples to find genetic differences linked to arrhythmias. The goal is to better understand the causes of these conditions, not to test a new treatme…
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Egypt launches major study to track rare genetic disorder NF1
Knowledge-focused Recruiting nowThis study is a disease registry that will collect information from 200 people in Egypt who have neurofibromatosis type 1 (NF1), a genetic condition that causes tumors to grow on nerves. The goal is to understand how the disease progresses over time, what treatments patients rece…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
New study tracks rare muscle disease to pave way for future treatments
Knowledge-focused Recruiting nowThis study follows 150 people aged 7 and older with RYR1-related muscle disorders for 3 to 5 years. Researchers will collect medical history, perform physical exams, and use questionnaires, activity trackers, and tests of heart, lung, and muscle function. The goal is to better un…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Could your DNA hold the key to preventing hearing loss?
Knowledge-focused Recruiting nowThis study aims to understand why people with Turner syndrome often lose their hearing. Researchers will look at genetic and epigenetic markers in 150 adults aged 18-60. Participants will have hearing, balance, blood, and imaging tests. The goal is to find new ways to treat or de…
Sponsor: Gødstrup Hospital • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Heat therapy for tremors: new study tracks Real-World results
Knowledge-focused Recruiting nowThis study is collecting information from 200 people with Parkinson's disease, dystonia, essential tremor, or other movement disorders who are scheduled to receive radiofrequency (RF) ablation—a procedure that uses heat to target small areas in the brain. The goal is to see how p…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Scientists hunt for lung disease genes in 3,500 volunteers
Knowledge-focused Recruiting nowThis study looks at how genes play a role in lung diseases like cystic fibrosis, asthma, and pulmonary fibrosis. Researchers will examine DNA from up to 3,500 people with and without lung disease to find genetic differences. The goal is to better understand what causes these cond…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Scientists launch deep dive into rare metabolic disease MMA
Knowledge-focused Recruiting nowThis study aims to learn more about methylmalonic acidemia (MMA) and related disorders by observing people with these conditions over time. Researchers will track complications, perform tests like blood draws and MRIs, and look for new genetic causes. The goal is to better unders…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
New study tracks worry in liver donors before and after surgery
Knowledge-focused Recruiting nowThis study looks at anxiety levels in 100 living liver donors before and after their surgery. Participants will fill out questionnaires to measure their worry and stress. The goal is to better understand how anxiety affects recovery and to improve care for future donors.
Sponsor: Inonu University • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Scientists seek genetic clues to mysterious fever diseases
Knowledge-focused Recruiting nowThis study aims to learn more about the genetics and natural history of autoinflammatory diseases, which cause repeated fevers and inflammation. Researchers will study up to 5,000 people, including patients, their relatives, and healthy volunteers. Participants provide blood and …
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Scientists probe the brain to unravel Suicide's mysteries
Knowledge-focused Recruiting nowThis study aims to understand what happens in the brain when someone thinks about or attempts suicide. Researchers will use brain scans, sleep monitoring, blood tests, and questionnaires to compare four groups: people with recent suicidal thoughts or attempts, those with past sui…
Phase 2 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Do Ultra-Processed meals make you eat faster and feel less full?
Knowledge-focused Recruiting nowResearchers at Ariel University are studying how the level of food processing and nutritional quality affect how much people eat, how fast they eat, how full they feel, and their blood sugar. Forty adults in Israel with a body mass index between 20 and 40 will eat three laborator…
Sponsor: Ariel University • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Magnetic pulses to the brain: can they speed up reading?
Knowledge-focused Recruiting nowResearchers at Georgia State University are studying how transcranial magnetic stimulation (TMS) affects reading speed and accuracy. About 50 adults with typical reading skills will receive either excitatory, inhibitory, or sham stimulation to a brain region called the supramargi…
Sponsor: Georgia State University • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
A genetic roadmap for Parkinson's: testing thousands to unlock clues
Knowledge-focused Recruiting nowThis study offers genetic testing and counseling to people with Parkinson's disease. Researchers aim to identify genetic mutations linked to the condition and build a large database for future research. Participants learn their genetic status, which may empower them to join clini…
Sponsor: Parkinson's Foundation • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Family DNA bank could unlock Alzheimer's secrets
Knowledge-focused Recruiting nowThis study collects blood or brain tissue from families with two or more members diagnosed with Alzheimer's or dementia. The goal is to build a large DNA bank that researchers can use to find genes linked to the disease. No individual results are returned, but the data may lead t…
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can blocking rogue immune cells stop a leading cause of blindness?
Knowledge-focused Recruiting nowThis study tests whether immune cells called monocytes from people with the atrophic form of age-related macular degeneration (AMD) survive longer on retinal cells than monocytes from healthy people. Researchers will collect blood samples from 80 participants, extract monocytes, …
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
New laser device could revolutionize eye disease detection
Knowledge-focused Recruiting nowThis study is testing a new non-invasive device that uses laser speckle to measure blood flow and structure inside the eye. Researchers will compare these images with standard vision tests in 500 people with various retinal conditions. The goal is to see if this technology can be…
Sponsor: Randy Kardon • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can MRI scans reveal the hidden fluid dynamics behind chiari malformation?
Knowledge-focused Recruiting nowThis study uses special MRI scans to measure the flow of cerebrospinal fluid and blood in the brain and spine of people with Chiari malformation. The goal is to see how these flows differ between people with symptoms and those without. Researchers will compare these measurements …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
New study aims to catch hidden brain diseases during driver Check-Ups
Knowledge-focused Recruiting nowThis study is looking for simple ways to detect early signs of multiple sclerosis and Parkinson's disease in people who drive. Researchers will test 200 drivers with these conditions using computer-based attention and reaction tests. The goal is to find quick, easy tests that cou…
Sponsor: University Hospital Olomouc • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can treating spinal muscular atrophy in the womb be safe and helpful? a new registry aims to find out
Knowledge-focused Recruiting nowThis study creates a registry of pregnancies where the fetus received a genetic diagnosis of spinal muscular atrophy (SMA) and was treated with a disease-modifying therapy while in the womb, such as risdiplam. Researchers will collect information from medical records and question…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Scientists launch major study to unlock secrets of deadly batten disease
Knowledge-focused Recruiting nowThis study follows 300 people with CLN3 Batten disease, a rare genetic disorder that causes vision loss, seizures, and decline in thinking and movement. Researchers collect samples like blood and spinal fluid to find biological markers that could be used in future treatment trial…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
New study tracks pregnancy safety of rare disease drug
Knowledge-focused Recruiting nowThis study monitors pregnancy outcomes in women who took patisiran-LNP for hereditary ATTR amyloidosis. Researchers will track birth defects, pregnancy complications, and infant health. The goal is to better understand the drug's safety during pregnancy, not to test a new treatme…
Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Scientists hunt for genetic clues behind childhood pituitary tumors
Knowledge-focused Recruiting nowThis study aims to uncover the genetic causes of pituitary and hypothalamic tumors in children. Researchers will collect blood and tumor samples from up to 2,000 participants to analyze DNA and look for inherited patterns. The study also trains doctors and tests new MRI technique…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Massive global study aims to unlock secrets of rare heart and nerve disease
Knowledge-focused Recruiting nowThis observational study will follow 1,500 people with ATTR amyloidosis, a rare disease that damages the heart and nerves, for many years. Researchers will track how the disease progresses, how patients are treated in real-world settings, and the safety of two approved drugs, pat…
Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Scientists launch eye tissue bank to unlock secrets of retinal disease
Knowledge-focused Recruiting nowThis study is creating a large collection of health information and biological samples (like blood, saliva, and eye tissue) from people with and without retinal diseases. Researchers aim to use this database to better understand conditions like age-related macular degeneration an…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Massive study tracks rare eye diseases to pave way for future treatments
Knowledge-focused Recruiting nowThis international study aims to collect genetic and health information from 1,500 people with rare inherited retinal diseases like retinitis pigmentosa. It has two parts: a registry to gather genetic and vision data, and a natural history study that follows participants over tim…
Sponsor: Jaeb Center for Health Research • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can early markers predict how atypical Parkinson's diseases progress?
Knowledge-focused Recruiting nowThis observational study follows 500 people with atypical parkinsonian syndromes, including multiple system atrophy, dementia with Lewy bodies, progressive supranuclear palsy, and corticobasal degeneration. Researchers track motor and non-motor symptoms and imaging changes every …
Sponsor: Second Affiliated Hospital of Soochow University • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Half a million people join quest to decode Parkinson's risk
Knowledge-focused Recruiting nowThis observational study collects health information from up to 500,000 adults with and without Parkinson's disease. Researchers aim to identify risk factors and early signs that predict who may develop the disease and how it progresses. Participants report their symptoms and med…
Sponsor: Michael J. Fox Foundation for Parkinson's Research • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Major study launches to unravel Parkinson's mysteries in patients with persistent movement problems
Knowledge-focused Recruiting nowThis study follows 300 people with Parkinson's disease who still have movement symptoms despite taking standard medications. Researchers will collect data over up to 5 years through questionnaires, diaries, medical records, blood samples, and a digital device. The goal is to bett…
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Can a gene biobank unlock better cancer screening for Li-Fraumeni families?
Knowledge-focused Recruiting nowThis study creates a database and biobank for people with Li-Fraumeni syndrome or related TP53 gene changes, conditions that raise the lifetime risk of cancer to as high as 90%. Researchers will collect clinical data, blood samples, and tumor tissue from up to 300 participants to…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Left vs. right brain stimulation: which side affects thinking more?
Knowledge-focused Recruiting nowThis study investigates how deep brain stimulation (DBS) affects cognitive and psychiatric symptoms in people with Parkinson's disease. Researchers will compare the effects of stimulating the left versus the right hemisphere of the brain on tasks like verbal fluency and impulsivi…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Scientists hunt for biomarkers to unlock DM1 treatments
Knowledge-focused Recruiting nowThis study follows 1,000 adults with myotonic dystrophy type 1 (DM1) over time to measure how the disease progresses. Researchers will track walking speed, hand muscle relaxation, grip strength, heart and lung function, and daily activity. The goal is to establish reliable biomar…
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
New study tracks eye disease progression in older adults
Knowledge-focused Recruiting nowThis study observes 75 adults aged 55 and older with geographic atrophy (a late stage of age-related macular degeneration) to see how the condition progresses over a short time. Researchers will measure changes in eye structure and function, and explore links to genetics and life…
Sponsor: Complement Therapeutics • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can a global patient registry unlock the secrets of a rare breathing disorder?
Knowledge-focused Recruiting nowResearchers are building an international registry to collect health information from people with congenital central hypoventilation syndrome (CCHS), a rare condition that affects breathing control. The study asks patients with a confirmed PHOX2B gene mutation to fill out surveys…
Sponsor: Ilya Khaytin • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
A clogged artery behind dry macular degeneration? a new scan puts it to the test
Knowledge-focused Recruiting nowResearchers are investigating whether narrowing of the ophthalmic artery, which supplies blood to the eye, contributes to geographic atrophy, an advanced form of dry age-related macular degeneration. The study will use a noninvasive imaging technique called PC-CTA to measure arte…
Sponsor: Scott Raymond • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
5,000 patient records to reveal Real-World impact of brain stimulation
Knowledge-focused Recruiting nowThis study reviews the medical records of up to 5,000 people who have received deep brain stimulation (DBS) for Parkinson's disease, essential tremor, or dystonia. Researchers want to see how well DBS improves symptoms over time in real-world settings. No new treatments are given…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Brain zap study reveals how DBS shapes impulse control in Parkinson's
Knowledge-focused Recruiting nowThis study looks at how deep brain stimulation (DBS) affects the ability to stop actions in people with Parkinson's disease. Researchers will measure brain waves and behavior during impulse control tasks before, during, and after DBS surgery. The goal is to understand how stimula…
Phase 4 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New study tracks Risdiplam's Real-World impact on spinal muscle atrophy
Knowledge-focused Recruiting nowThis study will observe 30 children with type I or type II spinal muscle atrophy who are taking risdiplam. Researchers will track motor function improvements over 24 months using standard tests. The goal is to see how well the drug works in everyday medical practice.
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can blood markers predict the course of a rare muscle disease?
Knowledge-focused Recruiting nowThis study follows 50 adults with facioscapulohumeral muscular dystrophy type 2 (FSHD2), a rare inherited muscle disease, for 18 months. Researchers will measure muscle function and severity using standard clinical tests and collect blood samples to look for markers that might pr…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can a 45-Minute iPad test unlock how CCHS affects the brain?
Knowledge-focused Recruiting nowThis study measures thinking, memory, and attention in people with congenital central hypoventilation syndrome (CCHS), a rare condition that can reduce oxygen to the brain. Participants complete a 45-minute app-based cognitive assessment on an iPad, and parents or adult participa…
Sponsor: Ilya Khaytin • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New kidney drug candidate SK-09 enters first human safety tests
Knowledge-focused Recruiting nowThis early-stage study is testing a new oral drug called SK-09 in 72 healthy adults to see if it is safe and how the body processes it. The study is split into two parts: one where participants get a single dose, and another where they get multiple doses. No one knows who gets th…
Phase 1 • Sponsor: Consun Pharmaceutical Group • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can a worldwide patient registry unlock better treatments for angelman syndrome?
Knowledge-focused Recruiting nowThis study builds a global online registry to collect long-term health information from children and adults with Angelman Syndrome. Parents and caregivers report on diagnosis, symptoms, and daily functioning over time. The goal is to better understand the condition's natural cour…
Sponsor: Foundation for Angelman Syndrome Therapeutics, Australia • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New study hopes to spot cancer early in NF1 patients
Knowledge-focused Recruiting nowThis study is for people aged 3 and older with neurofibromatosis type 1 (NF1), a genetic condition that often causes noncancerous nerve tumors. About half of people with NF1 get these tumors, and sometimes they turn cancerous. Researchers want to test a new method to predict whic…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Can exercise dose alter BDNF levels in Parkinson's patients?
Knowledge-focused Recruiting nowThis pilot study tests whether different volumes of aerobic exercise produce different changes in a blood marker called BDNF, which supports brain health. Researchers will enroll 30 adults with Parkinson's disease and assign them to either a standard rehabilitation program (180 M…
Sponsor: Casa di Cura San Raffaele Cassino • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Blood test may spot colon cancer return months before scans
Knowledge-focused Recruiting nowThis study follows 392 people with stage I-III colon cancer who have had surgery to remove their tumor. Researchers will take blood samples at regular intervals over three years to look for tiny pieces of tumor DNA, called molecular residual disease (MRD). The goal is to see if a…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
AI hunts for early clues to Parkinson's and Alzheimer's progression
Knowledge-focused Recruiting nowThis study follows 600 people with neurodegenerative diseases such as Parkinson's, Alzheimer's, and related conditions over 1 to 10 years. Researchers collect data from routine clinical exams, brain imaging, movement analysis, and blood tests. They use statistical tools and artif…
Sponsor: Casa di Cura San Raffaele Cassino • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
New study tracks heart disease in rare genetic disorder
Knowledge-focused Recruiting nowThis study follows 65 people with Friedreich ataxia who also have a thickened heart muscle (cardiomyopathy). Researchers will measure changes in heart structure over time using imaging. The goal is to better understand how heart disease progresses in this condition, which could h…
Sponsor: Lexeo Therapeutics • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Brain scans reveal how stuttering kids process speech differently
Knowledge-focused Recruiting nowThis study looks at how children who stutter process speech sounds compared to children who do not stutter. Researchers will use hearing tests, brain wave recordings (EEG), and brain scans (fMRI) to measure brain activity. The goal is to understand the differences in speech proce…
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Painless muscle test could change how we track nerve diseases
Knowledge-focused Recruiting nowThis study is testing a new, painless device called electrical impedance myography (EIM) to measure muscle health. Researchers will use it on healthy volunteers and people with neuromuscular diseases to see how well it works compared to standard tests like ultrasound and nerve st…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
NF2 patients wanted for Decade-Long observation study
Knowledge-focused Recruiting nowThis study follows 269 people with neurofibromatosis type 2 (NF2) for up to 10 years to learn how the disease progresses. Participants will have yearly exams, MRI scans, hearing tests, and blood draws. The goal is to understand tumor growth, hearing loss, and speech or swallowing…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Can a 25-Year global study unlock the secrets of friedreich ataxia?
Knowledge-focused Recruiting nowThis study follows 3,000 people with Friedreich ataxia, a rare inherited disease that affects movement and coordination, to map how the condition changes over time. Researchers will measure symptoms yearly using standard rating scales for up to 25 years. The goal is to build a de…
Sponsor: Friedreich's Ataxia Research Alliance • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Can a blood bank unlock the genetics of brain disease?
Knowledge-focused Recruiting nowResearchers at the University of Pennsylvania are building a large repository of blood, DNA, and family history data from people with age-related brain diseases like Alzheimer's, Parkinson's, and ALS, as well as their family members. The goal is to support studies into the geneti…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Can a massive natural history study unlock the secrets of rare movement disorders?
Knowledge-focused Recruiting nowThis study follows thousands of people with ataxia, hereditary spastic paraplegia, and spastic ataxia, rare conditions that cause progressive problems with walking, balance, and coordination. Researchers will track how symptoms evolve using clinical exams, patient reports, digita…
Sponsor: Heidelberg University • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Registry aims to unlock secrets of rare brain tumor in NF1 patients
Knowledge-focused Recruiting nowThis study creates a registry of medical records, scans, and surveys from adults with neurofibromatosis type 1 (NF1) who also have a glioma brain tumor. Researchers will track diagnosis, treatments, and quality of life over time to better understand the disease. The goal is to im…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Simple eye tests in your GP's office could save your sight
Knowledge-focused Recruiting nowThis study is testing whether a simple vision screening program in general practice can help detect vision loss early in adults over 70 who have at least one chronic condition. Participants will have three vision tests done by their GP or nurse, then visit a collaborating opticia…
Sponsor: University of Copenhagen • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Can treating a hidden hormone problem after brain injury restore quality of life?
Knowledge-focused Recruiting nowThis study looks at adults who had a traumatic brain injury at least a year ago. Researchers want to see whether those with growth hormone deficiency have worse quality of life, fatigue, mood, and sleep than those without it. Participants complete questionnaires and a test for gr…
Sponsor: University of Calgary • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Hidden heart risk: study aims to catch deadly protein buildup before symptoms start
Knowledge-focused Recruiting nowThis study is looking for early signs of heart amyloidosis in Black adults who carry a specific gene change (V122I TTR) that raises their risk. Researchers will use heart MRI scans and blood tests to detect protein buildup before symptoms appear. The goal is to find ways to diagn…
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Night vision test could reveal severity of eye disease
Knowledge-focused Recruiting nowThis study looks at how well people with retinal diseases like retinitis pigmentosa and Stargardt's disease see in the dark. Researchers want to find out if measuring dark adaptation can help detect and track these conditions. Healthy volunteers and people with retinal disease ag…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Sleep disorder may hold the key to spotting Parkinson's years earlier
Knowledge-focused Recruiting nowThis study looks at people with REM sleep behavior disorder (RBD), a condition where people act out their dreams and which often leads to Parkinson's disease. Researchers will use advanced brain imaging, sleep tests, and physical exams to compare 50 people with RBD to 50 healthy …
Sponsor: Danish Research Centre for Magnetic Resonance • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Can a questionnaire reveal the hidden burden of a rare genetic disease in women?
Knowledge-focused Recruiting nowThis study looks at women who carry the gene for X-linked adrenoleukodystrophy (X-ALD), a rare inherited condition that mainly affects the nervous system. Although the disease is linked to the X chromosome, up to 80% of female carriers may develop symptoms like leg weakness and b…
Sponsor: Leipzig University Medical Center • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Can a national biobank network end the diagnostic odyssey for rare diseases?
Knowledge-focused Recruiting nowThis study aims to create a network of biobanks across Italy that collect and store biological samples and health data from people with rare diseases and their families. The goal is to standardize how samples are collected and shared, so researchers can access high-quality materi…
Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Mapping the Brain's electrical signals to improve surgical precision
Knowledge-focused Recruiting nowThis study aims to build a comprehensive 'physiological brain atlas' by collecting electrical and other data from patients undergoing stereotactic brain surgery for conditions like Parkinson's disease, OCD, and epilepsy. The goal is to map this information onto a standard brain t…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
Can a simple test capture Parkinson's physical decline?
Knowledge-focused Recruiting nowThis observational study aims to paint a detailed picture of the physical, cognitive, and clinical characteristics of people with Parkinson's disease in Galicia, Spain. Researchers will also test whether a short physical performance battery (SPPB) is a reliable and valid tool for…
Sponsor: University of Vigo • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Could a breath test reveal Parkinson's risk?
Knowledge-focused Recruiting nowThis study explores whether methane gas produced by gut microbes is linked to the progression of Parkinson's disease and related conditions like dementia. Researchers will measure breath methane levels in 200 adults—including those with Parkinson's, those at high risk (REM sleep …
Sponsor: University of Cambridge • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
A window into the eye: could functional tests predict macular degeneration progression?
Knowledge-focused Recruiting nowThis study investigates whether specialized visual function tests can detect early changes in people with early or intermediate age-related macular degeneration (AMD). Researchers will follow 120 adults with good visual acuity but early signs of AMD, using tests like microperimet…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Can brain scans unlock the secret to Alzheimer's resilience?
Knowledge-focused Recruiting nowThis study investigates why some people with early-onset Alzheimer's disease or a variant called posterior cortical atrophy show different patterns of brain damage. Using advanced PET and MRI scans, researchers will map tau protein deposits and brain network activity to identify …
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Can 30,000 patients reveal Parkinson's hidden patterns?
Knowledge-focused Recruiting nowThis study follows a large group of people with Parkinson's disease and related conditions in France to map how the disease unfolds over time. Researchers collect detailed information on symptoms, treatments, and genetic samples at regular visits. The goal is to identify distinct…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Is the standard antibiotic dose enough to protect brain shunts?
Knowledge-focused Recruiting nowThis study looks at whether a standard dose of the antibiotic cefazolin, given before surgery to place a ventricular shunt, reaches high enough levels in the cerebrospinal fluid to prevent infection. Researchers will measure cefazolin in the fluid and blood of 15 adults undergoin…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Liver clues: a new way to stage heart amyloidosis?
Knowledge-focused Recruiting nowThis study looks at whether liver function and blood clotting tests can help doctors better understand and monitor cardiac transthyretin amyloidosis (ATTR-CA), a condition where abnormal protein builds up in the heart. Researchers will compare these tests in people with ATTR-CA a…
Sponsor: University of Messina • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Can a simple test predict Alzheimer's before symptoms worsen?
Knowledge-focused Recruiting nowThis study aims to understand brain changes in people with mild cognitive impairment (MCI) and Alzheimer's disease. Researchers will use MRI, EEG, cognitive tests, and blood and stool samples to find differences between healthy individuals and those with cognitive impairment. The…
Sponsor: Norwegian University of Science and Technology • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Can we decode the hidden subtypes of early Parkinson's?
Knowledge-focused Recruiting nowThis study investigates the biological mechanisms behind young-onset Parkinson's disease, which begins before age 50. Researchers will analyze genetic tests and protein markers in spinal fluid and skin biopsies from 250 participants to identify distinct disease subtypes. The goal…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Can we measure the progression of childhood myotonic dystrophy well enough to test new therapies?
Knowledge-focused Recruiting nowThis study follows children with congenital or childhood myotonic dystrophy over time to see how their symptoms change. Researchers will test a range of assessments, from walking speed and hand strength to language and quality of life, to find the best ways to measure the disease…
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Worldwide data pool could pave the way for mitochondrial disease trials
Knowledge-focused Recruiting nowThis study creates a global registry for people with mitochondrial disorders—rare diseases that affect energy production in cells. By collecting health data from 6,000 participants worldwide, researchers aim to understand how these diseases progress and identify the best ways to …
Sponsor: LMU Klinikum • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Can a family registry crack the code of inherited pancreatic cancer?
Knowledge-focused Recruiting nowThis study is a large registry that collects health and genetic information from people with a personal or family history of pancreatic tumors. The goal is to find the genes and other factors that cause pancreatic cancer to run in some families. By studying thousands of participa…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Rare disease mystery: can tracking SPLIS patients unlock its secrets?
Knowledge-focused Recruiting nowThis study follows people with SPLIS, a rare inherited metabolic condition, to map its natural history—how the disease unfolds over time. Researchers will track growth, organ function, quality of life, and survival in about 28 participants. The goal is to understand the full rang…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
A protein clue in the fight against muscular dystrophy?
Knowledge-focused Recruiting nowThis study looks at whether levels of a protein called HMGB1 are different in people with LAMA2-related muscular dystrophy, a condition that causes severe muscle weakness. Researchers will measure HMGB1 in blood and muscle samples already collected from about 25 patients. The goa…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Can eye tests track an inherited form of blindness?
Knowledge-focused Recruiting nowThis study follows people with a genetic condition called OPA1-associated optic atrophy, which causes gradual vision loss. Researchers will use a battery of eye exams—including vision charts, contrast sensitivity, and retinal imaging—to see how the disease changes over time. The …
Sponsor: Ludwig-Maximilians - University of Munich • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Tracking the emotional toll of a cancer diagnosis: when does anxiety peak?
Knowledge-focused Recruiting nowThis study follows adults with a suspected bone or soft tissue tumor to see how their stress and anxiety levels change at three critical moments: before biopsy, after learning the diagnosis, and when treatment begins. Participants fill out standard questionnaires about anxiety, d…
Sponsor: Istanbul University • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Parkinson's gene mutation may raise cancer risk – large study investigates
Knowledge-focused Recruiting nowThis large observational study is investigating whether people with Parkinson's disease who carry a mutation in the GBA1 gene have a higher chance of developing cancer. Researchers will compare cancer rates in this group to those in Parkinson's patients without the mutation and t…
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?
Knowledge-focused Recruiting nowThis study is testing whether a non-invasive eye scan called optical coherence tomography (OCT) can help track neurological diseases like multiple sclerosis, Alzheimer's, Parkinson's, and migraine. Over two years, researchers will measure the thickness of retinal layers in 840 pa…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Scientists probe the mysterious crash that defines ME/CFS
Knowledge-focused Recruiting nowThis study investigates post-exertional malaise (PEM), the hallmark symptom of ME/CFS, where even minor activity triggers severe symptom worsening. Researchers will compare 50 ME/CFS patients with 50 healthy volunteers matched by age, sex, and activity level. Participants undergo…
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
PET scans reveal hidden brain inflammation in rare movement disorder
Knowledge-focused Recruiting nowThis study uses advanced PET scans and blood tests to examine brain inflammation and white matter damage in people with corticobasal syndrome, a rare movement and thinking disorder. Researchers will compare these brain changes across different subtypes of the condition and agains…
Sponsor: Jennifer Whitwell • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Genetic clues to mysterious childhood movement disorders in vietnam
Knowledge-focused Recruiting nowThis study looks at children in Vietnam who have movement disorders—like tremors, jerks, or coordination problems—with no known cause. Researchers will collect medical information and blood samples to search for genetic changes that might explain these conditions. The goal is to …
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Brain zaps reveal secrets of movement in Parkinson's
Knowledge-focused Recruiting nowThis study investigates how a small brain region called the subthalamic nucleus controls movement in both healthy people and those with Parkinson's disease. Researchers will measure brain cell activity and electrical signals during arm movements and walking to understand why move…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
PET scans reveal how inflammation drives Alzheimer's variants
Knowledge-focused Recruiting nowThis study uses special PET scans to measure brain inflammation and tau protein buildup in people with different forms of Alzheimer's disease, including those with memory, vision, or language problems. Researchers aim to understand how inflammation relates to other brain changes …
Phase 2 • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Massive global registry aims to unlock secrets of rett syndrome
Knowledge-focused Recruiting nowThis study creates a large registry of people with Rett syndrome, a rare genetic disorder that causes severe intellectual and physical disabilities. Researchers will collect information from doctors and caregivers to understand how the disease progresses over time. The goal is to…
Sponsor: International Rett Syndrome Foundation • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Family study aims to unlock secrets of rare genetic brain disorder
Knowledge-focused Recruiting nowThis study looks at how differences in the NOTCH2NLC gene affect the symptoms and course of neuronal intranuclear inclusion disease (NIID), a rare inherited brain disorder. Researchers will follow 12 members of one family, including those with NIID, gene carriers without symptoms…
Sponsor: Sichuan Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Teamwork takedown: GPs and pharmacists join forces to curb risky pill use in seniors
Knowledge-focused Recruiting nowThis study tests whether having a general practitioner and pharmacist work together can help people aged 65 and older safely stop or reduce benzodiazepines (drugs for sleep or anxiety). These medications raise the risk of falls, confusion, and dementia in older adults. The trial …
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Global study tracks rare muscle disease to pave way for future treatments
Knowledge-focused Recruiting nowThis study follows children and adults worldwide who have a rare genetic muscle disease called TNNT1 myopathy. Researchers aim to document how the disease progresses over time, including survival and motor milestones. The goal is to identify reliable measures that can be used in …
Sponsor: Clinic for Special Children • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Scientists map cognitive profiles in rare brain disorder to personalize rehabilitation
Knowledge-focused Recruiting nowThis study investigates the specific cognitive strengths and weaknesses of children and adults with Sturge-Weber Syndrome (SWS), a rare condition affecting blood vessels in the brain, skin, and eyes. Participants complete a series of tests measuring memory, attention, language, a…
Sponsor: University of Roma La Sapienza • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can surgery go green? study measures carbon footprint of common orthopedic operations
Knowledge-focused Recruiting nowThis study compares carbon dioxide emissions from orthopedic surgeries performed with different materials and setups. Researchers will track waste, energy use, and sterilization methods for procedures like carpal tunnel release or wound revision. The goal is to identify ways to r…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can we predict who will lose their sight? new study aims to find out
Knowledge-focused Recruiting nowThis study is following 1,500 adults aged 55 and older to learn how early age-related macular degeneration (AMD) turns into the advanced form that can cause vision loss. Researchers will use eye imaging, genetic tests, and other measurements to find clues that predict progression…
Sponsor: Singapore National Eye Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Gene study aims to decode rare nerve disorder variations
Knowledge-focused Recruiting nowThis study looks at how different mutations in the MORC2 gene lead to different symptoms, from Charcot-Marie-Tooth disease to a more complex condition called DIFGAN. Researchers will collect skin and blood samples from 45 participants to measure epigenetic and genetic markers. Th…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Cheaper eye drug could save millions in AMD treatment costs
Knowledge-focused Recruiting nowThis study looks at three drugs (bevacizumab, ranibizumab, and aflibercept) used to treat age-related macular degeneration (AMD), a leading cause of blindness in older adults. Researchers will analyze costs and quality of life for 600 patients in France to see which treatment off…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New registry aims to unlock secrets of rare Kidney-Liver diseases
Knowledge-focused Recruiting nowThis study is creating a central database and tissue bank for rare diseases affecting the kidneys and liver, such as ARPKD and Joubert syndrome. Researchers will collect medical information, genetic samples, and tissues from 200 participants to help doctors and scientists better …
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study tracks rare brain disease in china to unlock its secrets
Knowledge-focused Recruiting nowThis study follows 214 people in China with multiple system atrophy, a rare and fast-worsening brain disease that affects movement and automatic body functions. Researchers will track symptoms over time to learn how the disease progresses and what factors influence it. The goal i…
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Small study probes brain chemical differences in genetic Parkinson's
Knowledge-focused Recruiting nowThis study looks at how a specific gene change (LRRK2 mutation) affects brain chemicals in people with Parkinson's disease. Researchers will compare 15 participants with the mutation to others without it using brain scans, thinking tests, and movement tests. The goal is to better…
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Scientists launch study to map rare baker gordon syndrome from childhood to adulthood
Knowledge-focused Recruiting nowThis study follows 50 children and adults with Baker Gordon Syndrome, a rare genetic disorder, to track how the condition changes over time. Participants will undergo brain scans, EEGs, and genetic testing, and complete developmental assessments. The goal is to create better tool…
Sponsor: University of Missouri-Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Nighttime seizures and dreams: new study probes the link
Knowledge-focused Recruiting nowThis study looks at how epileptic brain activity during sleep can cause awakenings and change dream recall or content. Researchers will use tiny electrical pulses in the brain during sleep to trigger mild epileptic activity and observe the effects. The goal is to better understan…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC